|
|
Page No. |
|
|
|
1 |
|
|
1 |
|
|
1 |
|
|
1 |
|
A. |
[Reserved]. |
1 |
|
B. |
Capitalization and Indebtedness. |
1 |
|
C. |
Reasons for the Offer and Use of Proceeds. |
1 |
|
D. |
Risk Factors. |
1 |
|
|
14 |
|
A. |
History and Development of the Company. |
14 |
|
B. |
Business Overview. |
15 |
|
C. |
Organizational Structure. |
24 |
|
D. |
Property, Plants and Equipment. |
24 |
|
|
24 |
|
|
24 |
|
A. |
Operating Results. |
24 |
|
B. |
Liquidity and Capital Resources |
30 |
|
C. |
Research and Development, Patents and Licenses. |
33 |
|
D. |
Trend Information. |
34 |
|
E. |
Critical Accounting Estimates. |
34 |
|
|
37 |
|
A. |
Directors and Senior Management. |
37 |
|
B. |
Compensation |
40 |
|
C. |
Board Practices |
41 |
|
D. |
Employees |
51 |
|
E. |
Share Ownership. |
52 |
|
F. |
Disclosure of a registrant’s action to recover erroneously awarded compensation |
53 |
|
|
54 |
|
A. |
Major Shareholders |
54 |
|
B. |
Related Party Transactions. |
54 |
|
C. |
Interests of Experts and Counsel. |
54 |
|
|
55 |
|
A. |
Consolidated Statements and Other Financial Information. |
55 |
|
B. |
Significant Changes. |
56 |
|
|
56 |
|
A. |
Offer and Listing Details. |
56 |
|
B. |
Plan of Distribution. |
56 |
|
C. |
Markets. |
56 |
|
D. |
Selling Shareholders. |
56 |
|
E. |
Dilution. |
56 |
|
F. |
Expenses of the Issue. |
56 |
|
|
56 |
|
A. |
Share Capital. |
56 |
|
B. |
Memorandum and Articles of Association. |
56 |
|
C. |
Material Contracts. |
58 |
|
D. |
Exchange Controls. |
58 |
|
E. |
Taxation. |
58 |
|
F. |
Dividends and Paying Agents. |
65 |
|
G. |
Statements by Experts. |
65 |
|
H. |
Documents on Display. |
65 |
|
I. |
Subsidiary Information. |
66 |
|
J. |
Annual Report to Security Holders |
66 |
|
|
66 |
|
|
66 |
|
|
66 |
|
|
66 |
|
|
66 |
|
|
67 |
|
|
67 |
|
|
67 |
|
|
68 |
|
|
68 |
|
|
68 |
|
|
68 |
|
|
69 |
|
|
69 |
|
|
69 |
|
|
69 |
|
|
69 |
|
|
69 |
|
|
69 |
|
|
70 |
INTRODUCTION
We are a leading international
provider of comprehensive physical, video, and access control security products and solutions. We offer comprehensive solutions for critical
sites, which leverage our broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS (Video Management Software)
with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies.
Based on our multi-decade
industry experience and interaction with customers, we have developed a comprehensive set of solutions and products, optimized for perimeter,
outdoor, and general security applications. Our broad portfolio of critical infrastructure protection and site protection technologies
includes a variety of smart barriers and fences, fence mounted sensors, virtual gates, buried and concealed detection systems, and sophisticated
sensors for sub-surface intrusion such as to secure pipelines, as well as advanced video analytics software and video management systems.
We have successfully installed customized solutions and products in more than 100 countries worldwide.
On June 30, 2021, we
completed the sale of our Integration Solution Division to Aeronautics Ltd., a subsidiary of RAFAEL Advanced Defense Systems Ltd., in
a share and asset purchase agreement for a total consideration of $35 million in cash, on a cash-free, debt-free basis. As part of the
acquisition, Aeronautics acquired our facility in Yehud, Israel.
Following the sale of
the Integrated Solutions (Project) Division, we changed our name to Senstar Technologies Ltd. (formerly known as Magal Security Systems
Ltd.) and focused our business on providing comprehensive physical, video and access control security products and solutions, with development
and manufacturing facilities located in Canada and sales and support offices in the US, EMEA, China and APAC regions as well as in Canada.
Our ordinary shares are
traded on the NASDAQ Global Market under the symbol “SNT.” Our website is www.senstartechnologies.com. The information on
our website is not incorporated by reference into this annual report. As used in this annual report, the terms “we,” “us,”
“our,” and “Senstar” mean Senstar Technologies Ltd. and its subsidiaries, unless otherwise indicated.
AIMETIS SYMPHONY, FIBERPATROL,
FLARE, FLEXPI, FLEXZONE, OMNITRAX, PINPOINTER, SENNET, SENSTAR, SENTIENT, ULTRAWAVE and XFIELD are our registered trademarks.
ARMOURFLEX, ENTERPRISE
MANAGER, INTELLI-FLEX, INTELLIFIBER, LM100, NETWORK MANAGER, STARLED, STARNET, SENSTAR CARE, SENSTAR logo, SENSTAR SYMPHONY, SENSTAR SAFE
SPACES and SENSTAR SENSOR FUSION, and all other marks used to identify particular products and services associated with our businesses
are trademarks. Any other trademarks and trade names appearing in this annual report are owned by their respective holders.
Our consolidated financial
statements appearing in this annual report are prepared in U.S. dollars and in accordance with generally accepted accounting principles
in the United States, or U.S. GAAP. All references in this annual report to “dollars” or “$” are to U.S. dollars,
all references to “NIS” are to New Israeli Shekels and all references to “CAD” are to Canadian dollars.
Statements made in this
annual report concerning the contents of any contract, agreement or other document are summaries of such contracts, agreements or documents
and are not complete descriptions of all of their terms. If we filed any of these documents as an exhibit to this annual report or to
any registration statement or annual report that we previously filed, you may read the document itself for a complete description of its
terms.
This Annual Report on
Form 20-F contains various “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and within the Private Securities Litigation Reform Act of
1995, as amended. Such forward-looking statements reflect our current view with respect to future events and financial results. Forward-looking
statements usually include the verbs, “anticipates,” “believes,” “estimates,” “expects,”
“intends,” “plans,” “projects,” “understands” and other verbs suggesting uncertainty.
We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors
and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry
results, to be materially different from any future results, performance, levels of activity, or our achievements expressed or implied
by such forward- looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. We undertake no obligation to publicly release any revisions to these forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. We have attempted to identify additional
significant uncertainties and other factors affecting forward-looking statements in the Risk Factors section which appears in Item 3.D
“Key Information -- Risk Factors.”
PART
I
ITEM 1. IDENTITY
OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
Not applicable.
ITEM 2. OFFER
STATISTICS AND EXPECTED TIMETABLE
Not applicable.
ITEM 3. KEY
INFORMATION
B. |
Capitalization and Indebtedness. |
Not
applicable.
C. |
Reasons for the Offer and Use of Proceeds. |
Not
applicable.
Investing
in our ordinary shares involves a high degree of risk and uncertainty. You should carefully consider the risks and uncertainties described
below before investing in our ordinary shares. If any of the following risks actually occurs, our business, prospects, financial condition
and results of operations could be harmed. In that case, the value of our ordinary shares could decline, and you could lose all or part
of your investment. These risks include, but are not limited to, the following:
Risks Related to Macroeconomic
Conditions
|
• |
Our operations have been negatively impacted by the global supply-chain challenges. |
|
• |
Our business, financial condition, results of operations, and cash flow may in the future be negatively impacted by challenging global
economic conditions. |
|
• |
The continuing effects of the COVID-19 pandemic are highly unpredictable and could be significant, and the duration and extent
to which this will impact our future results of operations and overall financial performance remains uncertain. |
Risks Related to Our
Business and Our Industry
|
• |
While we were profitable in 2022, we have incurred major losses in past years and may not operate profitably in the future.
|
|
• |
Our operating results may fluctuate from quarter to quarter and year to year. |
|
• |
Our financial results may be significantly affected by currency fluctuations. |
|
• |
We may make additional acquisitions in the future that could disrupt our operations and harm our operating results. |
|
• |
Our revenues depend in great measure on government procurement procedures and practices. A substantial decrease in our end-user’s
budgets would adversely affect our results of operations. |
|
• |
Because competition in our industry is intense, our business, operating results and financial condition may be adversely affected.
|
|
• |
Our business involves significant risks and uncertainties that may not be covered by indemnities or insurance. |
|
• |
The markets for our products may be affected by changing technology, requirements, standards and products, and we may be adversely
affected if we do not respond promptly and effectively to these changes. |
|
• |
Increasing scrutiny and changing expectations with respect to our ESG policies may impose additional costs on us or expose us to
additional risks. |
|
• |
Our failure to retain and attract personnel could harm our business, operations and product development efforts. |
|
• |
We face risks associated with doing business in international markets. |
|
• |
Our failure to comply with anti-corruption laws and regulations could adversely affect our reputation, business, financial condition
and results of operations. |
|
• |
We may be vulnerable to physical and electronic security breaches and cyber-attacks which could disrupt our operations and have a
material adverse effect on our financial performance and operating results. |
|
• |
We may not be able to protect our proprietary technology and unauthorized use of our proprietary technology by third parties may
impair our ability to compete effectively. |
|
• |
Claims that our products infringe upon the intellectual property of third parties may require us to incur significant costs, enter
into licensing agreements or license substitute technology. |
|
• |
Undetected defects in our products may increase our costs and harm the market acceptance of our products. |
|
• |
If suppliers terminate our arrangements with them, or amend them in a manner detrimental to us, we may experience delays in production
and implementation of our products and our business may be adversely affected. |
|
• |
We currently benefit from government programs and tax benefits that may be discontinued or reduced in the future, which would increase
our future tax expenses. |
|
• |
We may fail to maintain effective internal control over financial reporting, which could result in material misstatements in our
financial statements. |
|
• |
We may be adversely affected by regulations and market expectations related to sourcing and our supply chain, including conflict
minerals. |
Risks Relating to Our Ordinary Shares
|
• |
Volatility of the market price of our ordinary shares could adversely affect our shareholders and us. |
|
• |
We may not pay additional dividends in the future. |
|
• |
As a foreign private issuer whose shares are listed on the NASDAQ Global Market, we may follow certain home country corporate governance
practices instead of certain NASDAQ requirements. |
|
• |
We may in the future be classified as a passive foreign investment company, or PFIC, which would subject our U.S. investors to adverse
tax rules. |
Risks Relating to Our Location in Israel
|
• |
Political, economic and military instability in Israel may negatively affect our business condition, harm our results of operations
and adversely affect our share price. |
|
• |
The rights and responsibilities of the shareholders are governed by Israeli law and differ in some respects from the rights and responsibilities
of shareholders under U.S. law. |
|
• |
Provisions of Israeli law may delay, prevent or make difficult a change of control and therefore depress the price of our shares.
|
|
• |
Our shareholders generally may have difficulties enforcing a U.S. judgment against us, our executive officers and directors and some
of the experts named in this annual report or asserting U.S. securities law claims in Israel. |
Risks Related to Macroeconomic Conditions
Our operations have been negatively impacted
by the global supply-chain challenges.
Our
operations have been negatively affected by the worldwide shortage of various materials and sub-components required to produce certain
of our products. This negative effect continue influence us in 2022. We are monitoring the impact of the supply chain shortage against
our ongoing and forecasted manufacturing requirements, while implementing various procurement methodologies to meet current and forecasted
demand for our products. Our ability to continue meeting the demand for our products is dependent among others, on our ability to maintain
an effective procurement plan support from our suppliers, and when needed establish a contractual relationship with alternative suppliers.
Our failure to do so, or continued increases in goods prices, could have a material adverse effect on our business.
Our business, financial condition, results
of operations, and cash flow may in the future be negatively impacted by challenging global economic conditions.
Future
disruptions and volatility in global financial markets and declining customer and business confidence could lead to decreased levels of
spending. These macroeconomic developments could negatively impact our business, which depends on the general economic environment and
levels of sales. As a result, we may not be able to maintain our existing customer relationships or attract new customers. We are unable
to predict the likelihood of the occurrence, duration, or severity of such disruptions in the credit and financial markets and adverse
global economic conditions. Any general or market-specific economic downturn could have a material adverse effect on our business, financial
condition, results of operations, and cash flow.
Additionally,
natural disasters, such as earthquakes, hurricanes, tornadoes, floods, and other adverse weather and climate conditions; public health
crises, such as pandemics and epidemics; political crises, such as terrorist attacks, war, and other political instability, such as the
invasion of Ukraine by Russia and the conflict in the region; or other catastrophic events, whether occurring in North America or globally,
have and could continue to disrupt our operations or the operations of one or more of our suppliers and vendors. To the extent any of
these events occur, our business and results of operations could be adversely affected.
The
conflict between Russia and Ukraine could lead to disruption, instability and volatility in global markets and industries that could negatively
impact our supply chain. The U.S. government and other governments have already imposed severe sanctions and export controls against Russia
and Russian interests and may impose additional sanctions and controls. The impact of these measures, as well as potential responses to
them by Russia, could adversely affect our supply chain, which, in turn, could affect our business and operating results.
If
tariffs or other restrictions are placed by the United States or Canada on imports from China or other emerging markets, or any related
countermeasures are taken, our business, financial condition, results of operations and growth prospects may be harmed. Tariffs may increase
our cost of goods, which could result in lower gross margin on certain of our products. If we raise prices to account for any such increase
in costs of goods, the competitiveness of the affected products could potentially be reduced. In either case, increased tariffs on imports
from China or other countries could materially and adversely affect our business, financial condition and results of operations. Trade
restrictions and sanctions implemented by the United States or other countries could materially and adversely affect our business, financial
condition and results of operations.
Rising
interest rates, higher inflation, fluctuations in currency values, supply chain disruptions and the conflict between Russia and Ukraine
have resulted in significant economic disruption and adversely impacted the broader global economy, including our customers and suppliers.
Given the dynamic and uncertain nature of the current environment, we cannot reasonably estimate the impact of such developments on our
financial condition, results of operations or cash flows into the foreseeable future. The ultimate extent of the effects of these developments
remain highly uncertain, and such effects could exist for an extended period of time.
The
Inflation Reduction Act of 2022 (the “IRA”) was signed into law in August 2022. The IRA is federal legislation designed to
raise revenue from, among other things, the imposition of certain corporate tax measures, while authorizing spending on energy and climate
change initiatives and subsidizing the Affordable Care Act. The IRA also introduced a 1% excise tax on certain corporate stock buybacks,
which would impose a nondeductible 1% excise tax on the fair market value of certain stock that is “repurchased” during the
taxable year by a publicly traded U.S. corporation or acquired by certain of its subsidiaries. Management continues to monitor any potential
impact of the IRA on our results. No immediate or direct effect from the legislation has had a material impact on our results at this
time.
The continuing effects of the COVID-19 pandemic
are highly unpredictable and could be significant, and the duration and extent to which this will impact our future results of operations
and overall financial performance remains uncertain.
During
the years 2020 and 2021 the COVID-19 pandemic had an adverse effect on our industry and the markets in which we operate. During that time,
the COVID-19 outbreak significantly impacted our sales. We also experienced postponed and delayed orders in certain areas of our businesses.
Further, the guidance of social distancing, lockdowns, quarantines and the requirements to work from home in various key territories such
as Canada, United States, APAC, EMEA and other countries, in addition to greatly reduced travel globally, resulted in a substantial curtailment
of business activities, which affected our ability to deliver products and services in the areas where restrictions were implemented
by the local governments. In addition, certain of our sales and support teams were unable to travel or meet with customers and the pandemic
threat caused operating, manufacturing, supply chain and project development delays and disruptions, labor shortages, travel and shipping
disruptions and shutdowns (including as a result of government regulation and prevention measures). As a result, we experienced a
reduction in business in 2020. The regression of the pandemic during 2022, followed by lifting of travel restrictions and social distancing
regulations, except in APAC, led to some recovery in our business. In the twelve months ended December 31, 2022, our revenue was $35.6
million, compared to $34.9 million in the comparable period of 2021, and $33.4 million in the comparable period of 2020.
The
potential long-term impact and duration of the COVID-19 pandemic on the global economy and our business continue to be difficult to assess
or predict. Related public health and safety measures have resulted in significant social disruption and have had an adverse effect
on economic conditions and spending, inflation, interest rates, and business investment, all of which have affected our business. Moreover,
we may also experience business disruption if the operations of our contractors, vendors or business partners are adversely affected.
Risks Related to Our Business and Our Industry
While we were profitable in 2022, we have
incurred major losses in past years and may not operate profitably in the future.
While
we reported an operating profit from continuing operations of $1.5 million and net income attributable to our shareholders of $3.8 million
in the year ended December 31, 2022, we have incurred losses in the past. We may not be able to sustain profitable operations in the future
due to a number of factors, including global supply-chain challenges and other economic conditions . If we do not generate sufficient
cash from operations, we will be required to obtain financing or reduce our level of expenditure or cash balance. Such financing may not
be available in the future, or, if available, may not be on terms favorable to us. If adequate funds are not available to us, our business,
results of operations and financial condition will be materially and adversely affected.
Our operating results may fluctuate from quarter
to quarter and year to year.
Our
sales and operating results may vary significantly from quarter to quarter and from year to year in the future. Our operating results
are characterized by a seasonal pattern, with a higher volume of revenues towards the end of the year and lower revenues in the first
part of the year. In addition, our operating results are affected by a number of factors, many of which are beyond our control. Factors
contributing to these fluctuations include the following:
|
• |
changes in customers’ or potential customers’ budgets as a result of, among other things, government funding and procurement
policies; |
|
• |
changes in demand for our existing products and services; |
|
• |
our long and variable sales cycle; |
|
• |
our ability to maintain sales volumes at a level sufficient to cover fixed manufacturing and operating costs; |
|
• |
the timing of the introduction and market acceptance of new products, product enhancements and new applications. |
Our
expense levels are based, in part, on expected future sales. If the level of sales in a particular quarter does not meet expectations,
we may be unable to adjust operating expenses quickly enough to compensate for the shortfall of sales, and our results of operations may
be adversely affected. Due to these and other factors, we believe that quarter to quarter and year to year comparisons of our past operating
results may not be meaningful. You should not rely on our results for any quarter or year as an indication of our future performance.
Our operating results in future quarters and years may be below expectations, which would likely cause the price of our ordinary shares
to fall. Moreover, the presentation of our 2022 and 2021 and historical results in this report differs from previous annual reports, as
it excludes the results of our previously owned Integrated Solutions (Projects) division, sold to Aeronautics Ltd.
Our financial results may be significantly
affected by currency fluctuations.
Most
of our sales are made in North America, APAC and Europe. Our revenues are primarily denominated in Dollars and Euros while a portion of
our expenses, primarily labor expenses, is incurred in New Israeli Shekels and Canadian Dollars. As a result, fluctuations in rates of
exchange between the dollar and non-dollar currencies may affect our operating results and financial condition. The dollar cost of our
operations in Canada may be adversely affected by the appreciation of the CAD against the dollar. Further, the dollar cost of our operations
in Israel may be adversely affected by the appreciation of the NIS against the dollar. In addition, the value of our non-dollar revenues
could be adversely affected by the depreciation of the dollar against such currencies. Our financial expenses may also be adversely affected
by the depreciation of a currency in which we maintain our monetary assets.
We
recorded a foreign exchange gain, net of $0.4 million in the year ended December 31, 2022 and foreign exchange losses, net of $1 million
and $1 million in the years ended December 31, 2021 and 2020, respectively. This is due to the adjustment of monetary assets and liabilities,
denominated in currencies, other than the functional currency of the operational entities in the group. At the end of each period, a change
in currency valuation of monetary assets and liabilities is recorded as a non-cash financial expense or income. The Israeli Shekel appreciated
by 13.2% against the U.S. dollar in 2022 and depreciated by 3.3% and 7.0% against the U.S. dollar in 2021 and 2020, respectively. We may
incur exchange losses in the future which may materially affect our operating results.
We may make acquisitions in the future that
could disrupt our operations and harm our operating results.
We
have made a number of acquisitions in the past and may continue to do so in the future. Future acquisitions by us could result in potentially
dilutive issuances of our equity securities, the incurrence of debt and contingent liabilities and amortization expenses related to identifiable
intangible assets, any of which could materially adversely affect our operating results and financial position. Acquisitions also involve
other risks, including risks inherent in entering markets in which we have limited or no prior experience.
Mergers
and acquisitions of companies are inherently risky and subject to many factors outside of our control and no assurance can be given that
our future acquisitions will be successful and will not adversely affect our business, operating results, or financial condition. In the
future, we may seek to acquire or make strategic investments in complementary businesses, technologies, services or products, or enter
into strategic partnerships or alliances with third parties in order to expand our business. Failure to manage and successfully integrate
such acquisitions could materially harm our business and operating results. Prior acquisitions have resulted in a wide range of outcomes,
from successful introduction of new products technologies and professional services to a failure to do so. Even when an acquired company
has previously developed and marketed products, there can be no assurance that new product enhancements will be made in a timely manner
or that pre-acquisition due diligence will have identified all possible issues that might arise with respect to such products. If we acquire
other businesses, we may face difficulties, including:
|
• |
Difficulties in integrating the operations, systems, technologies, products, and personnel of the acquired businesses or enterprises;
|
|
• |
Diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and
more widespread operations resulting from acquisitions; |
|
• |
Integrating financial forecasting and controls, procedures and reporting cycles; |
|
• |
Difficulties in entering markets in which we have no or limited direct prior experience and where competitors in such markets have
stronger market positions; |
|
• |
Insufficient revenue to offset increased expenses associated with acquisitions; and |
|
• |
The potential loss of key employees, customers, distributors, vendors and other business partners of the companies we acquire following
and continuing after announcement of acquisition plans. |
Our revenues depend in great measure on government
procurement procedures and practices. A substantial decrease in our end-users’ budgets would adversely affect our results of operations.
Our
products are primarily sold, mainly indirectly, to governmental agencies, governmental authorities and government-owned companies, many
of which have complex and time-consuming procurement procedures. A substantial period of time often elapses from the time we begin marketing
a product until we actually sell that product to a particular end-user. In addition, our sales to governmental agencies, authorities and
companies are directly affected by these customers’ budgetary constraints and the priority given in their budgets to the procurement
of our products. A decrease in governmental funding for our end-users’ budgets would adversely affect our results of operations.
This risk is heightened during periods of global economic slowdown.
Accordingly,
governmental purchases of our systems, products and services may decline in the future as the governmental purchasing agencies may terminate,
reduce or modify contracts or subcontracts if:
|
• |
their requirements or budgetary constraints change; |
|
• |
they cancel multi-year contracts and related orders if funds become unavailable; |
|
• |
they shift spending priorities into other areas or for other products; |
Any
such event may have a material adverse effect on us.
Because competition in our industry is intense,
our business, operating results and financial condition may be adversely affected.
The
global market for security, safety, site management solutions and products are highly fragmented and intensely competitive. We compete
principally in the market for perimeter intrusion detection systems, or PIDS, Video Management Software, or VMS, Intelligent Video Analytics,
or IVA. Some of our competitors and potential competitors have greater research, development, financial and personnel resources, including
governmental support, as well as established greater penetration into certain vertical markets or geographical market segments. We cannot
assure you that we will be able to compete effectively relative to our competitors or continue to develop and market new products effectively.
Continued competitive pressures could cause us to lose significant market share or erode profitability margins.
Our business involves significant risks and
uncertainties that may not be covered by indemnity or insurance.
A
significant portion of our business relates to designing, developing, and manufacturing advanced security, systems and products. New technologies
may be untested or unproven. Failure of some of these products and services could result in extensive loss of life or property damage.
Accordingly, we also may incur liabilities that are unique to our products and services. In some, but not all circumstances, we may be
entitled to certain legal protections or indemnifications from our customers, either through regulatory protections, contractual provisions
or otherwise. The amount of insurance coverage that we maintain may not be adequate to cover all claims or liabilities, and it is not
possible to obtain insurance to protect against all operational risks and liabilities.
Substantial
claims resulting from an accident, failure of our products or services, or other incident, or liability arising from our products and
services in excess of any indemnity and our insurance coverage (or for which indemnity or insurance is not available or not obtained)
could adversely impact our financial condition, cash flows, or operating results. Any accident, even if fully indemnified or insured,
could negatively affect our reputation among our customers and the public, and make it more difficult for us to compete effectively. It
also could affect the cost and availability of adequate insurance in the future.
The markets for our products may be affected
by changing technology, requirements, standards and products, and we may be adversely affected if we do not respond promptly and effectively
to these changes.
The
markets for our products may be affected by evolving technologies, changing industry standards, changing regulatory environments, new
product introductions and changes in customer requirements. The introduction of products embodying new technologies and the emergence
of new industry standards and practices can render existing products obsolete and unmarketable. Our future success will depend on our
ability to enhance our existing products and to develop and introduce, on a timely and cost-effective basis, new products and product
features that keep pace with technological developments and emerging industry standards. In the future:
|
• |
we may not be successful in developing and marketing new products or product features that respond to technological change or evolving
industry standards; |
|
• |
we may experience difficulties that could delay or prevent the successful development, introduction and marketing of these new products
and features; or |
|
• |
our new products and product features may not adequately meet the requirements of the marketplace and achieve market acceptance.
|
If we are unable to respond promptly and effectively to changing
technologies and market requirements, we will be unable to compete effectively in the future.
Increasing scrutiny and changing expectations
from investors, lenders, customers and other market participants with respect to our Environmental, Social and Governance, or ESG, policies
may impose additional costs on us or expose us to additional risks.
Companies
across all industries are facing increasing scrutiny relating to their ESG policies. Investors, lenders and other market participants
are increasingly focused on ESG practices and in recent years have placed increasing importance on the implications and social cost of
their investments. The increased focus and activism related to ESG may hinder our access to capital, as investors and lenders may reconsider
their capital investment allocation as a result of their assessment of our ESG practices. If we do not adapt to or comply with investor,
lender or other industry shareholder expectations and standards, which are evolving, or if we are perceived to have not responded appropriately
to the growing concern for ESG issues, regardless of whether there is a legal requirement to do so, we may suffer from reputational damage
and the business, financial condition and the price of our company’s shares could be materially and adversely affected.
Our failure to retain and attract personnel
could harm our business, operations and product development efforts.
Our
products require sophisticated research and development, marketing and sales and technical customer support. Our success depends on our
ability to attract, train and retain qualified research and development, marketing and sales and technical customer support personnel.
Competition for personnel in all of these areas is intense and we may not be able to hire adequate personnel to achieve our goals or support
the anticipated growth in our business. Competition may be amplified by evolving restrictions on immigration, travel, or availability
of visas for skilled technology workers. If we fail to attract and retain qualified personnel, our business, operations and product development
efforts would suffer.
We face risks associated with doing business
in international markets.
A
large portion of our sales is to markets outside of Israel and Canada. For the years ended December 31, 2022, 2021 and 2020 approximately
87.2%, 93.3% and 93.1% respectively, of our revenues were derived from sales to markets outside of Israel and Canada. A key component
of our strategy is to continue to expand in such international markets. Our international sales efforts are affected by costs associated
with the shipping of our products and risks inherent in doing business in international markets, including:
|
• |
different and changing regulatory requirements in the jurisdictions in which we currently operate or may operate in the future;
|
|
• |
fluctuations in foreign currency exchange rates; |
|
• |
export restrictions, tariffs and other trade barriers; |
|
• |
difficulties in staffing, managing and supporting foreign operations; |
|
• |
difficulties in collecting accounts receivable; |
|
• |
political and economic changes, hostilities and other disruptions in regions where we currently sell our products or may sell our
products in the future; and |
|
• |
seasonal changes in business activity. |
Negative
developments in any of these areas in one or more countries could result in a reduction in demand for our products, the cancellation or
delay of orders already placed, difficulty in collecting receivables, and a higher cost of doing business, any of which could adversely
affect our business, results of operations or financial condition.
Our international operations require us to
comply with anti-corruption laws and regulations of various governments and different international jurisdictions, and our failure to
comply with these laws and regulations could adversely affect our reputation, business, financial condition and results of operations.
Doing
business on a worldwide basis requires us and our subsidiaries to comply with the laws and regulations of various governments and different
international jurisdictions, and our failure to successfully comply with these rules and regulations may expose us to liabilities. These
laws and regulations apply to companies, individual directors, officers, employees and agents, and may restrict our operations, trade
practices, investment decisions and partnering activities. In particular, as a company registered with the Securities and Exchange Commission,
or the SEC, we are subject to the regulations imposed by the Foreign Corrupt Practices Act, or FCPA. The FCPA prohibits us from providing
anything of value to foreign officials for the purposes of influencing official decisions or obtaining or retaining business or otherwise
obtaining favorable treatment and requires companies to maintain adequate record-keeping and internal accounting practices to accurately
reflect the transactions of the company. As part of our business, we deal with state-owned business enterprises, the employees and representatives
of which may be considered foreign officials for purposes of the FCPA. If our efforts to screen third-party agents and detect cases of
potential misconduct fail, we could be held responsible for the noncompliance of these third parties under applicable laws and regulations,
which may have a material adverse effect on our reputation and our business, financial condition and results of operations. In addition,
some of the international locations in which we operate lack a developed legal system and have elevated levels of corruption. As a result
of the above activities, we are exposed to the risk of violating anti-corruption laws. We have established policies and procedures designed
to assist us and our personnel to comply with applicable U.S. and international laws and regulations. However, there can be no assurance
that our policies and procedures will effectively prevent us from violating these regulations in every transaction in which we may engage,
and such a violation could adversely affect our reputation, business, financial condition and results of operations.
We may be vulnerable to physical and electronic
security breaches and cyber-attacks which could disrupt our operations and have a material adverse effect on our financial performance
and operating results.
A
party who is able to compromise the security measures on our networks or the security of our infrastructure could, among other things,
misappropriate our proprietary information and the personal information of our customers and employees, cause interruptions or malfunctions
in our or our customers’ operations, cause delays or interruptions to our ability to meet customer needs, cause us to breach our
legal, regulatory or contractual obligations, create an inability to access or rely upon critical business records or cause other disruptions
in our operations. These breaches may result from human errors, equipment failure, or fraud or malice on the part of employees or third
parties. Our exposure to cybersecurity threats and negative consequences of cybersecurity breaches will likely increase as we store increasing
amounts of customer data. Additionally, as we increasingly market the security features in our data centers, our data centers may be targeted
by computer hackers seeking to compromise data security.
We
have experienced and defended against certain threats to our systems and security (such as phishing attempts), none have had a material
adverse effect on our business or operations to date. However, we could incur significant costs in order to investigate and respond to
future attacks, to respond to evolving regulatory oversight requirements, to upgrade our cybersecurity systems and controls, and to remediate
security compromise or damage. In response to past threats and attacks, we have implemented further controls and planned for other preventative
actions to further strengthen our systems against future attacks. However, we cannot assure you that such measures will provide absolute
security, that we will be able to react in a timely manner, or that our remediation efforts following past or future attacks will be successful.
Consequently, our financial performance and results of operations would be materially adversely affected.
In
the event of a breach resulting in loss of data, such as personally identifiable information or other such data protected by data privacy
or other laws, we may be liable for damages, fines and penalties for such losses under applicable regulatory frameworks despite not handling
the data. Furthermore, if a high-profile security breach or cyber-attack occurs with respect to another provider of mission-critical data
center facilities, our customers and potential customers may lose trust in the security of these business models generally, which could
harm our reputation and brand image as well as our ability to retain existing customers or attract new ones. In addition, the regulatory
framework around data custody, data privacy and breaches varies by jurisdiction and is an evolving area of law. We may not be able to
limit our liability or damages in the event of such a loss.
We may not be able to protect our proprietary
technology and unauthorized use of our proprietary technology by third parties may impair our ability to compete effectively.
Our
success and ability to compete depend in large part upon protecting our proprietary technology. We have four patents and have one patent
applications pending. We also rely on a combination of trade secret and copyright law and confidentiality, non-disclosure and assignment-of-inventions
agreements to protect our proprietary technology. It is our policy to protect our proprietary rights in our products and operations through
contractual obligations, including confidentiality and non-disclosure agreements with certain employees, distributors and agents, suppliers
and subcontractors. These measures may not be adequate to protect our technology from third-party infringement, and our competitors may
independently develop technologies that are substantially equivalent or superior to ours. Additionally, our products may be sold in foreign
countries that provide less protection to intellectual property than that provided under U.S., Canadian or Israeli laws.
Claims that our products infringe upon the
intellectual property of third parties may require us to incur significant costs, enter into licensing agreements or license substitute
technology.
Third
parties may in the future assert infringement claims against us or claims asserting that we have violated a patent or infringed upon a
copyright, trademark or other proprietary right belonging to them. Any infringement claim, even one without merit, could result in the
expenditure of significant financial and managerial resources to defend against the claim. In addition, we purchase components for our
products from independent suppliers. Certain of these components contain proprietary intellectual property of these independent suppliers.
Third parties may in the future assert claims against our suppliers that such suppliers have violated a patent or infringed upon a copyright,
trademark or other proprietary right belonging to them. If such infringement by our suppliers or us were found to exist, a party could
seek an injunction preventing the use of their intellectual property. Moreover, a successful claim of product infringement against us
or a settlement could require us to pay substantial amounts or obtain a license to continue to use such technology or intellectual property.
Infringement claims asserted against us could have a material adverse effect on our business, operating results and financial condition.
Undetected defects in our products may increase
our costs and harm the market acceptance of our products.
Despite
our regular quality assurance testing, the development, enhancement and implementation of our complex systems entail substantial risks
of product defects or failures. Undetected errors or “bugs” may be found in existing or new products, resulting in delays,
loss of revenues, warranty expense, loss of market share, failure to achieve market acceptance, adverse publicity, product returns, loss
of competitive position or claims against us by customers. Any such problems could be costly to remedy and could cause interruptions,
delays, or cessation of our product sales, which could cause us to lose existing or prospective customers and could negatively affect
our results of operations. Moreover, the complexities involved in implementing our systems entail additional risks of performance failures.
We may encounter substantial difficulties due to such complexities which could have a material adverse effect upon our business, financial
condition and results of operations.
If suppliers terminate
our arrangements with them, or amend them in a manner detrimental to us, we may experience delays in production and implementation of
our products and our business may be adversely affected.
We
acquire most of the components utilized in our products, from a limited number of suppliers. We may not be able to obtain such items from
these suppliers in the future or we may not be able to obtain them on satisfactory terms. Temporary disruptions of our manufacturing operations
would result if we were required to obtain materials from alternative sources, which may have an adverse effect on our financial results.
We currently benefit from government programs
and tax benefits that may be discontinued or reduced in the future, which would increase our future tax expenses.
We
benefit from tax credits pursuant to the Scientific Research and Experimental Development Tax Incentive Program in Canada, and from research
grant programs such as the “Industrial Research Assistance Program” (IRAP).
If
we fail to comply with the conditions imposed by the Canadian tax program in the future, the benefits we receive could be cancelled and
we could be required to refund any payments previously received under these programs, including any accrued interest, or pay increased
taxes or royalties. Canadian research grant programs are dependent on the Government’s continued commitment to support R&D,
on availability of funding, and may be more difficult to realize or may not be available in the future. Such a result would adversely
affect our results of operations and financial condition.
If
the Canadian government resolves to end these programs and benefits, our business, financial condition, results of operations and net
income could be materially adversely affected.
We may fail to maintain effective internal
control over financial reporting, which could result in material misstatements in our financial statements.
The
Sarbanes-Oxley Act of 2002 imposes certain duties on us and our executives and directors. Our efforts to comply with the requirements
of Section 404 of the Sarbanes-Oxley Act of 2002 governing internal controls and procedures for financial reporting have resulted in increased
general and administrative expense and a diversion of management time and attention, and we expect these efforts to require the continued
commitment of significant resources. Section 404 of the Sarbanes-Oxley Act requires management’s annual review and evaluation of
our internal control over financial reporting in connection with the filing of the annual report on Form 20-F for each fiscal year. We
may identify material weaknesses or significant deficiencies in our internal control over financial reporting. Failure to maintain effective
internal control over financial reporting could result in material misstatements in our financial statements. Any such failure could also
adversely affect the results of our management’s evaluations and annual auditor reports regarding the effectiveness of our internal
control over financial reporting. We have documented and tested our internal control systems and procedures in order for us to comply
with the requirements of Section 404. While our assessment of our internal control over financial reporting resulted in our conclusion
that as of December 31, 2022, our internal control over financial reporting was effective, we cannot predict the outcome of our testing
in future periods. If we fail to maintain the adequacy of our internal controls, we may not be able to ensure that we can conclude on
an ongoing basis that we have effective internal controls over financial reporting. Failure to maintain effective internal control over
financial reporting could result in investigation or sanctions by regulatory authorities and could have a material adverse effect on our
operating results, investor confidence in our reported financial information and the market price of our ordinary shares.
Regulations related to “conflict minerals”
may force us to incur additional expenses, may make our supply chain more complex and may result in damage to our reputation with customers.
Pursuant
to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, the Securities and Exchange Commission,
or the SEC, has adopted requirements for companies that use certain minerals and metals, known as conflict minerals, in their products,
whether or not these products are manufactured by third parties. These requirements require companies to perform due diligence, disclose
and report whether or not such minerals originate from the Democratic Republic of the Congo and adjoining countries. These requirements
could adversely affect the sourcing, availability and pricing of minerals used in the manufacture of our products. While these requirements
continue to be subject to administrative uncertainty, we have incurred, and may continue to incur, costs to comply with the disclosure
requirements, including costs related to determining the source of any of the relevant minerals and metals used in our products. Since
our supply chain is complex, we may not be able to sufficiently verify the origins for these minerals and metals used in our products
through the due diligence procedures that we implement, which may harm our reputation. In such event, we may also face difficulties in
satisfying customers who require that all of the components of our products are certified as conflict mineral free.
Risks Relating to Our Ordinary Shares
Volatility of the market price of our ordinary
shares could adversely affect our shareholders and us.
The
market price of our ordinary shares has been, and is likely to be, highly volatile and could be subject to wide fluctuations in response
to numerous factors, including the following:
|
• |
actual or anticipated variations in our quarterly operating results or those of our competitors; |
|
• |
announcements by us or our competitors of technological innovations or new and enhanced products; |
|
• |
developments or disputes concerning proprietary rights; |
|
• |
introduction and adoption of new industry standards; |
|
• |
changes in financial estimates by securities analysts; |
|
• |
market changes or trends in our industry; |
|
• |
changes in the market valuations of our competitors; |
|
• |
announcements by us or our competitors of significant acquisitions; |
|
• |
entry into strategic partnerships or joint ventures by us or our competitors; |
|
• |
additions or departures of key personnel; |
|
• |
political and economic conditions, such as a recession or interest rate or currency rate fluctuations or political events;
|
|
• |
general economic conditions, including conditions related to the banking industry or caused by pandemics and high inflation, and
slow or negative market growth; and |
|
• |
other events or factors in any of the countries in which we do business, including those resulting from war, incidents of terrorism,
natural disasters or responses to such events. |
In
addition, the stock market in general, and the market for Israeli companies and homeland security companies in particular, has been highly
volatile. Many of these factors are beyond our control and may materially adversely affect the market price of our ordinary shares, regardless
of our performance. In the past, following periods of market volatility, shareholders have often instituted securities class action litigation
relating to the stock trading and price volatility of the company in question. If we were involved in any securities litigation, it could
result in substantial cost to us to defend and divert resources and the attention of management from our business.
The
FIMI partnerships owned approximately 42.3% of our outstanding ordinary shares as of April 17, 2023. For as long as FIMI has a controlling
interest in our company, it will have the ability to exercise a controlling influence over our business and affairs, including any determinations
with respect to potential mergers or other business combinations involving us, our acquisition or disposition of assets, our incurrence
of indebtedness, our issuance of any additional ordinary shares or other equity securities, our repurchase or redemption of ordinary shares
and our payment of dividends. Because the interests of FIMI may differ from the interests of our other shareholders, actions taken by
FIMI with respect to us may not be favorable to our other shareholders.
We may not pay additional
dividends in the future.
While
we have historically retained our earnings to finance operations and expand our business, on December 7, 2020, we announced a cash distribution
in the amount of US$1.079 per share (approximately US$ 25 million in the aggregate) which was paid on December 28, 2020, and, following
the completion of the sale of our Integration Solutions Division and court approval, we announced on August 16, 2021 a cash distribution
in the amount of $1.725 per share (approximately $40 million in the aggregate), which was paid on September 22, 2021. We have not determined
whether we will continue to make distributions in the future or refrain from similar distributions, whether in a form of capital reduction
or dividend distribution. According to the Israeli Companies Law, a company may distribute dividends out of its profits (as defined by
the Israeli Companies Law), provided that there is no reasonable concern that such dividend distribution will prevent the company from
paying all its current and foreseeable obligations, as they become due, or otherwise upon the permission of the court (as occurred in
connection with the 2021 dividend). The declaration of dividends is subject to the discretion of our board of directors, requires a shareholders
approval and would depend on various factors, including our operating results, financial condition, future prospects and any other factors
deemed relevant by our board of directors. You should not rely on an investment in our company if you require dividend income from your
investment.
As
a foreign private issuer whose shares are listed on the NASDAQ Global Market, we may follow certain home country corporate governance
practices instead of certain NASDAQ requirements. We follow Israeli law and practice instead of NASDAQ rules regarding the director nomination
process, compensation of executive officers and the requirement that our independent directors have regularly scheduled meetings at which
only independent directors are present.
As a foreign private issuer listed on the
NASDAQ Global Market, we may also follow home country practice with regards to, among other things, the composition of the board of directors
and quorum at shareholders’ meetings. In addition, we may follow home country practice instead of the NASDAQ requirement to obtain
shareholder approval for certain dilutive events (such as for the establishment or amendment of certain equity-based compensation plans,
an issuance that will result in a change of control of the company, certain transactions other than a public offering involving issuances
of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company). A foreign private issuer
that elects to follow a home country practice instead of NASDAQ requirements must submit to NASDAQ in advance a written statement from
an independent counsel in such issuer’s home country certifying that the issuer’s practices are not prohibited by the home
country’s laws. In addition, a foreign private issuer must disclose in its annual reports filed with the SEC, each such requirement
that it does not follow and describe the home country practice followed by the issuer instead of any such requirement. Accordingly, our
shareholders may not be afforded the same protection as provided under NASDAQ’s corporate governance rules.
We may be classified as a passive foreign
investment company, or PFIC, which would subject our U.S. investors to adverse tax rules.
U.S.
holders of our Ordinary Shares may face income tax risks. Based on the composition of our income, assets (including the value of our goodwill,
going-concern value or any other unbooked intangibles, which may be determined based on the price of the ordinary shares), and operations,
we believe we will not be classified as a “passive foreign investment company”, or PFIC, for the 2022 taxable year. However,
because PFIC status is based on our income, assets and activities for the entire taxable year, it is not possible to determine whether
we will be characterized as a PFIC for our current taxable year or future taxable years until after the close of the applicable taxable
year. Moreover, we must determine our PFIC status annually based on tests that are factual in nature, and our status in the current year
and future years will depend on our income, assets and activities in each of those years and, as a result, cannot be predicted with certainty
as of the date hereof. Furthermore, fluctuations in the market price of our ordinary shares may cause our classification as a PFIC for
the current or future taxable years to change because the aggregate value of our assets for purposes of the asset test, including the
value of our goodwill and unbooked intangibles, generally will be determined by reference to the market price of our shares from time
to time (which may be volatile). The IRS or a court may disagree with our determinations, including the manner in which we determine the
value of our assets and the percentage of our assets that are passive assets under the PFIC rules. Therefore, there can be no assurance
that we will not be a PFIC for the current taxable year or for any future taxable year. Our treatment as a PFIC could result in a reduction
in the after-tax return to U.S. Holders (as defined below under Item 10E. “Additional Information – Taxation”) of our
Ordinary Shares and would likely cause a reduction in the value of such shares. A foreign corporation will be treated as a PFIC for U.S.
federal income tax purposes if either (1) at least 75% of its gross income for any taxable year consists of certain types of “passive
income,” or (2) at least 50% of the average value of the corporation’s gross assets produce, or are held for the production
of, such “passive income.” For purposes of these tests, “passive income” includes dividends, interest, gains from
the sale or exchange of investment property and rents and royalties other than rents and royalties that are received from unrelated parties
in connection with the active conduct of a trade or business. If we are treated as a PFIC, U.S. Holders of Ordinary Shares would be subject
to a special adverse U.S. federal income tax regime with respect to the income derived by us, the distributions they receive from us,
and the gain, if any, they derive from the sale or other disposition of their Ordinary Shares. U.S. Holders should carefully read Item
10E. “Additional Information – Taxation” for a more complete discussion of the U.S. federal income tax risks related
to owning and disposing of our Ordinary Shares.
Risks Relating to Our Location in Israel
Political, economic and military instability
in Israel may negatively affect our business condition, harm our results of operations and adversely affect our share price.
We
are incorporated under the laws of Israel and our principal executive offices, are located in the State of Israel. As a result, political,
economic and military conditions affecting Israel indirectly influence us.
Conflicts
in North Africa and the Middle East, including in Lebanon and Syria which border Israel, have resulted in continued political uncertainty
and violence in the region. Efforts to improve Israel’s relationship with the Palestinian Authority have failed to result in a permanent
solution, and there have been numerous periods of hostility in recent years. In addition, relations between Israel and Iran continue to
be seriously strained, especially with regard to Iran’s nuclear program. Such instability may affect the local and global economy,
could negatively affect business conditions and, therefore, could adversely affect our operations. To date, these matters have not had
any material effect on our business and results of operations; however, the regional security situation and worldwide perceptions of it
are outside our control and there can be no assurance that these matters will not negatively affect us in the future.
Over
the past several years there have also been calls in Europe and elsewhere to reduce trade with Israel. Restrictive laws, policies or practices
directed towards Israel or Israeli businesses may have an adverse impact on our operations, our financial results or the expansion of
our business.
Furthermore, the Israeli government is currently
pursuing extensive changes to Israel’s judicial system. In response to the foregoing developments, individuals, organizations and
institutions, both within and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business environment
in Israel including due to reluctance of foreign investors to invest or conduct business in Israel, as well as to increased currency fluctuations,
downgrades in credit rating, increased interest rates, increased volatility in securities markets, and other changes in macroeconomic
conditions. Such proposed changes may also adversely affect the labor market in Israel or lead to political instability or civil unrest.
To the extent that any of these negative developments do occur, they may have an adverse effect on our business, our results of operations
and our ability to raise additional funds, if deemed necessary by our management and board of directors.
The rights and responsibilities of the shareholders
are governed by Israeli law and differ in some respects from the rights and responsibilities of shareholders under U.S. law.
We
are incorporated under Israeli law. The rights and responsibilities of holders of our ordinary shares are governed by our Memorandum of
Association and Articles of Association and by Israeli law. These rights and responsibilities differ in some respects from the rights
and responsibilities of shareholders in typical U.S. corporations. In particular, a shareholder of an Israeli company has a duty to act
in good faith in exercising his or her rights and fulfilling his or her obligations toward the company and other shareholders and to refrain
from abusing his power in the company, including, among other things, in voting at the general meeting of shareholders on certain matters.
Israeli law provides that these duties are applicable in shareholder votes on, among other things, amendments to a company’s articles
of association, increases in a company’s authorized share capital, mergers and interested party transactions requiring shareholder
approval. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine
the outcome of a shareholder vote or who has the power to appoint or prevent the appointment of a director or executive officer in the
company has a duty of fairness toward the company. However, Israeli law does not define the substance of this duty of fairness. There
is little case law available to assist in understanding the implications of these provisions that govern shareholder behavior.
Provisions of Israeli law may delay, prevent
or make difficult a change of control and therefore depress the price of our shares.
Some
of the provisions of Israeli law could discourage potential acquisition proposals, delay or prevent a change in control and limit the
price that investors might be willing to pay in the future for our ordinary shares. Israeli Companies law regulates mergers and acquisitions
of shares through tender offers, requires approvals for transactions involving significant shareholders and regulates other matters that
may be relevant to these types of transactions. Furthermore, Israel tax law treats stock-for-stock acquisitions between an Israeli company
and a foreign company less favorably than does U.S. tax law. For example, Israeli tax law may subject a shareholder who exchanges his
ordinary shares for shares in a foreign corporation to immediate taxation or to taxation before his investment in the foreign corporation
becomes liquid. These provisions may adversely affect the price of our shares.
Our shareholders generally may have difficulties
enforcing a U.S. judgment against us, our executive officers and directors and some of the experts named in this annual report or asserting
U.S. securities law claims in Israel.
We
are incorporated in Israel and all of our executive officers and directors named in this annual report reside outside the United States.
Service of process upon them may be difficult to effect within the United States. Furthermore, since substantially all of our assets and
all of our directors and officers are located outside the United States, any judgment obtained in the United States against us or these
individuals may not be collectible within the United States and may not be enforced by an Israeli court. It also may be difficult for
you to assert U.S. securities law claims in original actions instituted in Israel.
There
is doubt as to the enforceability of civil liabilities under the Securities Act and the Securities Exchange Act in original actions instituted
in Israel. However, subject to certain time limitations and other conditions, Israeli courts may enforce final judgments of U.S. courts
for liquidated amounts in civil matters, including judgments based upon the civil liability provisions of those and similar acts.
ITEM 4.
Information on the Company
A. |
History and Development of the Company. |
We
were incorporated under the laws of the State of Israel on March 27, 1984 under the name Magal Security Systems Ltd. On September 30,
2021, we changed our name to Senstar Technologies Ltd. We are a public limited liability company under the Israeli Companies Law, 5759-1999,
and operate under this law and associated legislation. Our principal executive offices are located near Tel Aviv, Israel, at Gibor Sport
Tower, 7 Menachem Begin Road, Ramat Gan 5268102, Israel and our telephone number is +972-74-794-5200. Our agent for service of process
in the United States is Senstar Inc., 13800 Coppermine Road, Second Floor, Herndon, Virginia 20171. Our website address is www.senstartechnologies.com.
The information on our website is not incorporated by reference into this annual report.
On
June 30, 2021, we completed the sale of our Integration Solutions Division to Aeronautics Ltd., a subsidiary of RAFAEL Advanced Defense
Systems Ltd., in a share and asset purchase agreement. We received $35 million in cash at closing on a cash-free, debt-free basis subject
to post-closing working capital and other customary adjustments. As part of the acquisition, Aeronautics acquired our facility in Yehud,
Israel.
Following
the sale of the Integrated Solutions (Projects) division, we continue to operate our Senstar Products Division, with development and manufacturing
facilities located in Canada and sales and support offices in the U.S., EMEA, APAC, and People’s Republic of China regions.
We
are a leading international provider of products and solutions for physical security. We commenced operations in 1969 as a department
of Israel Aircraft Industries Ltd., specializing in perimeter security systems and have delivered products, tailor-made solutions and
turnkey projects to thousands of satisfied customers in over 100 countries in some of the world’s most demanding locations.
We
offer broad portfolio of homegrown Perimeter Intrusion Detection Systems (PIDS), Video Management Software (VMS) combined with Electronic
Access Control (EAC), and Intelligent Video Analytics (IVA).
Our
strategy is to increase our revenues from our Products segment, which includes our PIDS, VMS and IVA products by (i) focusing our efforts
on our strategic verticals; (ii) locating new channels to promote and market our products; (iii) investing in research and development
thus maintaining technology leadership; (iv) entering into OEM agreements which will increase our offerings for the verticals on which
we focus; and (v) acquiring new technologies relevant to our target verticals independently or through mergers and acquisitions.
In
April 2018, we completed the acquisition of a 55% controlling interest in ESC BAZ Ltd. an Israeli-based company, focused on the development
and manufacturing of military-grade smart security video observation and surveillance systems, and in December 2020, we acquired the remaining
45% interest. We sold ESC BAZ Ltd in connection with the sale of our Integrated Solutions (Projects) division in June 2021.
In
April 2016, we acquired Aimetis, a Canadian-based company, which specializes in advanced video analytics software and intelligent IP video
management software (VMS). In July 2017 we amalgamated our two Canadian subsidiaries. Following the amalgamation, the company maintained
the name Senstar Corporation.
In
April 2014, we acquired a U.S. based fiber-optic technology company which provides advanced solutions for sensing, security, and communication.
In January 2013, we purchased CyberSeal Ltd., an Israeli cyber security company whose products and services complement our physical security
products and services. We sold Cyberseal Ltd. in connection with the sale of our Integrated Solutions (Projects) division in June 2021.
Our
continuing capital expenditures for property and equipment for the years ended December 31 2022, 2021 and 2020 were approximately $0.2
million, $0.6 million and 0.4 million, respectively.
Overview and Strategy
We
develop, manufacture, market and sell comprehensive lines of perimeter intrusion detection sensors, physical barriers, video analytics
and video management systems, as well as security video observation and surveillance systems to high profile customers. Our systems are
used in more than 100 countries to protect sensitive facilities, including national borders, military bases, power plants, airports, seaports,
prisons, industrial sites, large retailer organizations, banks, oil and gas facilities, sporting events including athlete villages and
stadiums, and municipalities from intrusion, terror, crime, sabotage or vandalism to infrastructure, assets and personnel. Our primary
objective is to become a leading international provider of security products and solutions.
The
sale of our Integrated Solutions (Projects) division, supports our strategy of prioritizing opportunities to provide technologically-rich
products, solutions and related services in our key verticals of energy, logistics, critical infrastructure and correctional facilities.
Operating as a pure product solutions company will increase visibility into our future performance and provide us with incremental opportunities
to deliver additional value to our different stakeholders. As a standalone business, post-divestiture, we continued our growth agenda
to leverage our Products division success and scale our business to capture a meaningful share of new market opportunities.
Based
on our decades of experience and interaction with customers, we have developed a comprehensive set of solutions and products, optimized
for perimeter, outdoor and general security applications. Our portfolio of mission critical infrastructure and site protection technologies
includes a variety of smart fences and barriers, fence mounted sensors, fence mounted sensors with perimeter lighting, virtual (volumetric)
fences and gates, buried and concealed detection systems and tunneling sensors to secure prisons, bank vaults and pipelines. We deliver
comprehensive IP technology and traditional closed-circuit television, or CCTV, solutions, supported by our own advanced Video Management
Software, or VMS solutions, which include Video Motion Detection, or VMD and Intelligent Video Analytics, or IVA.
Since
the addition of Aimetis’ products and expertise, we were able to address new markets and offer solutions incorporating advanced
video analytics and VMS for physical indoor and outdoor security applications. In addition, we were able to expand our overall solutions,
offer a wider range of products in addition to our PIDS solutions, and address new markets.
Post-divestiture
of our Integrated Solutions (Project) Division, we anticipate that our business will grow organically. We plan to leverage Senstar’s
industry-leading position in the security sector as a technology platform to optimize future strategic acquisitions and achieve incremental
growth in our global markets. To achieve this objective, we are implementing a business strategy incorporating the following key elements:
|
• |
Leverage existing customer relationships. We believe that we have the capability to offer
certain of our customers a comprehensive security package. As part of our product development process, we seek to maintain close relationships
with our customers to identify market needs and to define appropriate product specifications. We intend to expand the depth and breadth
of our existing customer relationships while initiating similar new relationships. Our VMS offering is an excellent opportunity to revisit
our existing customers. |
|
• |
Refine and broaden our product portfolio. We have identified the security needs of our customers
and intend to enhance our current products’ capabilities, develop new products, acquire complementary technologies and products
and enter into OEM agreements with third parties in order to meet those needs. |
|
• |
Develop and enhance our presence in verticals which we have identified as strategic. We intend
to enhance our presence in our target vertical markets: critical infrastructure, correctional facilities logistics and energy (among other,
oil and gas terminals as well as oil and gas pipelines infrastructure). Many if not all of the verticals are highly regulated and require
unique security solutions. As a solution provider with a wide selection of security technologies and products we believe that we can offer
a comprehensive security solution that meets the standards required by the applicable regulations. |
|
• |
Enhance our presence in emerging markets. We intend to enhance our presence in emerging markets
such as Chin and eastern Europe a in order to increase our exposure and sales. |
|
• |
Strengthen our presence in existing markets. We intend to increase our marketing efforts
in our existing markets mainly in North America, the European Union, and APAC region and to acquire or invest in complementary businesses
and joint ventures. |
Emerging Opportunities
We
believe that the proliferation of digital communication and information technology into the security market provides us with the opportunity
to consolidate safety and site management with security applications. Cities and municipalities, air and seaports, chemical factories,
green energy plants and distribution facilities, oil and gas terminals and pipeline infrastructure, large logistics warehouses, and critical
infrastructure sites are currently utilizing the benefits of this approach to security management. This integration allows users to share
diverse sensors (such as cameras and intrusion detection sensors), IT systems, traffic management tools and other resources and feed them
into a single command and control platform. Users from different departments within organizations can now share the same information,
allowing for improved communication and coordination, whether it is a routine operation or crisis situation. We believe that we are well
positioned and are in the forefront of this emerging market opportunity.
Products and Services
General
Our
principal physical (PIDS), VMS and EAC products and solutions include:
|
• |
Perimeter Intrusion Detection Systems (PIDS), fence mounted, buried and free standing; |
|
• |
PIDS fence sensor with intelligent perimeter LED based lighting; |
|
• |
Common Operating Platform for VMS, including IVA applications, PIDS applications and EAC systems; |
|
• |
EAC (Electronic Access Control) systems; |
|
• |
Security Thermal Imaging Observation & Surveillance systems (OEM); |
|
• |
Pipeline security, third party interference (TPI); and |
Perimeter
security products enable customers to monitor, limit and control access by unauthorized personnel to specific regions or areas. High-end
perimeter products are sophisticated in nature and are used for correctional facilities, borders, nuclear and conventional power plants,
air and seaports, military installations, logistics centers and other high-security installations.
Our
line of perimeter security products utilizes sophisticated sensor devices to detect and locate intruders and identify the nature of intrusions.
Our perimeter security products have been installed along tens of thousands of kilometers of borders and facility boundaries throughout
the world, including hundreds of correctional institutions and prisons in the United States and several other countries.
Our
line of outdoor perimeter security products consists of the following:
|
• |
Fence mounted detection systems – “microphonic” wire sensors, fiber optic sensors and electronic ranging sensors;
|
|
• |
Buried sensors – buried coaxial cable volumetric sensors and buried fiber sensors to secure pipelines, borders and critical
assets against intrusion by targets on the surface and excavation; |
|
• |
Electrical field disturbance sensors (volumetric); |
|
• |
Hybrid perimeter intrusion detection and intelligent lighting system. |
Fence Mounted Detection Systems
We
offer various types of detection systems. The adaptability of these systems to a wide range of pre-existing barrier structures makes these
products viable and effective alternatives for cost-conscious customers. Our detection devices are most effective when installed on common
metal fabric perimeter systems, such as chain link or welded mesh. Once attached to the fence, each sensor detects vibrations in the underlying
structures. The sensor system’s built-in electro-mechanical filtering combines with system input from a weather analysis component
to minimize the rate of alarms from wind, hail or other sources of nuisance vibrations.
FlexZone,
our latest coaxial cable based fence mounted ranging sensor can pinpoint intrusions to within ±3 m (±10 ft); it provides long
physical cable lengths (up to 600 m (1,968 ft) per processor) configurable through software to many smaller virtual zones for site operations.
Power and data between processors is supported through the sensor cable significantly reducing the requirement for supporting infrastructure.
A novel wireless gate sensor module is available with FlexZone providing an accelerometer based gate sensor integrated via wireless communications
into a FlexZone network eliminating the need to have sensor cables attached to sliding gates.
FiberPatrol,
our advanced FP1150 product is a perimeter intrusion detection system that can be fence-mounted, buried, or deployed in a wall-top configuration.
Featuring long distance ranging to 80 Km (50 mi) via a fence mounted fiber optic cable detects and locates fence cut and climb events
with an accuracy of approximately 4m (13 ft). Released in 2019 our latest FP400 product zone-based fiber optic cable PIDS solution replaces
the IntelliFiber product line. Its advanced features include the processing of 4 detection zones from a single remote processor with an
alarm given for each zone independently with up to 300 m (984 ft) per zone.
Buried Sensors
Omnitrax
is a fifth generation covert outdoor perimeter security intrusion detection sensor that generates an invisible radar detection field around
buried sensor cables. The exact location of an intruder is identified within approximately one meter when an intruder disturbs the detection
field. Targets are detected by their conductivity, size and movement and the digital processor is able to filter out nuisance alarms that
could be caused by environmental conditions and small animals.
FiberPatrol,
our advanced FP1150 product featuring long distance ranging fiber optic cable based detection technology in a single rack mount unit is
also offered as a buried solution detecting surface intrusion and to protect pipelines, as well as providing Data Conduit protection against
sabotage or accidental third party interference (TPI) for example by manual or machine excavation. FiberPatrol has the capability to protect
distances of up to 80 Km (50 mi) or up to 100 Km (62 mi) for Pipeline TPI and Data Conduit protection with a single indoor processor.
Electro-static Field Disturbance Sensors
Terrain
following volumetric sensors detect intrusions without requiring an intruder to touch the sensor. They can be installed on buildings,
free-standing posts, existing fences, walls or rooftops, and will sense changes in the electrostatic field when events, such as intruders
penetrating through the wires takes place. The system’s tall, narrow, well contained detection zone allows the sensor to be installed
in almost any application and minimizes nuisance alarms caused by nearby moving objects. Our flagship product is X-Field; it consists
of a set of four to as many as eight parallel field generating and sensing wires that form a volumetric detection height as much as 6m
(20 ft) in height for free standing and wall applications and up to 7.3m (24 ft) for fence installations.
Microwave Products
Ultrawave
is our K-band all digital bi-static microwave beam perimeter intrusion detection system designed for reliable operation in extreme outdoor
environments. Coverage distance range from 5 meters to 200 meters (16 to 656 ft). Older generations of X band microwaves are retired but
still supported.
Hybrid Perimeter Intrusion Detection and
Intelligent Lighting System
The
Senstar LM100 is the world’s first 2-in-1 perimeter intrusion detection and intelligent lighting system. Combining high performance
LED lighting with accelerometer-based vibration sensors, the LM100 deters potential intruders by detecting and illuminating them at the
fence line.
Video Products
VMS / IVA Solutions - Senstar Symphony Common
Operating Platform
The
Senstar Symphony Common Operating Platform with Sensor Fusion Engine or "Senstar Symphony", which is an evolution of our Senstar Symphony
7, is a modular solution for security management and data intelligence. In addition to being an open, highly scalable video management
system with built-in video analytics, it includes full-featured access control and perimeter intrusion detection modules. We believe that
what truly sets Senstar Symphony apart from other systems is its sensor fusion engine. By intelligently combining low-level sensor data
with video analytics, the sensor fusion engine achieves the highest levels of performance, far beyond that of the individual devices.
Senstar Symphony seamlessly incorporates sensor fusion, event algorithms, and rule-based actions to provide unmatched capabilities, flexibility,
and performance.
Senstar
Symphony’s Sensor Fusion Engine synthesizes data from separate systems to generate actionable information. More than just a simple
Boolean logic integration, the sensor fusion engine accesses low level data to intelligently characterize potential risks. Data synthesis
enables the system to achieve levels of performance that exceed those of the individual sensors. For security applications, this has direct,
practical benefits, namely the ability to maximize the strengths of individual sensor technologies while avoiding their shortcomings.
When signal response data from outdoor sensors is synthesized with video analytic data, nuisance alarms generated by wind, debris, or
background activity are virtually eliminated while maintaining the system’s high probability of detection.
The
Senstar Symphony Common Operating Platform includes a full-featured Windows®-based client, a HTML5-client web client, a thin client
hardware appliance, and mobile apps (iOS and Android). With Senstar Symphony’s camera-based licensing scheme, our customers and
end-users can install and use as many clients as they need. The Windows® client includes on-screen camera hotlinks, a full-featured
alarm console that integrates alarms with video feeds and sensor data, timeline view, and intuitive graphical maps with precise alarm
location data. Senstar Symphony installs on standard commercial off-the-shelf hardware and supports thousands of network devices as well
as ONVIF profiles S and T (H.265 and metadata). Senstar Symphony integrates with a wide variety of security and access control products,
while its RESTful API and TCP/IP listener services enable it to interact with virtually any network-based device.
The
Senstar Symphony Common Operating Platform is highly scalable, easy to set up and use, and can be used in both single server installations
and multi-server deployments. Senstar Symphony can meet any business requirements, both today and in years to come. Functionality sets
including video management, video analytics, security management, access control, and data intelligence can be used individually, added
when needed, or combined together as a complete integrated solution. It is a highly cost-effective solution, licensed per security device
(camera, door, or sensor), so that our customers only license what they need. All managed devices report to a shared rules and alarms
management system, enabling operators to perform site security or operational functions from a ‘single pane of glass’.
The
Senstar Symphony solution offers web-based administrator capabilities, centralized cloud management, native analytics applications which
include motion tracking, auto-PTZ (pan–tilt–zoom) tracking, people counting, and high security and server and storage failover
reducing the need for costly Microsoft clustering and extra servers. We intend to expand the Symphony product line over time to address
a broad new market of applications.
Our
intelligent video analytics (IVA) transforms IP video into more than a passive monitoring tool with video analytics that are seamlessly
incorporated into Senstar Symphony 7. Each video analytic is specially designed for physical security and business intelligence applications,
providing value across many vertical markets.
Our
intelligent video analytics (IVA) capabilities include:
|
• |
Face Recognition - Senstar Symphony-based video analytic identifies known and unknown individuals. Using a combination of patented
2D to 3D pose correction technology, this analytic is designed for fast, reliable identification under real-world challenges, including
lighting, angles, facial hair, pose, glasses and other occlusions, motion, crowds, and expression. |
|
• |
Automatic License Plate Recognition - Senstar Symphony-based video analytic reads license plates and other vehicle markings, and
seamlessly integrates the data into the site’s security and operational processes. The analytic can be used for automating vehicle
access systems such as gates and other barriers, flag vehicle in/out times in surveillance footage, notifying customer management systems
of client arrivals, and track vehicles crossing toll and border checkpoints. |
|
• |
Outdoor People and Vehicle Tracking - a Senstar Symphony-based video analytic optimized for detecting and monitoring the movement
of vehicles and people in outdoor environments. Typical applications include perimeter intrusion detection, parking lot monitoring, public
safety, and wrong-way detection. The analytic retains its extremely high tracking and object classification accuracy even in the presence
of challenging weather and lighting conditions. Organizations can use tracked events to trigger alarms and direct operators to specific
concerns, making it the perfect addition to any video surveillance system. |
|
• |
Left and Removed Item Detection - Monitor changes in an environment to detect when objects are added or removed from a scene. Set
alarms to notify security staff when an item has been removed from an area or left unattended for a designated amount of time. This solution
designed for use in airports, train stations, and other public spaces. |
|
• |
Indoor People Tracking - Detect and track people moving within the frame of a camera. Alarms can be set when unauthorized entry into
an area is detected and dwell times can be tracked and recorded for the detection of unwanted loitering. Heat maps can also be created
in retail stores and public spaces to determine areas of highest traffic and interest. |
|
• |
Crowd Detection - Real-time occupancy estimation for indoor and outdoor deployments, ideal for monitoring public spaces, event venues,
and capacity restricted environments. Crowd Detection also offers numerous business intelligence applications. |
|
• |
PTZ Auto-Tracking (Auto PTZ) - Auto PTZ can automatically control a PTZ camera, enabling it to zoom in and follow moving people and
vehicles within the field of the camera. This is designed for use in outdoor perimeter monitoring and provides a closer look at people
and vehicles for future forensic purposes. |
|
• |
Hardware solutions supporting our VMS software products are an “R series” of preconfigured servers, “E series”
of physical appliances for smaller applications and a novel POE powered "Thin Client device for convenient network access for monitors
or other applications. |
|
• |
The Senstar E5000 Physical Security Appliance (PSA) - is a complete security management system in a box. Available in two models,
it combines compact, purpose-built hardware with Senstar Symphony Common Operating Platform and is ideal for sites where vibration and
extreme temperatures are difficult to manage, including remote utility and energy infrastructure, as well as space-constrained environments.
|
|
• |
The Senstar Thin Client - is a simple and cost-effective device designed to display 1080p video from 30+ network video camera manufacturers
via ONVIF Profile S, as well as from the Senstar Symphony VMS or any RTSP-compatible video source. The device is ideal for space-constrained
environments due to its compact design while its web-based interface makes it easy to configure and manage. |
|
• |
The R-Series Operator Station - complements the R-Series Network Video Recorders (NVR). Featuring Dell hardware, the Operator Station
is ideal for customers looking for a preconfigured, validated video surveillance client. The R001 model is optimized for everyday video
monitoring applications and supports up to three displays. |
Senstar
Life SafetyTM
Senstar
Safe Spaces™ is an all-in-one video analytics solution [to help businesses operate safely amidst COVID-19]. Consisting of the Senstar
Edge Platform, a simple plug-and-play, stand-alone device with embedded software, Senstar Safe Spaces uses network cameras to verify if
health and safety protocols are being followed. Face Mask Detection, Physical Distancing, Sanitization Station Monitoring, and Occupancy
Counting.
Command and Control Systems
The
development of communication and IT technology has significantly affected the security market. Multiple security systems and technologies,
sometimes supplied by different vendors, can now be integrated into a unified command and control system. We offer three types of command
and control systems:
|
• |
Senstar Symphony Common Operating Platform - Video, Security and Data Intelligence Platform with Sensor Fusion Engine; |
|
• |
StarNet 2 – feature-rich Security Management System (SMS) optimized for the management and operation of perimeter protection
and intrusion detection systems. Organized around a visual, map- based interface, StarNet 2 provides a streamlined user experience for
operators handling everything from daily routines to crisis situations, enabling organizations to reduce reaction times, improve efficiency
and safeguard personnel, our security management system, or SMS, was launched in the latter part of 2015 and replaces the legacy StarNet
1000; and |
|
• |
Network Manager - a middleware (software) package interfacing between our family of PIDS sensors and any command and control solution,
be it our own system or an external third party application. It is provided to integrators with a full software development kit to enable
fast integration of our PIDS into any other SMS and physical security information system. It offers an entry level operator display system
called the Alarm Information Module (AIM), typically for management of a single PIDS sensor. |
Marketing, Sales and Distribution
We
believe that our reputation as a leading global vendor of sophisticated security products and our global presence provides us and our
sales representatives with access to decision-makers in all of our main four verticals: energy, corrections, critical infrastructure and
logistics.
Our
sales efforts focus on:
|
• |
PIDS products are sold indirectly through system integrators and distribution channels. Due to the sophistication of our products,
we often need to approach end-users directly and be in contact with system integrators; however, sales are directed through third parties.
Our sales team is trained on cross-selling PIDS, VMS, IVA and EAC. |
|
• |
VMS, EAC and IVA. Video management system software and Intelligent Video Applications licenses, the associated maintenance and support
services, are sold primarily through locally based distributor partners. Some key accounts are managed directly with the end-users. Our
sales team is trained on cross-selling PIDS, VMS, IVA and EAC. |
In
addition to our global corporate office in Israel and our principal facilities in Canada, the United States and Germany, we have sales
and technical support offices in China, the Philippines and other countries.
Customers
The
following table shows the geographical breakdown of our consolidated revenues with respect to our continuing operations for the three
years ended December 31, 2022, 2021 and 2020:
|
|
Year ended in December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America |
|
$ |
16,042 |
|
|
$ |
15,902 |
|
|
$ |
17,520 |
|
Europe |
|
|
10,396 |
|
|
|
8,913 |
|
|
|
9,052 |
|
APAC |
|
|
6,571 |
|
|
|
8,387 |
|
|
|
5,267 |
|
South and Latin America |
|
|
1,334 |
|
|
|
1,296 |
|
|
|
1,322 |
|
Israel |
|
|
1,195 |
|
|
|
317 |
|
|
|
- |
|
Others |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
Installation, Support and Maintenance
Our
systems are generally installed by an integrating partner or in some cases by the customer after appropriate training, depending on the
size of the specific project and the location of the customer’s facilities, as well as prior experience with our systems. We generally
provide our customers with training on the use and maintenance of our systems, which we conduct either on-site or at our facilities. In
addition, some of our local perimeter security products customers have signed maintenance contracts with us. The life expectancy of a
high-security perimeter system is approximately ten years. Consequently, many miles of perimeter systems need to be replaced each year.
We
also provide services, maintenance and support on an “as needed” basis, as well as on a subscription basis, through the Senstar
Care Program - our multi-year maintenance and support program.
During
the years ended December 31, 2022, 2021 and 2020, we derived approximately 17.7%, 17.9% and 14.0% of our total Products revenues, respectively,
from maintenance and services.
Research and Development; Royalties
We
place considerable emphasis on research and development to improve our existing products and technology and to develop new products and
technology. We believe that our future success will depend upon our ability to enhance our existing products and technology and to introduce
on a timely basis new commercially viable products and technology addressing the needs of our customers. We intend to continue to devote
a significant portion of our personnel and financial resources to research and development. As part of our product development process,
we seek to maintain close relationships with our customers to identify market needs and to define appropriate product specifications.
Our development activities are a direct result of the input and guidance we receive from our marketing personnel during our annual meetings
with such personnel. In addition, the heads of research and development for each of our development centers discussed below meet annually
to identify market needs for new products.
We
have centralized all our development centers in Canada, in Carp near Ottawa and Waterloo near Toronto, each of which develops products
and technologies based on its area of expertise. Our development center in Israel was part of the assumed assets under the assets and
shares purchase agreement of our Integrated Solutions (Projects) division sold to Aeronautics.
Our
research and development expenses relating to our continuing Products' segment operations during 2022, 2021 and 2020 were $4.0 million,
$3.9 million and $4.0 million, respectively. In addition to our own research and development activities, we also acquire know-how from
external sources. We cannot assure you that any of our research and development projects will yield profitable results in the future.
Manufacturing and Supply
Our
manufacturing operations consist of engineering, fabricating, assembly, quality control, final testing and shipping of finished products.
Substantially all of our manufacturing operations are currently performed at our facilities in Canada. In 2018 we launched a “Made
in USA” version of our FlexZone product to better serve our US - based partners and customers. See Item 4D. “Information on
the Company – Property, Plants and Equipment.”
We
acquire most of the components utilized in our products, and certain services from a limited number of suppliers and subcontractors. Supply
chain disruptions were exacerbated in 2022 as major shipping ports and manufacturing facilities in Asia have been affected by outbreaks
of the Covid-19 variants, either closing or reducing capacity. The disruption to global supply chains has led to longer supplier delivery
times and an increase in material prices. Despite the supply chain said disruptions we were able to source the needed material and sub-components
to continue manufacturing and deliveries to our customers, we cannot assure you that we will continue to be able to obtain such items
from our suppliers on satisfactory terms. Alternative sources of supply may be difficult to obtain. Therefore, temporary disruptions of
our manufacturing operations would result if we were required to obtain materials from alternative sources, which may have an adverse
effect on our financial results. We also maintain an inventory of systems and spare parts in order to enable us to overcome potential
temporary supply shortages until an alternate source of supply is available. Nevertheless, temporary disruptions of our manufacturing
operations would result if we were required to obtain materials from alternative sources, which may have an adverse effect on our financial
results.
Competition
PIDS
Sensors. The principal factors affecting competition in the market for security systems are a system’s high probability for
detection and low probability of false and nuisance alarms. We believe that a manufacturer’s reputation for reliable equipment is
a major competitive advantage, and that such a reputation will usually be based on the performance of the manufacturer’s installed
systems. Additional competitive factors include quality of customer support, maintenance and price.
The
PIDS market is very fragmented. Our most frequently encountered competitors include Southwest Microwave Inc., AVA (formerly named Future
Fibre Technologies Pty. Ltd.), Fibersensys Inc. (an Optex Company), CIAS Elettronica Srl, Vitaprotech,in France and Gallagher (New Zealand).
We
believe that our principal competitors for our pipeline security products (FiberPatrol) are: AVA, Optasense, a Luna Innovations company,
Omnisens SA, and Fotech Solutions Ltd.
The
video management software market is well developed internationally with several large manufacturers. Our most frequently encountered competitors
are Genetec Inc., Avigilon Corp., Milestone Systems A/S, and SeeTec GmbH.
We
also face indirect competition from competing technologies such as ground based radar and thermal cameras as PIDS sensors with principal
competitors being, SpotterRF, Navtech, FLIR, SightLogix and PureTech.
Some
of our competitors and potential competitors have greater research, development, financial and personnel resources, including governmental
support, or more extensive business experience than we do. We cannot assure you that we will be able to maintain the quality of our products
relative to those of our competitors or continue to develop and market new products effectively.
Intellectual Property Rights
We
have four patents in the U.S. and have one patent application pending and have obtained licenses to use proprietary technologies developed
by third parties. We cannot assure you:
|
• |
that patents will be issued from any pending applications, or that the claims allowed under any patents will be sufficiently broad
to protect our technology; |
|
• |
that any patents issued or licensed to us will not be challenged, invalidated or circumvented; or |
|
• |
as to the degree or adequacy of protection any patents or patent applications may or will afford. |
In
addition, we claim proprietary rights in various technologies, know-how, trade secrets and trademarks relating to our principal products
and operations. We cannot assure you as to the degree of protection these claims may or will afford. It is our policy to protect our proprietary
rights in our products and operations through contractual obligations, including confidentiality and non-disclosure agreements with certain
employees and distributors. We cannot assure you as to the degree of protection these contractual measures may or will afford. Although
we are not aware that we are infringing upon the intellectual property rights of others, we cannot assure you that an infringement claim
will not be asserted against us in the future. We believe that our success is less dependent on the legal protection that our patents
and other proprietary rights may or will afford than on the knowledge, ability, experience and technological expertise of our employees.
We cannot provide any assurance that we will be able to protect our proprietary technology. The unauthorized use of our proprietary technology
by third parties may impair our ability to compete effectively. We could become subject to litigation regarding intellectual property
rights, which could seriously harm our business.
AIMETIS
SYMPHONY, FIBERPATROL, FLARE, FLEXPI, FLEXZONE, OMNITRAX, PINPOINTER, SENNET, SENSTAR, SENTIENT, ULTRAWAVE and XFIELD are registered trademarks.
ARMOURFLEX,
ENTERPRISE MANAGER, INTELLI-FLEX, INTELLIFIBER, LM100, NETWORK MANAGER, STARLED, STARNET, SENSTAR CARE, SENSTAR logo, SENSTAR SYMPHONY,
SENSTAR SAFE SPACES and SENSTAR SENSOR FUSION and all other marks used to identify particular products and services associated with our
businesses are trademarks (unregistered). Any other trademarks and trade names appearing in this annual report are owned by their respective
holders.
Government Regulations
At
present, none of our products require a permit or license for export. We cannot assure that we will receive all the required permits and
licenses for which we may apply in the future. Furthermore, solicitations for procurements by governmental purchasing agencies are usually
governed by laws, regulations and procedures relating to procurement integrity, including avoiding conflicts of interest and corruption
in the procurement process.
In
addition, antitrust laws and regulations in countries in which we operate may require governmental approvals for transactions that are
considered to limit competition. Such transactions may include cooperative agreements for specific programs or areas, as well as mergers
and acquisitions.
C. |
Organizational Structure. |
We
have wholly owned and majority-owned active subsidiaries that operate world-wide. Set forth below are our significant subsidiaries.
Subsidiary Name |
Country of Incorporation/Organization |
Ownership Percentage |
Senstar Corporation |
Canada |
100% |
Senstar Inc. |
United States (Delaware) |
100% |
Senstar GmbH. |
Germany |
100% |
D. |
Property, Plants and Equipment. |
We
own a 33,000 square foot facility in Carp, Ontario, Canada. Approximately 9,000 square feet are devoted to administrative, marketing and
management functions, and approximately 8,000 square feet are used for engineering, system integration and customer service. We use the
remaining area of approximately 16,000 square feet for production operations, including cable manufacturing, assembly, testing, warehousing,
shipping and receiving. We own an additional 182,516 square feet of vacant land adjacent to this property, which is being held for future
expansion. We also lease 358,560 square feet of land near this facility for use as an outdoor sensor test and demonstration site for our
products including the Omnitrax buried cable intrusion detection system, the X-Field volumetric system, the FlexZone microphonic fence
detection system, Flash and Flare, and various perimeter monitoring and control systems. The lease expense for this site is approximately
$3,500 per year plus taxes under a lease that expires in November 2024.
We
lease office space in Waterloo, Canada, which houses our video management software operations. We also lease other sites world-wide. The
aggregate annual rent for such offices was approximately $260,000 in 2022.
We
also lease office space in Ramat-Gan, Israel which houses our corporate operations. The annual rent for this space is approximately $55,000
per year under a lease that expires in November 2023.
We
believe that our facilities are suitable and adequate for our current operations and the foreseeable future.
ITEM 4A.
Unresolved Staff Comments
Not
applicable.
ITEM 5. Operating
and Financial Review and Prospects
The
following discussion of our results of operations and financial condition should be read in conjunction with our consolidated financial
statements and the related notes thereto included elsewhere in this annual report. This discussion contains forward‑looking statements
that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward‑looking statements
as a result of certain factors, including, but not limited to, those set forth in Item 3.D. “Key Information–Risk Factors.”
Overview
Historically,
we had two operating segments, which also represented our reportable segments and reporting units. Magal Integrated Solutions (“Projects”
segment) and Senstar Product division (“Products” segment). On June 30, 2021, the Projects segment was sold. Therefore, the
results of the Projects segment were classified as discontinued operations in our consolidated statements of operations and thus excluded
from both continuing operations and segment results for all periods presented. Accordingly, we have one reportable segment with the change
reflected in all periods presented.
Our
consolidated revenues for the years ended December 31, 2022, 2021 and 2020 for our continuing operations were approximately $35.6 million,
$34.9 million and $33.4 million, respectively.
Products (PIDS, VMS, IVA and EAC)
We
sell our products worldwide. Our products include Video Management Software (VMS), Intelligent Video Analytics (IVA) and PIDS products.
The PIDS, VMS and IVA activities offer an unmatched portfolio of PIDS technologies, as well as, integrated intelligent video management
solutions for security surveillance and business intelligence applications worldwide.
Business Challenges/Areas of Focus
Our
primary business challenges and areas of focus include:
|
• |
continuing the growth of revenues and profitability of our perimeter security systems and video management systems lines of products;
|
|
• |
enhancing the introduction and recognition of our new products; |
|
• |
penetrating new markets and strengthening our presence in existing markets; |
|
• |
strengthening our presence in our strategic verticals; |
|
• |
succeeding in selling our comprehensive PIDS, VMS and EAC products as a combined solution. |
Our
business is subject to the effects of general global economic conditions. If general economic conditions or economic conditions in key
markets will be uncertain or weaken further, demand for our products could be adversely affected.
Key Performance Indicators and Sources of
Revenues
Our
management believes that our revenues and operating income are the two key performance indicators for our business.
Key Factors Affecting Our Business
Our
operations and the operating metrics discussed below have been, and will likely continue to be affected by certain key factors as well
as certain historical events and actions. The key factors affecting our business and results of operations include among others, reliance
on public sector projects, and competition. For further discussion of the factors affecting our results of operations, see “Risk
Factors.”
Growth Strategy
During
2022 and following the divestiture of our Integrated Solutions (Projects) division,] we continued our recent strategic growth plan focusing
on the sale of our Senstar products and solutions. Pursuant to the plan, we streamlined our product sales activity in our three main regions,
the Americas (including LATAM), EMEA, and APAC. In 2022, we addressed the Chinese market with the establishment of Senstar China. We are
continuing to focus on our strategic verticals: critical infrastructure, Energy (oil and gas), logistics and correctional facilities).
We intend to continue to expand our sales to these verticals through allocation of resources and funds, including the acquisition of complementary
technologies that will increase our offerings to these targeted verticals.
If
we are successful in the implementation of our strategic plan, we may be required to hire additional employees in order to meet customer
demands. If we are unable to attract or retain qualified employees, our business could be adversely affected.
We
may not be able to implement our growth strategy plan and may not be able to successfully expand our business activity and increase our
sales. Our failure to successfully integrate the operations of an acquired business or to retain key employees of acquired businesses
and integrate and manage our growth may have a material adverse effect on our business, financial condition, results of operation or prospects.
We may not be able to realize the anticipated benefits of any acquisition. Moreover, future acquisitions by us could result in potentially
dilutive issuances of our equity securities, the incurrence of debt and contingent liabilities and amortization expenses related to identifiable
intangible assets, any of which could materially adversely affect our operating results and financial position. Acquisitions also involve
other risks, including risks inherent in entering markets in which we have no or limited prior experience.
Reliance on government contracts
Our
products are primarily sold to end-users such as governmental agencies, governmental authorities, and government-owned companies, many
of which have complex and time-consuming procurement procedures. A substantial period of time often elapses from the time we begin marketing
a product until we actually sell that product to a particular customer. In addition, our sales to governmental agencies', authorities'
and companies' projects are directly affected by these end-users budgetary constraints and the priority given in their budgets to the
procurement of our products. A decrease in governmental funding for our end-users’ budgets would adversely affect our results of
operations. This risk is heightened during periods of global economic slowdown. Accordingly, governmental purchases of our systems, products
and services may decline in the future if governmental purchasing agencies terminate, reduce or modify contracts.
Competition
The
global market for safety, security, video management, site management solutions and products is highly fragmented and intensely competitive.
It is characterized by changing technology, new product introductions and changing customer requirements. We compete principally in the
market for perimeter intrusion detection systems, or PIDS and video management systems. Some of our competitors and potential competitors
have greater research, development, financial and personnel resources, including governmental support. We cannot assure you that we will
be able to maintain the quality of our products relative to those of our competitors or continue to develop and market new products effectively.
Continued competitive pressures could cause us to lose significant market share.
Functional Currency and
Financial Statements in U.S. Dollars
While
our functional currency in Israel is the NIS, our reporting currency is the U.S. dollar. Translation adjustments resulting from translating
our financial statements from NIS and other local operation currencies to the U.S. dollar are reported as a separate component in shareholders’
equity.
The
first step in the translation process is to identify the functional currency for each entity included in the financial statements. The
accounts of each entity are then “re-measured” in its functional currency. All transaction gains and losses from the re-measurement
of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate. Non-monetary
assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction.
After
the re-measurement process is complete the financial statements are translated into our reporting currency, which is the U.S. dollar,
using the current rate method. Equity accounts are translated using historical exchange rates. All other balance sheet accounts are translated
using the exchange rates in effect at the balance sheet date. Statement of operations amounts have been translated using the average exchange
rate for the year. The resulting translation adjustments are reported as a component of shareholders’ equity. For the years ended
December 31, 2022, 2021 and 2020, our foreign currency translation adjustments totaled $9.7 million, $9.7 million and $9.1 million, respectively.
We recorded foreign exchange gain, net of $0.4 million in the years ended December 31, 2022 and foreign exchange losses, net of $1 million
and $1 million in the years ended December 31, 2021 and 2020, respectively. This is due to the adjustment of monetary assets and liabilities,
denominated in currencies, other than the functional currency of the operational entities in the group. At the end of each period, a change
in currency valuation of monetary assets and liabilities is recorded as a non-cash financial expense or income. The Israeli Shekel appreciated
by 13.2% against the U.S. dollar in 2022 and depreciated by 3.3% and 7.0% against the U.S. dollar in 2021 and 2020, respectively.
Concentrations of credit
risk
Financial
instruments that are potentially subject to concentrations of credit risk consist principally of cash and cash equivalents, short and
long-term bank deposits, unbilled accounts receivable, trade receivables, long-term trade receivables and long-term loans.
As
of December 31, 2022, $8.8 million of our cash and cash equivalents and restricted cash and short-term deposits were invested in major
Israeli and U.S. banks, and approximately $6.2 million were invested in other banks, mainly with the Royal Bank of Canada, Deutsche Bank
and Natwest Bank. Cash and cash equivalents deposited with U.S. banks or other banks may be in excess of insured limits and are not insured
in other jurisdictions. Generally, these deposits maybe redeemed upon demand and therefore bear low risk.
The
trade receivables and the unbilled accounts receivable of our company and our subsidiaries are derived from sales to large and solid organizations
located mainly the United States, Canada, and Europe. We perform ongoing credit evaluations of our customers and to date have generally
not experienced any material losses. An allowance for credit losses is recognized with respect to those amounts that we have determined
to be doubtful of collection. In certain circumstances, we may require letters of credit, other collateral or additional guarantees. During
the years ended December 31, 2022, 2021 and 2020 we recorded less than $0.1 million, $0.1 million and $0.1 million of expenses related
to credit losses, respectively. As of December 31, 2022, our allowance for credit losses amounted to $0.1 million.
We
have no significant off-balance sheet concentration of credit risks, such as foreign exchange contracts or foreign hedging arrangements.
Recent Developments
During
the years 2020 and 2021 the COVID-19 pandemic had an adverse effect on our industry and the markets in which we operate. During that time,
the COVID-19 outbreak significantly impacted our sales. We also experienced postponed and delayed orders in certain areas of our businesses.
Further, the guidance of social distancing, lockdowns, quarantines and the requirements to work from home in various key territories such
as Canada, United States, APAC, EMEA and other countries, in addition to greatly reduced travel globally, resulted in a substantial curtailment
of business activities, which affected our ability to deliver products and services in the areas where restrictions were implemented
by the local governments. In addition, certain of our sales and support teams were unable to travel or meet with customers and the pandemic
threat caused operating, manufacturing, supply chain and project development delays and disruptions, labor shortages, travel and shipping
disruptions and shutdowns (including as a result of government regulation and prevention measures). As a result, we experienced a
reduction in business in 2020. The regression of the pandemic during 2022, followed by lifting of travel restrictions and social distancing
regulations, except in APAC, led to some recovery in our business. In the twelve months ended December 31, 2022, our revenue was $35.6
million, compared to $34.9 million in the comparable period of 2021, and $33.4 million in the comparable period of 2020.
COVID
was still a major factor in APAC during 2022 which caused delays in sales and marketing activities.
Most
of our administrative functions can be performed remotely. Our ability to collect money, pay bills, handle customer communications, schedule
production, and order raw materials necessary for our production has not been materially impacted. To date we have not experienced a significant
change in the timeliness of payments of our invoices and our cash position remains stable.
We
had to occasionally adjust our manufacturing routine due to restrictions resulting from the Covid-19 pandemic, such as lack of material.
We had managed to continue manufacturing and deliveries of our products to our customers throughout 2022.
Supply
chain disruptions have been exacerbated in 2022 as major shipping ports and manufacturing facilities in Asia have been affected by Covid-19
variants. The disruption to global supply chains has led to longer supplier delivery times and an increase in material prices.
The
following table presents certain financial data expressed as a percentage of revenues for the periods indicated for the continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
100 |
% |
|
|
100 |
% |
|
|
100 |
% |
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, net
|
|
|
11 |
% |
|
|
11 |
% |
|
|
12 |
% |
Selling and marketing, net
|
|
|
25 |
% |
|
|
29 |
% |
|
|
26 |
% |
General and administrative
|
|
|
20 |
% |
|
|
20 |
% |
|
|
19 |
% |
Operating income |
|
|
4 |
% |
|
|
3 |
% |
|
|
9 |
% |
Financial income (expenses), net |
|
|
- |
|
|
|
(3 |
)% |
|
|
(3 |
)% |
Income before income taxes |
|
|
5 |
% |
|
|
- |
|
|
|
6 |
% |
Taxes on income (tax benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2022 Compared with
Year Ended December 31, 2021 (for continuing operations)
Revenues.
Revenues from continuing operations increased by 1.8% to $35.6 million for the year ended December 31, 2022 from $34.9 million
for the year ended December 31, 2021. The increase relates to some recovery in our business which was impacted by the COVID-19 pandemic.
Cost
of revenues. Cost of revenues increased by 8.7% to $14.1 million for the year ended December 31, 2022 from $12.9 million for the
year ended December 31, 2021. Cost of revenues as a percentage of revenues increased to 40% in 2022 from 37.0% in 2021, primarily due
to our revenue mix, some increases in the material costs and due to subsidies granted to our Canadian subsidiary under the Canada Emergency
Wage Subsidy program in 2021.
Research
and development expenses, net. Research and development expenses, net slightly increased by 2.5% to $4.0 million for the year ended
December 31, 2022 from $3.9 million for the year ended December 31, 2021.
Selling
and marketing expenses. Selling and marketing expenses decreased by 9.9% to $9.0 million for the year ended December 31, 2022 from
$10.0 million for the year ended December 31, 2021, primarily due to reduction costs is sales employees. Selling and marketing expenses
as a percentage of revenues decreased to 25.3% in 2022 from 28.6% in 2021.
General
and administrative expenses. General and administrative expenses slightly increased by 0.1% to $7 million for the year ended December
31, 2022 from $7.0 million for the year ended December 31, 2021. General and administrative expenses amounted to 19.6% and 20% of revenues
in 2022 and 2021, respectively.
Operating
income. We had operating income of $1.5 million for the year ended December 31, 2022 compared to operating income of $1.1 million
for the year ended December 31, 2021. The increase in operating income was primarily attributable to an increase in revenues and operating
expenses savings.
Financial
income (expenses), net. Our financial income, net, for the year ended December 31, 2022 was $0.1 million compared to financial
expenses, net of $1 million for the year ended December 31, 2021. The financial income in 2022 were primarily attributable to foreign
exchange gain, net, offset by interest expenses during the year.
Income
taxes. We recorded tax benefits, net $2.4 million in the year ended December 31, 2022 compared to tax expenses of $2.3 million
in the year ended December 31, 2021, primarily due to a different geographical mix of pre-tax profitability as well as recovery of provisions
for uncertain tax positions and deferred tax asset.
Year Ended December 31, 2021 Compared with
Year Ended December 31, 2020 (for continuing operations)
Please
see Item 5 in the Form 20-F for the Year ended December 31, 2021 filed on April 27, 2022 for this comparison
Seasonality
Our
operating results are characterized by a seasonal pattern, with a higher volume of revenues towards the end of the year and lower revenues
in the first part of the year. This pattern, which is expected to continue, is mainly due to two factors:
|
• |
our customers are mainly budget-oriented organizations with lengthy decision processes, which tend to mature late in the year; and
|
|
• |
due to harsh weather conditions in certain areas in which we operate during the first quarter of the calendar year, certain projects
and services are put on hold and consequently revenues are delayed. |
Our
revenues are partly dependent on government procurement procedures and practices therefore our revenues and operating results are subject
to substantial periodic variations.
Impact of Currency Fluctuations on Results
of Operations, Liabilities and Assets
We
sell most of our products in North America, Europe and APAC. Our financial results, which are reported in U.S. dollars, are affected by
changes in foreign currency. Our revenues are primarily denominated in U.S. dollars and Euros, while a portion of our expenses, primarily
labor expenses, is incurred in NIS and CAD. Additionally, certain assets, especially cash, trade receivables and other accounts receivables,
as well as part of our liabilities are denominated in NIS and CAD. As a result, fluctuations in rates of exchange between the U.S. dollar
and non-U.S. dollar currencies may affect our operating results and financial condition. The dollar cost of our operations in Israel may
be adversely affected by the appreciation of the NIS against the U.S. dollar. The dollar cost of our operations in Canada may be adversely
affected by the appreciation of the CAD against the U.S. dollar. In addition, the value of our non-U.S. dollar revenues could be adversely
affected by the depreciation of the U.S. dollar against such currencies.
The
appreciation of the NIS, the CAD and the Euro in relation to the U.S. dollar has the effect of increasing the U.S. dollar value of any
unlinked assets and the U.S. dollar amounts of any unlinked liabilities and increasing the U.S. dollar value of revenues and expenses
denominated in other currencies. Conversely, the depreciation of the NIS, the CAD and the Euro in relation to the U.S. dollar has the
effect of reducing the U.S. dollar value of any of our liabilities which are payable in New Israeli Shekel, Canadian dollars and Euro
(unless such costs or payables are linked to the U.S. dollar). Such depreciation also has the effect of decreasing the U.S. dollar value
of any asset that is denominated in NISs, CADs and Euros or receivables payable in NIS, CAD and Euro (unless such receivables are linked
to the U.S. dollar). In addition, the U.S. dollar value of revenues and expenses denominated in NIS, CAD or Euro would increase. Because
foreign currency exchange rates fluctuate continuously, exchange rate fluctuations may have an impact on our profitability and period-to-period
comparisons of our results. The effects of foreign currency re-measurements are reported in our consolidated financial statements in current
operations.
The
following table presents the rate of devaluation or appreciation of the NIS against the dollar. These metrics provide insight on the impact
of currency fluctuations on our financial results.
Year
ended
December
31, |
|
NIS
devaluation (appreciation)
rate
% |
|
|
|
2018
|
|
8.1 |
2019
|
|
(9.8) |
2020
|
|
(7.0) |
2021
|
|
(3.3) |
2022
|
|
13.2 |
The
U.S. dollar cost of our operations in Canada is influenced by the exchange rate between the U.S. dollar and the CAD. In 2022, the CAD
depreciated against the U.S. dollar by 6.4%. In 2021 and 2020 the CAD appreciated against the U.S. dollar by 0.1% and 2.1%, respectively.
In
2022 foreign currency fluctuations had a positive impact on our results of operations as we recorded foreign exchange gain, net of $0.4
million. In 2021 and 2020, foreign currency fluctuations had a negative impact on our results of operations as we recorded foreign exchange
loss, net of $1 million and $1 million, respectively.
We
expect that our results of operations will continue to be affected by currency fluctuations in the future.
Conditions in Israel
We
are incorporated under the laws of State of Israel. See Item 3D “Key Information – Risk Factors – Risks Relating to
Our Location in Israel” for a description of governmental, economic, fiscal, monetary and political policies or factors that have
materially affected or could materially affect our operations.
Effective Corporate Tax Rate
The
Israeli corporate tax rate has been 23% since 2018.
Our
effective corporate tax rate may substantially exceed the Israeli tax rate since our U.S.-based subsidiaries will generally be subject
to applicable federal, state, local and foreign taxation, and we may also be subject to taxation in the other foreign jurisdictions in
which we own assets, have employees or conduct activities. Because of the complexity of these local tax provisions, it is not possible
to anticipate the actual combined effective corporate tax rate, which will apply to us.
As
of December 31, 2022, we had a net deferred tax assets of $1.1 million, of which $0.7 million in domestic deferred tax liability offset
by $1.8 million in foreign deferred tax asset. We had total estimated available operating tax loss carryforwards of $9.4 million with
respect to our operations in Israel to offset against future taxable income. We have recorded a full valuation allowance for such carryforward
tax losses due to the uncertainty of their future realization. As of December 31, 2022, our subsidiaries outside of Israel had estimated
total available carryforward operating tax losses of $5.6 million, of which $5.3 million was attributable to our U.S. subsidiaries (federal
only), which may be used as an offset against future taxable income for periods ranging between 1 and 20 years. Utilization of U.S. net
operating losses may be subject to a substantial annual limitation due to the “change in ownership” provisions of the Internal
Revenue Code of 1986 and similar state tax law provisions. The annual limitation may result in the expiration of net operating losses
before utilization.
Trade Relations
Israel
is a member of the United Nations, the International Monetary Fund, the International Bank for Reconstruction and Development and the
International Finance Corporation. Israel is a member of the World Trade Organization and is a signatory to the General Agreement on Tariffs
and Trade. Israel is also a member of the Organization for Economic Co-operation and Development, or the OECD, an international organization
whose members are governments of mostly developed economies. The OECD’s main goal is to promote policies that will improve the economic
and social well-being of people around the world. In addition, Israel has been granted preferences under the Generalized System of Preferences
from the United States, Australia, Canada and Japan. These preferences allow Israel to export products covered under such programs either
duty-free or at reduced tariffs.
B. |
Liquidity and Capital Resources |
Cash
and cash equivalents and short-term deposits amounted to $15.0 million at December 31, 2022 compared to $26.4 million at December 31,
2021. The decrease in cash and cash equivalents is primarily due to net cash used in operating activities as well as investing activities
which was slightly offset by net cash used in financing activities. Our cash and cash equivalents, short and long-term bank deposits are
held in various banks, mainly in U.S. dollars, Euros, NIS and CAD.
From
our inception until our initial public offering in March 1993, we financed our activities mainly through cash flow from operations. In
March 1993, we received proceeds of $9.8 million from our initial public offering of 1,380,000 ordinary shares. Subsequently, we made
follow-on public offerings, in February 1997 (of 2,085,000 ordinary shares) and in April 2005 (of 1,700,000 ordinary shares), in which
we raised $9.4 million and $14.9 million, respectively. To allow us to begin to implement a new strategic plan, on September 8, 2010,
a company affiliated with our former principal shareholder, provided us with a bridge loan of $10.0 million. To repay the loan and to
raise permanent capital for general working capital purposes including facilitating the implementation of our new business strategy, in
July and August 2011 we raised $16.2 million from rights offering of 5,273,274 ordinary shares and a private placement of 150,000
of our ordinary shares.
In
October 2016, we completed a rights offering in which we received gross proceeds of approximately $23.8 million from the sale of 6,170,386
ordinary shares. Our controlling shareholders, FIMI V Funds purchased 3,392,869 ordinary shares including through an exercise of over-subscription
rights.
In
2016, we paid approximately $12.1 million, (including $0.8 million placed in escrow to secure potential indemnity obligations and net
of cash acquired) in consideration of our acquisition of Aimetis in 2016, and approximately $0.4 million (net of $2.4 million of acquired
cash) in consideration of our acquisition of a majority interest in ESC BAZ Ltd. in 2018.
In
connection with our acquisition of CyberSeal, we issued warrants to purchase 898,203 of our ordinary shares at an exercise price of $4.16
per share to CyberSeal's former owners. Of such warrants, 60,000 warrants were exercised in 2017. In October 2018, we agreed to purchase
the remaining 838,203 warrants from the warrant holders for an aggregate consideration of $375,000. Under Israeli law, the consummation
of such transaction was subject to court approval, which was granted on January 16, 2019. The closing of the purchase of the warrants
occurred in March 2019.
On
December 7, 2020, following receipt of the required court approval under Israeli law, we announced a cash distribution in the amount of
US$1.079 per share (approximately US$ 25 million in the aggregate) which was paid on December 28, 2020. On December 31, 2020 we paid approximately
$1.9 million in consideration for the remaining 45% interest in ESC BAZ.
On
August 16, 2021, following the completion of the sale of our Integration Solution Division and the receipt of the required court approval
under Israeli law, we announced a cash distribution in the amount of US$1.725 per share (approximately US$40 million in the aggregate)
which was paid on September 22, 2021.
We
expect that our total research and development expenses in 2023 will be approximately $4.6 million. Our research and development plan
for 2023 covers development of new and innovative products, as well as the improvement of existing technologies.
We
believe that our cash and cash equivalents, bank facilities, bank deposits and our expected cash flows from operations will be sufficient
to meet our ongoing cash requirements through 2023. However, our liquidity could be negatively affected by a decrease in demand for our
products, including the impact of potential reductions in customer purchases that may result from the current general economic climate.
Cash Flows
The following table summarizes our cash
flows for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
|
Net cash provided by (used in) operating activities |
|
|
(9,515 |
) |
|
|
6,029 |
|
|
|
2,317 |
|
Net cash provided by (used in) investing activities |
|
|
(237 |
) |
|
|
31,725 |
|
|
|
16,220 |
|
Net cash provided by (used in) financing activities |
|
|
19 |
|
|
|
(39,683 |
) |
|
|
(28,785 |
) |
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(1,727 |
) |
|
|
981 |
|
|
|
2,828 |
|
Increase (decrease) in cash, cash equivalents and restricted
cash |
|
|
(11,460 |
) |
|
|
(948 |
) |
|
|
(7,420 |
) |
Cash, cash equivalents and restricted cash at the beginning of
the year, including cash attributable to discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash at the end of the
year, including cash attributable to discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
Less: Cash, cash equivalents, and restricted cash attributable
to discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and restricted cash from continuing operations
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
cash used in operating activities in the year ended December 31, 2022 was approximately $9.5 million, compared to net cash provided by
operating activities of approximately $6.0 million and $2.3 million in the year ended December 31, 2021 and 2020, respectively.
Net
cash used in operating activities in the year ended December 31, 2022 was primarily attributable to a decrease of $7.4 million in other
accounts payable and accrued expenses and deferred revenues, an increase of $3.2 million in inventories, an increase of $2.5 million in
trade receivables, an increase of $1.4 million in deferred income taxes and an increase of $0.3 million in unbilled receivables. This
was offset in part by our profit in 2022, as well as $1.4 million of depreciation and amortization expenses and a decrease of $0.5 million
in other accounts receivable and prepaid expenses.
Net cash provided by operating activities
in the year ended December 31, 2021 was primarily attributable to our profit in 2021, as well as $1.9 million of depreciation and amortization
expenses, a decrease of $11.1 million in trade receivables, a decrease of $2.6 million in unbilled receivables and a decrease of $1.4
million in deferred income taxes. This was offset in part by the gain on divestiture of the Integrated Solutions Division of $14.9 million,
a decrease of $0.8 million in trade payables, an increase of $0.7 million in inventories, a decrease of $0.5 million in customer advances,
changes in accrued severance pay, net of $0.3 million and a decrease of $0.2 million in other accounts payable and accrued expenses and
deferred revenues.
Net
cash provided by operating activities in the year ended December 31, 2020 was primarily attributable to our profit in 2020, as well as
$2.0 million of depreciation and amortization expenses, an increase of $1.9 million in trade payables, an increase of $1.8 million in
other accounts payable and accrued expenses and deferred revenues, a decrease of $0.9 million in deferred income taxes and a decrease
of $0.8 million in inventories. This was offset in part by an increase of $2.1 million in unbilled receivables, an increase of $1.6 million
in trade receivables, a decrease of $1.5 million in customer advances and an increase of $0.5 million in other accounts receivables and
prepaid expenses.
Net
cash used in investing activities of approximately $0.2 million in the year ended December 31, 2022, compared to net cash provided by
investing activities of approximately $31.7 million and $16.2 million in the years ended December 31, 2021 and 2020, respectively.
In
the year ended December 31, 2022, our net cash used in investing activities was primarily attributable to purchase of property and equipment
for $0.2 million.
In
the year ended December 31, 2021, our net cash provided by investing activities was primarily attributable to the divestiture of the Integrated
Solutions Division for $32.6 million. This was offset in part by purchase of property and equipment for $0.8 million.
In
the year ended December 31, 2020, our net cash provided by investing activities was primarily attributable to sale of short-term bank
deposits of $17.0 million. This was offset in part by purchase of property and equipment for $0.8 million.
Net
cash provided by financing activities of approximately $19 thousands in the year ended December 31, 2022, compared to net cash used in
financing activities of approximately $39.7 million and $28.8 million in the years ended December 31, 2021 and 2020, respectively.
In
the year ended December 31, 2022, our net cash provided by financing activities was attributable to the proceeds from the issuance of
shares upon exercise of options of $19 thousands.
In
the year ended December 31, 2021, our net cash used in financing activities was attributable to cash distribution to Company’s shareholders
of $40.1 million. This was offset in part by the proceeds from the issuance of shares upon exercise of options of $0.4 million.
In
the year ended December 31, 2020, our net cash used in financing activities was attributable to the cash distribution to our company’s
shareholders of $25 million, a dividend to redeemable non-controlling interests of $1.9 million and the purchase of redeemable non-controlling
interests of $1.9 million.
For
our continuing operations, we had capital expenditures for property and equipment of approximately $0.2 million, $0.6 million and $0.4
million, in the years ended December 31, 2022 and 2021 and $2020, respectively. We estimate that our capital expenditures for 2023 will
total approximately $0.4 million. We expect to finance these expenditures primarily from our cash and cash equivalents and our operating
cash flows. However, the actual amount of our capital expenditures will depend on a variety of factors, including general economic conditions
and changes in the demand for our products.
Credit Lines and Other Debt
As
of December 31, 2022, we had credit lines with Bank Leumi Le-Israel B.M., or Bank Leumi, and Mizrahi-Tefahot Bank., or UMTB, totaling
$1.6 million in the aggregate, out of which $0.1 million was available as of December 31, 2022. Our credit lines at Bank Leumi and UMTB
have no restrictions as to our use of the credit. We are not under any obligation to maintain financial ratios or other terms in respect
of our credit lines. In addition, as of December 31, 2022, our foreign subsidiary had credit lines with the Royal Bank of Canada of $0.6
million in the aggregate, of which $0.5 million was available at December 31, 2022.
As
of December 31, 2022, our outstanding balances under our credit lines in Israel consisted of several bank performance, advance payment
and bid guarantees totaling approximately $1.5 million, at an annual cost of 0.65%-1%. As of December 31, 2022, the outstanding balances
under the credit lines of our subsidiary consisted of several bank performance, advance payment and bid guarantees totaling approximately
$0.1 million, at an annual cost of approximately 1.7%.
We
have no significant off-balance sheet concentration of credit risks, such as foreign exchange contracts or foreign hedging arrangements.
C. |
Research and Development, Patents and Licenses. |
Government Grants
We
participate in programs sponsored by the Industrial Research Assistance Program (IRAP) in Canada. During 2022 our Canadian subsidiary
recognized IRAP funding in the amount of $89,000. During 2021 and 2020 our Canadian subsidiary did not receive any grants with respect
to such programs.
Investment Tax Credit
Our
Canadian subsidiary is eligible for investment tax credits for its research and development activities and for certain current expenditures.
For the years ended December 31, 2022, 2021 and 2020, our Canadian subsidiary recognized $140,000, $152,000 and $151,000, respectively,
of investment tax credits.
In
addition, as of December 31, 2022, our U.S. subsidiary had available investment tax credits of approximately $165,000 to reduce future
federal and state income taxes payable. These credits will expire in 2023 through 2025 in the U.S. As of December 31, 2022, our subsidiaries
made a full valuation allowance in respect of such investment tax credits.
Our
operations were negatively affected by the worldwide shortage of various materials and sub-components required to produce certain of our
PIDS products. We are monitoring the supply chain shortage, vs our ongoing and forecasted manufacturing requirements, while implementing
various procurement methodologies to meet current and forecasted demand for our products. However, our ability to continue meeting the
demand for our products is dependent among others, on our ability to maintain an effective procurement plan support from our suppliers,
and when needed establish a contractual relationship with alternative suppliers.
E. |
Critical Accounting Estimates |
The
preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and the use of
different assumptions would likely result in materially different results of operations. Critical accounting policies are those that are
both most important to the portrayal of our financial position and results of operations and require management’s most difficult,
subjective or complex judgments. Although not all of our significant accounting policies require management to make difficult, subjective
or complex judgments or estimates, the following policies and estimates are those that we deem most critical
Explanation
of Key Income Statement Items
Cost
of revenues. Our cost of revenues for perimeter products consists of component and material costs, direct labor costs, subcontractor
costs, shipping expenses, overhead related to manufacturing and depreciation. Our cost of revenues for Video Security sales consists primarily
of direct labor costs, some component, material and subcontractor costs and overhead related to those sales.
In
the past, our gross margin was affected by the proportion of our revenues generated from our Products and Projects segments. Historically,
our revenues from Products generally had higher gross margins than our Projects revenues.
Research
and development expenses, net. Research and development expenses, net consists primarily of expenses for on-going research and
development activities and other related costs.
Selling
and marketing expenses. Selling and marketing expenses consist primarily of commission payments, compensation and related expenses
of our sales teams, attendance at trade shows and advertising expenses and related costs for facilities and equipment.
General
and administrative expenses. Our general and administrative expenses consist primarily of salary and related costs associated with
our executive and administrative functions, public company related expenses, legal and accounting expenses, allowances for credit losses
and bad debts and other miscellaneous expenses. Staff costs include direct salary costs and related costs, such as severance pay, social
security and retirement fund contributions, vacation and other pay.
Depreciation
and Amortization and impairment of goodwill. The
amount of depreciation and amortization attributable to our Products segment for the years ended December 31, 2022, 2021 and 2020 were
approximately $1.4 million, $1.5 million and $1.2 million, respectively.
Financial
Expenses, Net. Financial expenses, net include exchange rate differences arising from changes in the value of monetary assets and
monetary liabilities stated in currencies other than the functional currency of each entity, currency transactions as well as interest
income on our cash and cash equivalents and short term investments.
Revenue Recognition
We
recognize revenues from continuing operations in accordance with ASC No. 606, "Revenue from Contracts with Customers" ("ASC No. 606").
As such, we identify a contract with a customer, identify the performance obligations in the contract, determine the transaction price,
allocate the transaction price to each performance obligation in the contract and recognize revenues when (or as) we satisfy a performance
obligation.
Following
the sale of the Integrated Solution Division, we generate our revenues mainly from: (1) sales of security products; (2) services and maintenance,
which are performed either on a fixed-price basis or as time-and-materials based contracts; (3) software license fees and related services;
and (4) force protection systems project for which revenues are generated from long-term fixed price contracts.
We
enter into contracts that can include combinations of products and services, which are generally capable of being distinct and accounted
for as separate performance obligations. The perpetual license is distinct as the customer can derive the economic benefit of the software
without any professional services, updates or technical support.
The
transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services
to the customer. We usually do not grant a right of return to our customers.
In
instances of contracts where revenue recognition differs from the timing of invoicing, we generally determined that those contracts do
not include a significant financing component. We use the practical expedient and do not assess the existence of a significant financing
component when the difference between payment and revenue recognition is a year or less.
Maintenance
and support agreements provide customers with rights to unspecified software product updates, if and when available. These services grant
the customers online and telephone access to technical support personnel during the term of the service. We recognize maintenance and
support services revenues ratably over the term of the agreement, usually one year.
We
generate revenues from the sales of its software products user licenses as well as from maintenance, support, consulting and training
services.
As
required by ASC 606, following the determination of the performance obligations in the contract, we allocate the total transaction price
to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised license fees or
services underlying each performance obligation. Standalone selling price is the price at which we would sell a promised license or service
separately to a customer.
Revenues
for performance obligations that are not recognized over time are recognized at the point in time when control is transferred to the customer
(which is generally upon delivery) and included mainly revenues from the sales of security products without significant installation work.
We generally do not provide a right of return to our customers. For performance obligations that are satisfied at a point in time, we
evaluated the point in time when the customer can direct the use of, and obtain the benefits from, the products. Shipping and handling
costs are not considered performance obligations and are included in cost of sales as incurred.
Services
and maintenance are performed under either fixed-price or time-and-materials based contracts. Under fixed-price contracts, we agreed to
perform certain work for a fixed price. Under time-and-materials contracts, we are reimbursed for labor hours at negotiated hourly billing
rates and for materials. Our service contracts included contracts in which the customer simultaneously receives and consumes the benefits
provided as the performance obligations are satisfied, accordingly, related revenues are recognized, as those services are performed or
over the term of the related agreements.
For
our force protection systems contract, where our performance does not create an asset with an alternative use, we recognized revenue over
performance time because of continuous transfer of control to the customer. For these performance obligations that are satisfied over
time, we recognize revenue using an input method with revenue amounts being recognized proportionately as costs are incurred relative
to the total expected costs to satisfy the performance obligation.
Inventories
Inventories
are stated at the lower of cost or market value. We periodically evaluate the quantities on hand relative to historical and projected
sales volumes, current and historical selling prices and contractual obligations to maintain certain levels of parts. Based on these evaluations,
inventory write-offs are provided to cover risks arising from slow-moving items, discontinued products, excess inventories, market prices
lower than cost and adjusted revenue forecasts. Cost is determined as follows:
|
• |
Raw materials, parts and supplies – using the “first-in, first-out” method. |
|
• |
Work-in-progress and finished products – on the basis of direct manufacturing costs with the addition of allocable indirect
manufacturing costs. |
During
the years ended December 31, 2022, 2021 and 2020 we recorded inventory write-offs from continuing operations in the amounts of $21,000,
$0.1 million and $29,000, respectively. Such write-offs were included in cost of revenues.
Income taxes
We
account for income taxes in accordance with ASC 740 “Income Taxes.” This statement prescribes the use of the liability method
whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases
of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected
to reverse. We provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.
As
part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions
in which we operate. This process involves estimating our actual current tax exposure together with assessing temporary differences resulting
from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which
are included within our consolidated balance sheet. We must then assess the likelihood that our deferred tax assets will be recovered
from future taxable income and we must establish a valuation allowance to reduce our deferred tax assets to the amount that is more likely
than not to be realized. Increases in the valuation allowance result in additional expense to be reflected within the tax provision in
the consolidated statement of income.
As
of December 31, 2022, we had a net deferred tax assets of $1.1 million, of which $0.7 million in domestic deferred tax liability offset
by $1.8 million in foreign deferred tax asset. We had total estimated available operating tax loss carryforwards of $9.4 million with
respect to our operations in Israel. Our non-Israeli subsidiaries had estimated total available operating tax loss carryforwards of $5.6
million, of which $5.3 million was attributable to our U.S. subsidiaries (federal only), which may be used as an offset against future
taxable income for periods ranging between 1 and 20 years. As of December 31, 2022, we recorded a partial valuation allowance on these
carryforward tax losses and other temporary differences that management believes are not expected to be realized in the foreseeable future
and other temporary differences that management believes are not expected to be realized in the foreseeable future. Utilization of U.S.
net operating losses may be subject to a substantial annual limitation due to the “change in ownership” provisions of the
Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses
before utilization.
Goodwill
Goodwill
and certain other purchased intangible assets have been recorded as a result of acquisitions. Goodwill represents the excess of the purchase
price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill is not amortized, but rather
is subject to an impairment test.
ASC
No. 350, "Intangible-Goodwill and other" requires goodwill to be tested for impairment at least annually and, in certain circumstances,
between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment
testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value
is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that
the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. Alternatively, ASC No. 350 permits
an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment
test
If
the carrying value of a reporting unit exceeds its fair value, we should recognize an impairment of goodwill for the amount of this excess.
We perform an annual impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present.
As
of June 30, 2021, as a result of the sale of the Projects segment, we began operating as one operating segment with a single reporting
unit.
In
2020, we operated as two operating segments, each comprised of one reporting unit. For the purposes of impairment testing of goodwill,
we identified two reporting units to which goodwill relates: (1) Products reporting unit which comprises the Products segment and; (2)
ESC BAZ reporting unit within the Projects segment.
For
the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.
Intangible assets
Our
intangible assets are comprised of patents, acquired technology, customer relations and backlog. Intangible assets are amortized over
their useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are
consumed or otherwise used up, in accordance with ASC 350, “Intangibles – Goodwill and Other.”
For
the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.
Impairment of long-lived
assets
Our
long-lived assets (assets group) to be held or used, including right of use assets and intangible assets that are subject to amortization,
are reviewed for impairment in accordance with ASC 360, "Property, Plant, and Equipment" whenever events or changes in circumstances indicate
that the carrying amount of a group of assets may not be recoverable. Recoverability of a group of assets to be held and used is measured
by a comparison of the carrying amount of the group to the future undiscounted cash flows expected to be generated by the group. If such
group of assets is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of
the assets exceeds their fair value. For the years ended December 2022, 2021 and 2020, we did not record any impairment charges attributable
to long-lived assets.
ITEM 6.
Directors, Senior Management and Employees
A. |
Directors and Senior Management. |
Set
forth below are the name, age, principal position and a biographical description of each of our directors and executive officers:
Name |
|
Age |
|
Position |
Gillon Beck |
|
61 |
|
Chairman of the Board of Directors |
Jacob Berman |
|
74 |
|
Director |
Avraham Bigger (1)(2)
|
|
77 |
|
Director |
Limor
Steklov (1)(2) |
|
52 |
|
External Director |
Moshe
Tsabari (1)(2) |
|
69 |
|
External Director |
Dror Sharon* |
|
57 |
|
Chief Executive Officer |
Tomer Hay |
|
46 |
|
Chief Financial Officer |
Fabien Haubert |
|
48 |
|
Vice President & Managing Director of Senstar - Head of the
Product Division |
(1) Member of our Audit Committees.
(2) Member of our Compensation Committee
* In January 2023, Mr. Sharon notified the Company of his intention
to retire from the position as Chief Executive Officer in the near future.
Gillon
Beck has served as a director and Executive Chairman of our board of directors since September 2014. Since 2003, Mr. Beck has been
a Senior Partner at FIMI Opportunity Funds, the controlling shareholder of Senstar, as well as a Director of the FIMI Opportunity Funds’
General Partners and SPV companies. In addition, Mr. Beck currently serves as Chairman of the Board of ImageSat NV, Emet Computing Ltd.
(TASE), Gal-Shvav Ltd, Bet Shemesh Engines Ltd. (TASE: BSEN), Inrom Industries Ltd., Bird Aerosystems Ltd, and is a director of Rafa Laboratories
Ltd., Simplivia Ltd., Orbit Technologies Ltd (TASE: ORBI), Carmel Forge Ltd., AITECH Ltd, Stern Engineering Ltd., Utron Ltd. ( TASE) and
Unitronics (1989) (RG) Ltd (TASE: UNIT). During the past five years, Mr. Beck had served as a member of the Board of Directors of the
following public companies: Overseas Commerce Ltd (TASE: OVRS), Ham-Let Ltd., Inrom Construction Ltd. From 1999 to 2003, Mr. Beck served
as Chief Executive Officer and President of Arad Ltd. (TASE Mr. Beck received a Bachelor of Science degree (Cum Laude) in Industrial Engineering
in 1990 from the Technion – Israel Institute of Technology, and a Master of Business Administration in Finance in 1992 from Bar-Ilan
University.
Jacob
Berman has served as a director since November 2013. Since November 2014 until March 2019, Mr. Berman had served as the chairman
of the board of directors of Israel Discount Bank of New York and acted as a member of our audit committee and compensation committee
between September 2014 and December 2014. Mr. Berman is the President and founder of JB Advisors, Inc., a New York based financial advisory
firm with extensive experience in international private banking, real estate investment counseling, and commercial/retail banking since
2002. Mr. Berman was the founder, President and CEO of the Commercial Bank of New York.
Avraham
Bigger has served as a director since September 2014. Mr. Bigger has been, since 2010, the owner and a member of the Board of Directors
of Bigger Investments Ltd. Mr. Bigger currently serves as the chairman of the board of PCB Technologies Ltd. and of the board at Recha,
board member at MCA (car import and distributor), international board member of the Weitzman Science Institute and a board member of the
Israel Nature and Heritage Foundation. He formerly served as the Chief Executive Officer and Chairman of the Board of Directors of Adama
Ltd. (formerly) Makhteshim Agam Industries Ltd.), Chairman of the Boards of Directors of Supersol Ltd. (TASE:SAE), Caniel Beverages &
Caniel Packaging Industries Ltd., the Edmond Benjamin de Rothschild Caesarea Foundation and as managing director of Paz Oil Company Ltd.
(TASE:PZOL) and Israel General Bank (U Bank). Mr. Bigger also served as a member of the Boards of Directors of Bank Leumi Le-Israel Ltd.
(TASE:LUMI), First International Bank of Israel Ltd. (TASE:FIBI), Strauss Group Ltd. (formerly known as Strauss-Elite Ltd.) (TASE:STRS),
Partner Communications Company Ltd. (TASE, NASDAQ:PTNR), Cellcom Israel Ltd. (TASE, NYSE:CEL), El-Al Israel Airlines Ltd., Migdal Insurance
and various private companies. Mr. Bigger received a Bachelor of Economics degree and an M.B.A. degree, both from the Hebrew University
of Jerusalem.
Limor
Steklov has served as an external director since August 2019. Ms. Steklov serves as the CFO of TNT Express Worldwide (Israel) Ltd.
Ms. Steklov has extensive experience in business partnering, combining business and financial visions, leading economic and business analytics,
leading worldwide/local projects, creating effective and efficient processes, and leading, coaching, motivating and mentoring large finance
teams. Ms. Steklov currently serves as a board member of the parent company of FEDEX Israel. Ms. Steklov holds a B.A. degree in economics
and accountancy from College of Management – Academic Studies (COMAS) in Rishon LeZion and a M.A. degree in law from Bar-Ilan University.
Moshe
Tsabari has served as an external director since December 2014. Since 2018 Mr. Tsabari has served as EVP for innovation at ICTS
Europe S.A. which is part of Groupe Sofinord S.A. Until 2018 Mr. Tsabari was the owner and had served as the joint CEO of GME Trust, a
company that advises on crisis management and improvement of work processes, in Israel and worldwide. Since 2005, Mr. Tsabari has served
as the owner and director of Osher – Training & Consulting Ltd. From 2006 to 2011 Mr. Tsabari served as a senior partner in
the International Company for Defense and Rescue Ltd. and in QG Company, two companies that are engaged in the provision of consultancy
and training projects in the security field in Israel. In addition, Mr. Tsabari is the founder of the International Institute for Researching
the Arab World, is a former director in Links Aviation and is the former CEO of SYS-TRY, an electronic equipment development company.
Prior to that, Mr. Tsabari served for 15 years, until 2004, in the Israeli Security Agency (ISA) in a number of positions, including Director
of Personal in the Human Resources Division, Director of Security Assistance Division (rank in both positions equivalent to Major General)
and Head of the Operations Division (rank equivalent to Brigadier). Mr. Tsabari holds a B.Sc. degree in Geodetic Engineering, a M.A. degree
in Industrial and Management Engineering and a PhD degree in Science, all from the Technion – The Israeli Institute of Technology.
In addition, Mr. Tsabari is an A.M.P. graduate from the Wharton School of the University of Pennsylvania.
Dror
Sharon has served as our Chief Executive Officer since June 24, 2018, following a six years career as President and CEO of Controp
Precision Technology Ltd., a company specializing in developing, manufacturing and selling electro optical and precision motion control
systems for the global defense and homeland security (HLS) markets. Prior to that, Mr. Sharon served in various positions at Opgal Optronics
Ltd., the last four years as its President and CEO. Mr. Sharon holds an MBA degree from Derby University, United Kingdom and a B.Sc. degree
in Mechanical Engineering (Dean’s award of excellence) from the Technion -Israel Institute of Technology, Haifa, Israel. In January
2023, Mr. Sharon notified the Company of his intention to retire from the position as Chief Executive Officer in the next few months.
Tomer
Hay has served as Chief Financial Officer since July 2021. Mr. Hay joined the Company in 2012 as Corporate Controller and progressed
to the position of VP Finance before his appointment as CFO. As VP Finance, Mr. Hay was responsible for the Company’s financial
reporting, analysis, controls and tax matters. In addition, he was actively involved in strategic processes, including M&A and restructuring.
Prior to joining the Company, Mr. Hay had a successful career within the high-tech sector at Ernst and Young Israel, ending as Senior
Audit Manager. Mr. Hay brings over 18 years of professional experience and knowledge of financial management of NASDAQ-listed companies
engaged in the tech sector. Mr. Hay is a certified public accountant in Israel and holds a B.A. degree in Accounting and Economics from
Tel-Aviv University.
Fabien
Haubert joined our company in February 2018 as Vice President Sales – EMEA Region, based in Paris, France. Mr. Haubert’s
most recent experience (February 2014 – February 2018) was with UK based CCTV solution provider Indigo Vision located in Edinburgh
where he was Regional Director – EMEA South. Previous to his four years at Indigo he worked with several companies in the VMS, IP
CCTV, intrusion, access control and integration areas since 2002. He has extensive experience in sales management with past responsibility
for the EMEA region. Mr. Haubert has a technical background with a Master of Science degree in Electronics Engineering (Ecole Supérieure
d’Ingénieurs en Electrontechnique et Electronique) as well as a Master of Strategy and Engineering of International business
(Ecole Supérieure des Sciences Economiques et Commerciales). He speaks French, English, Spanish, and Italian and has a working knowledge
of Dutch.
The
terms of office of Messrs. Beck, Berman and Bigger will expire at our 2023 annual general meeting of shareholders. The terms of our external
directors, Mr. Tsabari and Ms. Steklov, expire at our 2023 and 2025 annual general meetings, respectively.
Compensation of Directors and Executive Officers
The
aggregate compensation costs on behalf of our directors and executive officers as a group during 2022 (including executive officer which
does not longer serves as executive officer) consisted of approximately $1.6 million in salary, fees, bonus, equity based compensation,
commissions and directors’ fees, but excluding dues for professional and business associations, business travel and other expenses
commonly reimbursed or paid by companies. As of December 31, 2022, the aggregate amount set aside or accrued for pension, retirement and
vacation or similar benefits for our directors and executive officers was approximately $0.1 million. In addition, we provide automobiles
to our executive officers at our expense.
We
pay our directors an annual fee of NIS 90,000 (approximately $25,600) and a fee of NIS 4,000 (approximately $1,150) for each board or
committee meeting that they attend. Such amounts are linked to the Israeli consumer price index, or CPI, and are updated on a semi-annual
basis and accordingly, are adjusted to reflect changes in the CPI in February and August, each year. In addition, we pay to our Executive
Chairman a monthly payment of NIS 15,000 (approximately $4,250). Our executive Chairman is also entitled to a director fees paid to all
of our directors as described above. In addition, Mr. Beck is entitled to annual cash bonus of $30,000 payable in the event our net profit
pursuant to our annual audited and consolidated financial statement exceeds $5,000,000.
As
of December 31, 2022, our directors and executive officers as a group, then consisting of 9 persons, held options to purchase an aggregate
of 510,000 ordinary shares, having exercise prices ranging from $1.9 to $3.28 and expiration dates ranging from 2023 to 2028. Generally,
the options vest over a two to four year period. See this Item 6E. “Directors, Senior Management and Employees – Share Ownership
– Stock Option Plans.”
Compensation of Senior Office Holders –
Israel Companies Law Disclosure
The
table below sets forth the compensation paid to our five most highly compensated senior office holders (as defined in the Israeli Companies
Law) during the year ended December 31, 2022 (which include one former senior officer), in the disclosure format of Regulation 21 of the
Israeli Securities Regulations (Periodic and Immediate Reports), 1970. We refer to the five individuals for whom disclosure is provided
herein as our “Covered Executives.”
Information Regarding
the Covered Executive(1) (dollars in thousands) |
Name
and Principal Position(2) |
Base Salary |
Benefits
and Perquisites(3) |
Variable
Compensation(4) |
Equity-Based
Compensation(5) |
Total |
Dror Sharon – Chief Executive Officer |
333 |
155 |
43 |
31 |
562 |
Fabien Haubert –Vice President & Managing Director of Senstar - Head of the Product Division
|
194 |
43 |
25 |
25 |
287 |
Tomer Hay – Chief Financial Officer |
144 |
62 |
18 |
19 |
243 |
Doron Kerbel – Former Vice President General Counsel and Company Secretary |
147 |
66 |
- |
14 |
227 |
Jeremy Weese –Vice President & Managing Director of Senstar - Head of the Product Division
|
172 |
21 |
22 |
3 |
218 |
(1) |
All amounts reported in the table are in terms of cost to our company, as recorded in our financial statements.
|
(2) |
All current Covered Executives listed in the table are full-time employees. Cash
compensation amounts denominated in currencies other than the U.S. dollar were converted into U.S. dollars at the average conversion rate
for the year ended December 31, 2022. |
(3) |
Amounts reported in this column include benefits and perquisites or on account of such benefits and perquisites,
including those mandated by applicable law. Such benefits and perquisites may
include, to the extent applicable to each executive, payments, contributions and/or
allocations for savings funds, pension, severance, vacation, car or car allowance, medical insurances and benefits, risk insurances (e.g.,
life, disability, accident), convalescence pay, payments for social security, tax gross-up payments and other benefits and perquisites
consistent with our guidelines. |
(4) |
Amounts reported in this column refer to Variable Compensation such as commission, incentive and bonus
payments as recorded in our financial statements for the year ended December 31, 2022. |
(5) |
Amounts reported in this column represent the expense recorded in our financial statements for the year
ended December 31, 2022. |
Pursuant
to the Israeli Companies Law, we have adopted a compensation policy and are required to follow certain approval requirements with respect
to the compensation of our directors and executive officers. See below “Board of Directors – Compensation Committee”
and Item 10. Additional Information –– Office Holders.
We
follow Israeli law and practice instead of the requirements of the NASDAQ Stock Market Rules regarding the compensation of our chief executive
office and other executive officers. See Item 16G. “Corporate Governance.”
C. |
Board Practices Introduction |
According
to the Israeli Companies Law and our articles of association, the management of our business is vested in our board of directors. The
board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders. Our executive
officers are responsible for our day-to-day management. The executive officers have individual responsibilities established by our chief
executive officer and board of directors. Executive officers are appointed by and serve at the discretion of the board of directors, subject
to any applicable agreements.
Election of Directors
Our
articles of association provide for a board of directors of not less than three and not more than 11 members, as may be determined from
time to time at our annual general meeting. Our board of directors is currently composed of five (5) directors.
Our
directors (except the external directors, as detailed below), are elected by our shareholders at our annual general meeting and hold office
until the next annual general meeting. All the members of our board of directors (except the external directors), may be reelected upon
completion of their term of office. Our annual general meetings of shareholders are held at least once every calendar year, but not more
than 15 months after the last preceding annual general meeting. In the intervals between our annual general meetings of shareholders,
the board of directors may from time to time appoint a new director to fill a casual vacancy or to add to their number, and any director
so appointed will remain in office until our next annual general meeting of shareholders and may be re-elected.
Under
the Israeli Companies Law, our board of directors is required to determine the minimum number of directors who must have “accounting
and financial expertise,” as such term is defined in regulations promulgated under the Israeli Companies Law. Our board of directors
has determined that at least one director must have “accounting and financial expertise.” Our board of directors has further
determined that Ms. Limor Steklov has the requisite “accounting and financial expertise.”
We
do not follow the requirements of the NASDAQ Stock Market Rules regarding the nomination process of directors, and instead, we follow
Israeli law and practice, in accordance with which our directors are recommended by our board of directors for election by our shareholders.
See Item 16G. “Corporate Governance.”
External and Independent Directors
External
directors. The Israeli Companies Law requires Israeli companies with shares that have been offered to the public in or outside
of Israel to appoint at least two external directors. The Israeli Companies Law provides that a person may not be appointed as an external
director if the person, or the person’s relative, partner, employer or an entity under that person’s control, has or had during
the two years preceding the date of appointment any affiliation with the company, or any entity controlling, controlled by or under common
control with the company. The term “relative” means a spouse, sibling, parent, grandparent, child or child of spouse or spouse
of any of the above as well as a sibling, brother, sister or parent of the foregoing relatives. In general, the term “affiliation”
includes an employment relationship, a business or professional relationship maintained on a regular basis, control and service as an
office holder. Furthermore, if the company does not have a controlling shareholder or a shareholder holding at least 25% of the voting
rights, “affiliation” also includes a relationship, at the time of the appointment, with the chairman of the board, the chief
executive officer, a substantial shareholder or the most senior financial officer of such company. Regulations promulgated under the Israeli
Companies Law include certain additional relationships that would not be deemed an “affiliation” with a company for the purpose
of service as an external director. In addition, no person may serve as an external director if the person’s position or other activities
create or may create a conflict of interest with the person’s responsibilities as director or may otherwise interfere with the person’s
ability to serve as director or if such person is an employee of the Israel Securities Authority or of an Israeli stock exchange. If,
at the time an external director is appointed, all current members of the board of directors are of the same gender, then that external
director must be of the other gender. A director of one company may not be appointed as an external director of another company if a director
of the other company is acting as an external director of the first company at such time.
At
least one of the elected external directors must have “accounting and financial expertise” and any other external director
must have “accounting and financial expertise” or “professional qualification,” as such terms are defined by regulations
promulgated under the Israeli Companies Law.
The
external directors are elected by shareholders at a general meeting. The shareholders voting in favor of their election must include at
least a majority of the shares voted by shareholders other than controlling shareholders or shareholders who have a personal interest
in the election of the external director (unless such personal interest is not related to such persons relationship with the controlling
shareholder) present and voting at such meeting (excluding abstentions). This majority requirement will not be required if the total number
of shares of such non-controlling shareholders and disinterested shareholders who vote against the election of the external director represent
2% or less of the voting rights in the company.
In
general, under the Israeli Companies Law, external directors serve for a three-year term and may be reelected to two (2) additional three-year
terms. However, Israeli companies listed on certain stock exchanges outside Israel, including The NASDAQ Global Market, such as our company,
may appoint an external director for additional terms of not more than three years subject to certain conditions. Such conditions include
the determination by the audit committee and board of directors, that in view of the director’s professional expertise and special
contribution to the company’s board of directors and its committees, the appointment of the external director for an additional
term is in the best interest of the company. External directors can be removed from office only by the same special percentage of shareholders
that can elect them, or by a court order, and then only if the external directors cease to meet the statutory qualifications with respect
to their appointment or if they violate their fiduciary duty to the company.
Pursuant
to the Israeli Companies Law, external directors up for re-election are nominated either by the board of directors or by any shareholder(s)
holding at least 1% of the voting rights in the company. If the board of directors proposed the nominee, the reelection must be approved
by the shareholders in the same manner required to appoint external directors for an initial term, as described above. If such reelection
is proposed by shareholders, such reelection requires the approval of the majority of the shareholders voting on the matter, and satisfaction
of all of the following requirements: (i) In calculating the majority votes, the votes of the controlling shareholders and other shareholders
that have personal interest in such reelection (unless such personal interest is not related to such persons relationship with the controlling
shareholder) as well as abstentions are not included; (ii) the votes of the non-controlling shareholders in favor of the reelection and
of the shareholders who do not have personal interest in the reelection (unless such personal interest is not related to such person’s
relationship with the controlling shareholder) is greater than 2% of the voting rights in the company; and (iii) the external director
is not, at the time of such reelection, a related shareholder or competitor or a relative thereof and does not have any affiliation to
any related shareholder, competitor or any relative thereof during the two years prior to such re-election. A related shareholder or a
competitor are defined as the shareholder proposing the reelection, any substantial shareholder (within the meaning of the Israeli Companies
Law) if at the time of reelection either such shareholder, its controlling shareholder or any company controlled by either of them has
business relations with the company or that either such shareholder, its controlling shareholder or a company controlled by either of
them is a competitor of the company.
Each
committee of the board of directors that is authorized to exercise powers vested in the board of directors must include at least one external
director and the audit committee must include all the external directors. An external director is entitled to compensation as provided
in regulations adopted under the Israeli Companies Law and is otherwise prohibited from receiving any other compensation, directly or
indirectly, in connection with such service.
Ms.
Steklov and Mr. Tsabari serve as our external directors under the Israeli Companies Law. Ms. Steklov’s first term will expire in
2025 and Mr. Tsabari’s third term will expire in 2023.
Independent
Directors. Pursuant to the Israeli Companies Law, a director may be qualified as an independent director if such director is either
(i) an external director; or (ii) or a director who is appointed or classified as such, and who meets the qualifications of an external
director (other than the professional qualifications/accounting and financial expertise requirement), who the audit committee has confirmed
meets the external director qualifications, and who has not served as a director for more than nine consecutive years (with any period
of up to two years during which such person does not serve as a director not being viewed as interrupting a nine-year period).
In
general, NASDAQ Stock Market Rules require that the board of directors of a NASDAQ-listed company has a majority of independent directors
and that its audit committee has at least three members and be comprised only of independent directors, each of whom satisfies the “independence”
requirements of NASDAQ and the SEC. However, foreign private issuers, such as our company, may follow certain home country corporate governance
practices instead of certain requirements of the NASDAQ Stock Market Rules. On June 30, 2006, we provided NASDAQ with a notice that instead
of maintaining a majority of independent directors, we follow Israeli law, under which we are required to appoint at least two external
directors, within the meaning of the Israeli Companies Law, to our board of directors. In addition, in accordance with the rules of the
SEC and NASDAQ, our audit committee is composed of three independent directors, as defined in the rules of the SEC and NASDAQ. At present
the majority of our directors satisfy the independence requirements of NASDAQ and the SEC.
Our
board of directors has determined that our external directors, Ms. Steklov and Mr. Tsabari, qualify as independent directors under the
requirements of the SEC and NASDAQ. Our board of directors has further determined that Messrs. Bigger and Berman also qualify as independent
directors under the requirements of the SEC and NASDAQ.
Audit Committee under Israeli Law
Under
the Israeli Companies Law, the board of directors of any public company must establish an audit committee, or the Israeli Audit Committee.
The Israeli Audit Committee must consist of at least three directors and must include all of the external directors, the majority of which
must be independent directors. The Israeli Audit Committee may not include the chairman of the board of directors; any director employed
by the company or providing services to the company on an ongoing basis (other than as a director); a controlling shareholder or any of
the controlling shareholder’s relatives; and any director who is employed by, or rendered services to, the controlling shareholder
or an entity controlled by the controlling shareholder, or a director whose main livelihood is from the controlling shareholder. Any person
who is not permitted to be a member of the Israeli Audit Committee may not be present in the meetings of the Israeli Audit Committee unless
the chairman of the Israeli Audit Committee determines that such person’s presence is necessary in order to present a specific matter.
However, an employee who is not a controlling shareholder or relative of a controlling shareholder may participate in the audit committee’s
discussions but not in any vote, and at the request of the Israeli Audit Committee, the secretary of the company and its legal counsel
may be present during the meeting. The chairman of the Israeli Audit Committee must be an external director.
The
role of the Israeli Audit Committee, pursuant to the Israeli Companies Law, includes:
|
• |
monitoring deficiencies in the management of the company, including in consultation with the independent auditors or the internal
auditor, and to advise the board of directors on how to correct such deficiencies. If the audit committee finds a material deficiency,
it will hold at least one meeting regarding such material deficiency, with the presence of the internal auditor or the independent auditors
but without the presence of the senior management of the company. However, a member of the company’s senior management can participate
in the meeting in order to present an issue which is under his or her responsibility; |
|
• |
determining, on the basis of detailed arguments, whether to classify certain engagements or transactions as material or extraordinary,
as applicable, and therefore as requiring special approval under the Israeli Companies Law. The audit committee may make such determination
according to principles and guidelines predetermined on an annual basis; |
|
• |
determining if transactions (excluding extraordinary transactions) with a controlling shareholder, or in which a controlling shareholder
has a personal interest, are required to be rendered pursuant to a competitive procedure; |
|
• |
deciding whether to approve engagements or transactions that require the Israeli Audit Committee approval under the Israeli Companies
Law; |
|
• |
determining the approval procedure of non-extraordinary transactions, following classification as such by the Israeli Audit Committee,
including whether such specific non-extraordinary transactions require the approval of the Israeli Audit Committee; |
|
• |
examining and approving the annual and periodical working plan of the internal auditor; |
|
• |
overseeing the company’s internal auditing and the performance of the internal auditor; confirm that the internal auditor has
sufficient tools and resources at his disposal, considering, among other matters, the special requirements of the company and its size;
|
|
• |
examining the scope of work of the independent auditor and its pay, and bringing such recommendations on these issue before the Board;
|
|
• |
determining the procedure of addressing complaints of employees regarding shortcomings in the management of the company and ensure
the protection of employees who have filed such complaints; |
|
• |
determining with respect to transactions with the controlling shareholder or in which such controlling shareholder has personal interest,
whether such transactions are extraordinary or not, an obligation to conduct competitive process under supervisions of the audit committee
or determination that prior to entering into such transactions the company shall conduct other process as the audit committee may deem
fit, all taking into account the type of the company; and |
|
• |
determining the manner of approval of transactions with the controlling shareholder or in which it has personal interest which (i)
are not negligible transactions (pursuant to the committee’s determination) and (ii) are not qualified by the Israeli Audit Committee
as extraordinary transactions. |
Our
Israeli Audit Committee is currently composed of Ms. Steklov and Messrs. Bigger and Tsabari. Both Ms. Steklov and Mr. Tsabari satisfy
the “independence” requirements of the Israeli Companies Law. Our board of directors has determined that Ms. Steklov has the
requisite accounting and financial expertise to serve as our audit committee financial expert. Ms. Steklov also serves as the chairperson
of our Israeli Audit Committee. The Israeli Audit Committee meets at least once each quarter.
Audit Committee under U.S. Laws and Regulations
The
NASDAQ Stock Market Rules require us to establish an audit committee consisting of at least three members, each of whom must be financially
literate and satisfy the respective ‘‘independence’’ requirements of the SEC and NASDAQ and one of whom has accounting
or related financial management expertise. Such audit committee is established for the primary purpose of assisting the Board in overseeing
the:
|
• |
integrity of the Company’s financial statements; |
|
• |
independent auditor’s qualifications, independence and performance; |
|
• |
Company’s financial reporting processes and accounting policies; performance of the Company’s internal audit function;
and |
|
• |
Company’s compliance with legal and regulatory requirements. |
Ms.
Steklov and Messrs. Bigger and Tsabari satisfy the respective “independence” requirements of the SEC and NASDAQ. Our board
of directors has determined that Ms. Steklov has the requisite accounting and financial expertise to serve as our Audit Committee financial
expert and that both Mr. Bigger and Mr. Tsabari are financially literate, having a basic understanding of financial controls and reporting.
The U.S. Audit Committee meets at least once each quarter. Mr. Bigger serves as chairperson of our U.S. Audit Committee for purposes of
compliance with U.S. law and regulations.
Compensation Committee
Pursuant
to the Israeli Companies Law, each publicly traded company is required to establish a compensation committee which must be comprised of
at least three directors, including all of the external directors. The additional members of the compensation committee must be directors
that receive compensation in accordance with the provisions and limitations set forth in the regulations promulgated under the Israeli
Companies Law with respect to external directors. An external director shall serve as the chairman of the compensation committee. Under
the Israeli Companies Law, the external directors shall constitute a majority of the compensation committee. Similar to the rules that
apply to the audit committee, the compensation committee may not include the chairman of the board, or any director employed by us, by
a controlling shareholder or by any entity controlled by a controlling shareholder, or any director providing services to us, to a controlling
shareholder or to any entity controlled by a controlling shareholder on a regular basis, or any director whose primary income is dependent
on a controlling shareholder, and may not include a controlling shareholder or any of its relatives. Individuals who are not permitted
to be compensation committee members may not participate in the committee’s meetings other than to present a particular issue; provided,
however, that an employee that is not a controlling shareholder or relative may participate in the committee’s discussions but not
in any vote, and the company’s legal counsel and corporate secretary may participate in the committee’s discussions and votes
if requested by the committee.
The
compensation committee is responsible for (i) recommending the compensation policy to the board of directors for its approval (and subsequent
approval by shareholders) and (ii) duties related to the compensation policy and to the approval of the terms of engagement of office
holders, including: recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater
than three (3) years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any
case occur every three years), recommending to the board of directors periodic updates to the compensation policy, assessing implementation
of the compensation policy; determining whether the compensation terms of a proposed new Chief Executive Officer of the company need not
be brought to approval of the shareholders; and determining whether to approve transactions concerning the terms of engagement and employment
of the company’s officers and directors that require compensation committee approval under the Israeli Companies Law or the company’s
compensation plans and policies.
Our
compensation committee is currently composed of Ms. Steklov and Messrs. Bigger and Tsabari. Mr. Tsabari serves as the chairperson of our
Compensation Committee. The composition and function of the Compensation Committee comply with the requirements of the Israeli Companies
Law and NASDAQ Stock Market Rules.
Israeli Regulations
In
March 2016, the Israeli Companies Law Regulations were amended to reduce certain duplicative regulatory burden to which Israeli companies
publicly traded on NASDAQ are subject to.
Generally,
pursuant to the new regulations, an Israeli company traded on NASDAQ that does not have a “controlling shareholder” (as defined
in the Israeli Companies Law) will be able to elect not to appoint External Directors to its Board of Directors and not to comply with
the Audit Committee and Compensation Committee composition and chairman requirements of the Israeli Companies Law (as described above
under); provided, the company complies with the applicable NASDAQ independent director requirements and the NASDAQ Audit Committee and
Compensation Committee composition requirements.
Since our largest shareholder,
the limited partnerships managed by FIMI FIVE 2012 Ltd., are deemed to be a “controlling shareholder” under the Israeli Companies
Law, we are not currently eligible to benefit from the relief provided by these new amended Israeli regulations.
Internal Auditor
Under
the Israeli Companies Law, the board of directors of a publicly traded company must appoint an internal auditor nominated by the audit
committee. The role of the internal auditor is to examine whether the company’s actions comply with the law, integrity and orderly
business practice. Under the Israeli Companies Law, the internal auditor may not be an interested party, an office holder, or an affiliate,
or a relative of an interested party, office holder or affiliate, nor may the internal auditor be the company’s independent accountant
or its representative. KPMG serves as our Internal Auditor.
Directors’ Service Contracts
There are no arrangements or understandings
between us and any of our subsidiaries, on the one hand, and any of our directors, on the other hand, providing for benefits upon termination
of their employment or service as directors of our company or any of our subsidiaries.
Chairman of the Board
Under
the Israeli Companies Law, the general manager of a company (or a relative of the general manager) may not serve as the chairman of the
board of directors, and the chairman of the board of directors (or a relative of the chairman of the board of directors) may not serve
as the general manager, unless approved by the shareholders by a special majority vote prescribed by the Israeli Companies Law. The shareholder
vote cannot authorize the appointment for a period of longer than three years, which period may be extended from time to time by the shareholders
with a similar special majority vote. The chairman of the board of directors shall not hold any other position with the company (except
as general manager if approved in accordance with the above procedure) or in any entity controlled by the company, other than as chairman
of the board of directors of a controlled entity, and the company shall not delegate to the chairman duties that, directly or indirectly,
make him or her subordinate to the general manager.
Approval of Related Party Transactions under
Israeli Law
Fiduciary Duties of Office Holders
The
Israeli Companies Law codifies the fiduciary duties that “office holders,” including directors and executive officers, owe
to a company. An “office holder” is defined in the Israeli Companies Law as a director, general manager, chief business manager,
deputy general manager, vice general manager, other manager directly subordinate to the general manager or any other person assuming the
responsibilities of any of the foregoing positions without regard to such person’s title. An office holder’s fiduciary duties
consist of a duty of care and a fiduciary duty. The duty of care requires an office holder to act at a level of care that a reasonable
office holder in the same position would employ under the same circumstances. This includes the duty to utilize reasonable means to obtain
(i) information regarding the appropriateness of a given action brought for his approval or performed by him by virtue of his position
and (ii) all other information of importance pertaining to the foregoing actions. The fiduciary duty includes (i) avoiding any conflict
of interest between the office holder’s position in the company and any other position he holds or his personal affairs, (ii) avoiding
any competition with the company’s business, (iii) avoiding exploiting any business opportunity of the company in order to receive
personal gain for the office holder or others, and (iv) disclosing to the company any information or documents relating to the company’s
affairs that the office holder has received due to his position as an office holder.
Disclosure of Personal Interests of an Office
Holder; Approval of Transactions with Office Holders
The
Israeli Companies Law requires that an office holder promptly, and no later than the first board meeting at which such transaction is
considered, disclose any personal interest that he or she may have and all related material information known to him or her and any documents
in their position, in connection with any existing or proposed transaction by us. In addition, if the transaction is an extraordinary
transaction, that is, a transaction other than in the ordinary course of business, other than on market terms, or likely to have a material
impact on the company’s profitability, assets or liabilities, the office holder must also disclose any personal interest held by
the office holder’s spouse, siblings, parents, grandparents, descendants, spouse’s descendants and the spouses of any of the
foregoing, or by any corporation in which the office holder or a relative is a 5% or greater shareholder, director or general manager
or in which he or she has the right to appoint at least one director or the general manager.
Some
transactions, actions and arrangements involving an office holder (or a third party in which an office holder has an interest) must be
approved by the board of directors or as otherwise provided for in a company’s articles of association, however, a transaction that
is adverse to the company’s interest may not be approved. In some cases, such a transaction must be approved by the audit committee
and by the board of directors itself, and under certain circumstances shareholder approval may also be required. A director who has a
personal interest in a transaction that is considered at a meeting of the board of directors or the audit committee may not be present
during the board of directors or audit committee discussions and may not vote on the transaction, unless the transaction is not an extraordinary
transaction or the majority of the members of the board or the audit committee have a personal interest, as the case may be. In the event
the majority of the members of the board of directors or the audit committee have a personal interest, then the approval of the general
meeting of shareholders is also required.
Approval of a Compensation Policy for Office
Holders
The
Israeli Companies Law and the regulations adopted thereunder require the compensation committee to adopt a policy for director and office
holders. In adopting the compensation policy, the compensation committee must consider factors such as the office holder’s education,
experience, past compensation arrangements with the company, and the proportional difference between the person’s cost of compensation
and the average cost of compensation of the company’s employees.
The
compensation policy must be approved at least once every three years at the company’s general meeting of shareholders, and is subject
to the approval of a majority vote of the votes of the shareholders present and voting at a shareholders’ meeting, provided that
either: (i) such majority includes at least a majority of the votes of all shareholders who are not controlling shareholders and do not
have a personal interest in the approval of the compensation policy, present and voting at such meeting (excluding abstentions); or (ii)
the total number of ordinary shares of non-controlling shareholders and shareholders who do not have a personal interest in the approval
of the compensation policy, voting against the resolution does not exceed 2% of the aggregate voting rights in the company. Our compensation
policy was last approved by the shareholders in November 2020.
The
Board may approve the compensation policy even if such policy was not approved by the shareholders, provided that the compensation committee
and the board of directors resolve, based on detailed consideration of the compensation policy that approval of the policy, is in the
best interest of the company, despite the fact that it was not approved at the shareholders’ meeting.
The
compensation policy serves as the basis for decisions concerning the financial terms of employment or engagement of officer holders, including
exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation
policy must relate to certain factors, including advancement of the company’s objectives, the company’s business and its long-term
strategy, and creation of appropriate incentives for executives. It must also consider, among other things, the company’s risk management,
size and the nature of its operations. The compensation committee must also consider among others, the ratio between the cost of terms
offered to the relevant director or office holder and the average and median cost of compensation of the other employees of the company,
including those employed through manpower companies, the effect of disparities in salary upon work relationships in the company, the possibility
of reducing variable compensation at the discretion of the board of directors; the possibility of setting a limit on the exercise value
of non-cash variable compensation; and as to severance compensation (in excess of those promulgated by applicable labor law), the period
of service of the director or office holder, the terms of his or her compensation during such service period, the company’s performance
during that period of service, the person’s contribution towards the company’s achievement of its goals and the maximization
of its profits, and the circumstances under which the person is leaving the company.
The
compensation policy must also include the link between variable compensation and long-term performance and measurable criteria, the relationship
between variable and fixed compensation, and the upper limit for the value of variable compensation, the conditions under which a director
or an office holder would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation
was based was inaccurate and was required to be restated in the company’s financial statements, the minimum holding or vesting period
for variable, equity-based compensation whilst referring to appropriate a long-term perspective based incentives; and maximum limits for
severance compensation.
Once
a compensation policy is properly adopted, the Israeli Companies Law requires the compensation policy to be approved by the company’s
compensation committee, with subsequent approval of the board of directors. In addition, compensation of the directors and the chief executive
officer is also subject to the approval of the shareholders at a general meeting. The approval of the compensation of the chief executive
officer that complies with the compensation policy is subject to the same majority requirements as the approval of a transaction between
a company and its controlling shareholder. Where the director is also a controlling shareholder, the requirements for approval of transactions
with controlling shareholders apply. The terms of employment of the company’s directors and executive officers must satisfy the
requirements of the compensation policy in respect of matters relating to compensation. Any deviations from the compensation policy in
respect of the compensation of the office holders require the approval of the compensation committee, the board of directors and the shareholders.
If the deviation is with respect to the compensation of the chief executive office then such approval must be made by the majority of
the shareholders provided that such majority includes the majority of the votes of the non-controlling shareholder and other shareholders
who have personal interest in the proposal (unless such personal interest is not related to the controlling shareholder) present and voting
(excluding abstention). Such special majority is not required if the number of votes of the non-controlling shareholders and shareholder
who do not have personal interest in the proposal as previously mentioned is lower than 2% of the aggregate voting rights in the company.
Under
the Israeli Companies Law, all arrangements as to compensation of office holders who are not directors require the approval of the compensation
committee prior, and in addition, to the approval of the board of directors. However, if the Company duly adopts a compensation plan for
its office holders, the approval of the board of directors is not required if the new arrangement only modifies an existing arrangement
and the compensation committee determines that such modification is not material. Generally, the compensation of the CEO must be approved
by the compensation committee, the board of directors and by the majority of the shareholders provided that either: (i) such majority
includes a majority of the total votes of shareholders who are not controlling shareholders and do not have a Personal Interest in the
approval of the compensation policy and who participate in the voting, in person, by proxy or by written ballot, at the meeting (abstentions
not taken into account); or (ii) the total number of votes of shareholders mentioned in (i) above that are voted against the approval
of the compensation policy do not represent more than 2% of the total voting rights in the company. The compensation of office holders
who are directors must be approved by the compensation committee, board of directors and simple majority vote of the shareholders.
External
directors of the company are prohibited from receiving, directly or indirectly, any compensation from the company, other than for their
services as external directors pursuant to the provisions and limitations set forth in regulations promulgated under the Israeli Companies
Law, which compensation is determined prior to their appointment and may not be changed throughout the term of their service as external
directors (except for certain exceptions set forth in such regulations).
Disclosure of Personal Interests of a Controlling
Shareholder; Approval of Transactions with Controlling Shareholders
Pursuant
to the Israeli Companies Law, the disclosure requirements regarding personal interests that apply to directors and executive officers
also apply to a controlling shareholder of a public company. A controlling shareholder is a shareholder who has the ability to direct
the activities of a company, but excludes a shareholder whose power derives solely from its position on the board of directors or any
other position at the company. A person is presumed to be a “controlling shareholder” if it holds or controls, by itself or
together with others, one half or more of any one of the “Means of Control” of the company. “Means of Control”
is defined as any one of the following: (i) the right to vote at a General Meeting of the company, or (ii) the right to appoint directors
of the company or its chief executive officer. For the purpose of related party translations, under the Israeli Companies Law, a controlling
shareholder is also a shareholder who holds 25% or more of the voting rights if no other shareholder who holds more than 50% of the voting
rights. For this purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated. Certain
shareholders also have a duty of fairness toward the company. These shareholders include any controlling shareholder, together with any
shareholder who knows that it has the power to determine the outcome of a shareholder vote and any shareholder who has the power to appoint
or to prevent the appointment of an office holder of the company or exercise any other rights available to it under the company’s
articles of association with respect to the company. The Israeli Companies Law does not define the substance of this duty of fairness,
except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty of
fairness.
An
extraordinary transaction between a public company and a controlling shareholder, or in which a controlling shareholder has a personal
interest, including a private placement in which the controlling shareholder has a personal interest, and the terms of engagement of the
company, directly or indirectly, with a controlling shareholder or a controlling shareholder’s relative (including through a corporation
controlled by a controlling shareholder), regarding the company’s receipt of services from the controlling shareholder, and if such
controlling shareholder is also an office holder of the company, regarding his or her terms of employment, require the approval of a company’s
audit committee (or compensation committee with respect to compensation arrangements), board of directors and shareholders, in that order.
Such transaction must be elected by a majority vote of the Ordinary Shares present and voting at a shareholders’ meeting, provided
that either: (i) such majority includes at least a majority of votes held by all shareholders who do not have a personal interest in such
transaction, present and voting at such meeting (excluding abstentions); or (ii) the total number of votes of shareholders who do not
have a personal interest in such transaction voting against the approval of the transaction, does not exceed 2% of the aggregate voting
rights in the company.
Pursuant
to the Israeli Companies Law, the audit committee of the company should determine in connection with such transaction if it requires rendering
pursuant to a competitive procedure or pursuant to other proceedings. See
“Audit Committee” above.
To
the extent that any such transaction with a controlling shareholder or his relative is for a period extending beyond three years, shareholder
approval is required once every three years, unless, in respect to certain transactions, the audit committee determines that the longer
duration of the transaction is reasonable under the circumstances.
Pursuant
to regulations promulgated pursuant to the Israeli Companies Law, a transaction with a controlling shareholder that would otherwise require
approval of the shareholders is exempt from shareholders’ approval if each of the audit committee and the board of directors determine
that the transaction meets certain criteria that are set out in specific regulations promulgated under the Israeli Companies Law. Under
these regulations, a shareholder holding at least 1% of the issued share capital of the company may require, within 14 days of the publication
of such determination, that despite such determination by the audit committee and the board of directors, such transaction will require
shareholder approval under the same majority requirements that otherwise apply to such transactions.
The
Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a tender offer if as a result
of the acquisition the purchaser would become a 25% or greater shareholder of the company. This rule does not apply if there is already
another 25% or greater shareholder of the company. Similarly, the Israeli Companies Law provides that an acquisition of shares in a public
company must be made by means of a tender offer if as a result of the acquisition the purchaser would hold greater than a 45% interest
in the company, unless there is another shareholder holding more than a 45% interest in the company. These requirements do not apply if,
in general, (i) the acquisition was made in a private placement that received shareholder approval, (ii) was from a 25% or greater shareholder
of the company which resulted in the acquirer becoming a 25% or greater shareholder of the company, if there is not already a 25% or greater
shareholder of the company, or (iii) was from a shareholder holding a 45% interest in the company which resulted in the acquirer becoming
a holder of a 45% interest in the company if there is not already a 45% or greater shareholder of the company.
If,
as a result of an acquisition of shares, the acquirer will hold more than 90% of a public company’s outstanding shares or a class
of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares or a class of shares. If less than
5% of the outstanding shares are not tendered in the tender offer, all the shares that the acquirer offered to purchase will be transferred
to the acquirer. If more than 5% of the outstanding shares are not tendered in the tender offer, then the acquirer may not acquire shares
in the tender offer that will cause his shareholding to exceed 90% of the outstanding shares. The Israeli Companies Law provides for appraisal
rights if any shareholder files a request in court within six months following the consummation of a full tender offer. However, in the
event of a full tender offer, the offeror may determine that any shareholder who accepts the offer will not be entitled to appraisal rights.
Such determination will be effective only if the offeror or the company has timely published all the information that is required to be
published in connection with such full tender offer pursuant to all applicable laws.
Exculpation, Indemnification and Insurance
of Directors and Officers
Exculpation
of Office Holders. The Israeli Companies Law provides that an Israeli company cannot exculpate an office holder from liability
with respect to a breach of his or her fiduciary duty. If permitted by its articles of association, a company may exculpate in advance
an office holder from his or her liability to the company, in whole or in part, with respect to a breach of his or her duty of care. However,
a company may not exculpate in advance a director from his or her liability to the company with respect to a breach of his duty of care
in the event of distributions.
Office
Holders’ Insurance. Israeli law provides that a company may, if permitted by its articles of association, enter into a contract
to insure its office holders for liabilities incurred by the office holder with a respect to an act performed in his or her capacity as
an office holder, as a result of: (i) a breach of the office holder’s duty of care to the company or another person; (ii) a breach
of the office holder’s fiduciary duty to the company, provided that the office holder acted in good faith and had reasonable cause
to assume that the act would not prejudice the company’s interests; and (iii) a financial liability imposed upon the office holder
in favor of another person.
Indemnification
of Office Holders. Under Israeli law a company may, if permitted by its articles of association, indemnify an office holder for
acts performed by the office holder in such capacity for (i) a monetary liability imposed upon the office holder in favor of another person
by any court judgment, including a settlement or an arbitration award approved by a court; (ii) reasonable litigation expenses, including
attorney’s fees, actually incurred by the office holder as a result of an investigation or proceeding instituted against him by
a competent authority, provided that such investigation or proceeding concluded without the filing of an indictment against the office
holder or the imposition of any monetary liability in lieu of criminal proceedings, or concluded without the filing of an indictment against
the office holder and a monetary liability was imposed on him or her in lieu of criminal proceedings with respect to a criminal offense
that does not require proof of criminal intent; and (iii) reasonable litigation expenses, including attorneys’ fees, actually incurred
by the office holder or imposed upon the office holder by a court: in an action, suit or proceeding brought against the office holder
by or on behalf of the company or another person, or in connection with a criminal action in which the office holder was acquitted, or
in connection with a criminal action in which the office holder was convicted of a criminal offence that does not require proof of criminal
intent.
Israeli
law provides that a company’s articles of association may permit the company to (a) indemnify an office holder retroactively, following
a determination to this effect made by the company after the occurrence of the event in respect of which the office holder will be indemnified;
and (b) undertake in advance to indemnify an office holder, except that with respect to a monetary liability imposed on the office holder
by any judgment, settlement or court-approved arbitration award, the undertaking must be limited to types of occurrences, which, in the
opinion of the company’s board of directors, are, at the time of the undertaking, foreseeable due to the company’s activities
and to an amount or standard that the board of directors has determined is reasonable under the circumstances.
Limitations
on Exculpation, Insurance and Indemnification. The Israeli Companies Law provides that neither a provision of the articles of association
permitting the company to enter into a contract to insure the liability of an office holder, nor a provision in the articles of association
or a resolution of the board of directors permitting the indemnification of an office holder, nor a provision in the articles of association
exculpating an office holder from duty to the company shall be valid, where such insurance, indemnification or exculpation relates to
any of the following: (i) a breach by the office holder of his fiduciary duty unless, with respect to insurance coverage or indemnification,
the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company; (ii) a breach
by the office holder of his duty of care if such breach was committed intentionally or recklessly, unless the breach was committed only
negligently; (iii) any act or omission done with the intent to unlawfully yield a personal benefit; or (iv) any fine or forfeiture imposed
on the office holder.
Pursuant
to the Israeli Companies Law, exculpation of, procurement of insurance coverage for, and an undertaking to indemnify or indemnification
of, our office holders must be approved by our audit committee and board of directors and, if the office holder is a director, also by
our shareholders.
Our
articles of association allow us to insure, indemnify and exempt our office holders to the fullest extent permitted by Israeli law. We
maintain a directors’ and officers’ liability insurance policy with a per claim and aggregate coverage limit of $20 million,
including legal costs incurred in Israel. In addition, our audit committee, board of directors and shareholders resolved to indemnify
our office holders, pursuant to a standard indemnification agreement that provides for indemnification of office holders up to an aggregate
amount of 25% the company's equity, according to our latest consolidated financial statements prior to the date that the indemnity was
given. To date, we have provided letters of indemnification to all of our officers and directors.
Board Diversity
While
we do not have a formal policy on diversity, our Board considers diversity to include the skill set, background, reputation, type and
length of business experience of our board members, as well as a particular nominee’s contribution to that mix. Although there are
many other factors, the Board seeks individuals with experience in the defense industry, sales and marketing, legal and accounting skills
and board experience. In accordance with Nasdaq’s Board Diversity Rules, our board-level diversity statistics are published on our
website at https://senstartechnologies.com/about/
We
consider our employees the most valuable asset of our company. We offer competitive compensation and comprehensive benefits to attract
and retain our employees. The remuneration and rewards include retention through share-based compensation and performance-based bonuses.
We
believe that an engaged workforce is key to maintaining our ability to innovate. We have steadily increased our workforce and have been
successful in integrating our new employees and keeping our employees engaged. Investing in our employees’ career growth and development
is an important focus for us. We offer learning opportunities and training programs including workshops, guest speakers and various conferences
to enable our employees to advance in their chosen professional paths.
We
are committed to providing a safe work environment for our employees in compliance with applicable regulations.
As
of December 31, 2022, we employed 158 full-time employees, of whom 23 were employed in general management and administration, 49 were
employed in selling and marketing, 50 were employed in production, customers' support and maintenance and 36 were employed in engineering
and research and development. Of such full-time employees, 99 were located in Canada, 20 were in the United States and 39 were in various
other countries.
As
of December 31, 2021, following the divestiture of our Integrated Solutions (Projects) division, we employed 160 full-time employees,
of whom 24 were employed in general management and administration, 55 were employed in selling and marketing, 46 were employed in production,
customers’ support and maintenance, and 35 were employed in engineering and research and development. Of such full-time employees,
107 were located in Canada, 22 were in the United States and 31 were in various other countries.
As
of December 31, 2020, prior to the divestiture of our Integrated Solutions (Projects) division, we employed 394 full-time employees, of
whom 57 were employed in general management and administration, 77 were employed in selling and marketing, 17 were employed in projects
management, 181 were employed in production, installation and maintenance, and 62 were employed in engineering and research and development.
Of such full-time employees, 157 were located in Israel, 116 were in Canada, 24 were in the United States and 97 were in various other
countries.
We
generally provide our employees with benefits and working conditions beyond the required minimums. Each of our subsidiaries provides a
benefits package and working conditions which we believe are competitive with other companies in their field of operations.
The
following table sets forth certain information regarding the ownership of our ordinary shares by our directors and executive officers
as of April 17, 2023.
Name |
|
Number
of Ordinary Shares Owned (1) |
|
|
Percentage
of Outstanding Ordinary Shares (2) |
|
|
|
|
|
|
|
|
Gillon
Beck (3) |
|
|
- |
|
|
|
- |
|
Jacob Berman |
|
|
13,750 |
|
|
|
* |
|
Avraham Bigger |
|
|
- |
|
|
|
- |
|
Limor Steklov |
|
|
- |
|
|
|
- |
|
Moshe Tsabari |
|
|
- |
|
|
|
- |
|
Dror Sharon (4)
|
|
|
360,000 |
|
|
|
1.5 |
% |
Tomer Hay |
|
|
- |
|
|
|
- |
|
Fabien Haubert (5)
|
|
|
16,000 |
|
|
|
* |
|
All
directors and executive officers as a group (8 persons) (6) |
|
|
389,750 |
|
|
|
1.7 |
% |
(1) |
Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with
respect to securities. Ordinary shares relating to options or convertible debenture notes currently exercisable or exercisable within
60 days of the date of this table are deemed outstanding for computing the percentage of the person holding such securities but are not
deemed outstanding for computing the percentage of any other person. Except as indicated by footnote, the persons named in the table above
have sole voting and investment power with respect to all shares shown as beneficially owned by them. |
(2) |
The percentages shown are based on 23,309,987 ordinary shares issued and outstanding as of April 17, 2023. |
(3) |
Does not include any ordinary shares held by the FIMI Funds. |
(4) |
Includes 360,000 ordinary shares issuable upon the exercise of currently exercisable options. |
(5) |
Includes 16,000 ordinary shares issuable upon the exercise of currently exercisable options. |
(6) |
Includes 376,000 ordinary shares issuable upon the exercise of currently exercisable options. |
Share Option Plans
2010 Israeli Share Option Plan
In
June 2010, we adopted our 2010 Israeli Share Option Plan, or the 2010 Plan. Under the 2010 Plan, stock options to purchase 510,575 ordinary
shares may be granted to our employees, officers, directors and consultants of our company and subsidiaries. In addition, an aggregate
498,384 ordinary shares that remained available for future option grants under the 2003 Plan and any ordinary shares that become available
in the future under the 2003 Plan as a result of expiration, cancellation or relinquishment of any option were rolled over to the 2010
Plan. In June 2013, our shareholders approved an increase to the number of ordinary shares available for issuance under the 2010 Plan
by additional 500,000 shares. The 2010 Plan had an original term of ten years, which was extended in August 2020 for an additional 5 years,
on which date our board of directors had also increased and set the number of ordinary shares available for issuance under the 2010 Plan
to 1,200,000.
The
2010 Plan is designed to allow the grantees to benefit from the tax benefits under Section 102 of the Israeli Income Tax Ordinance [New
Version], 1961. Our Board of Directors has resolved
that all options that will be granted to Israeli residents under the 2010 Plan will be taxable under the “capital gains route.”
Pursuant to this route, the profit realized by an employee is taxed as a capital gain (25%) if the options or underlying shares are held
by a trustee for at least 24 months from their date of the grant or issuance. Any difference between the exercise price of the options
and the average price of the company’s shares during the 30 trading days before the date of grant of the options will be treated
as ordinary income and will be taxed according to the employee’s marginal tax rates plus social contribution. If the underlying
shares are sold before the elapse of such period, the profit is re-characterized as ordinary income. As of December 31, 2022, options
to purchase 552,332 ordinary shares were outstanding under the 2010 Plan, exercisable at an average exercise price of $2.826 per share.
During 2022, no options were awarded under the 2010 Plan. Options to purchase 8,334 ordinary shares were exercised during 2022.
F. |
Disclosure Of A Registrant’s Action To Recover Erroneously Awarded Compensation |
Not
applicable
ITEM 7.
Major Shareholders and Related Party Transactions
The following table sets
forth certain information as of April 17, 2023 regarding the beneficial ownership of our ordinary shares, by each person or entity known
to us to own beneficially 5% or more of our ordinary shares.
Name |
|
Number of Ordinary Shares Beneficially Owned (1) |
|
|
Percentage of Outstanding Ordinary Shares (2) |
|
|
|
|
|
|
|
|
FIMI Opportunity Five (Delaware), Limited Partnership (3)
|
|
|
4,646,924 |
|
|
|
19.9 |
% |
FIMI Israel Opportunity Five, Limited Partnership (3)
|
|
|
5,207,235 |
|
|
|
22.4 |
% |
|
(1) |
Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with
respect to securities. Ordinary shares relating to options or convertible notes currently exercisable or exercisable within 60 days of
the date of this table are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding
for computing the percentage of any other person. Except as indicated by footnote, the persons named in the table above have sole voting
and investment power with respect to all shares shown as beneficially owned by them. |
|
(2) |
The percentages shown are based on 23,309,987 ordinary shares issued and outstanding as of April 17, 2023. |
|
(3) |
Based on Schedule 13D/A filed with the SEC on October 11, 2016 and other information available to us. The address of FIMI Opportunity
Five (Delaware), Limited Partnership and FIMI Israel Opportunity Five, Limited Partnership is c/o FIMI FIVE 2012 Ltd., Electra Tower,
98 Yigal Alon St., Tel-Aviv 6789141, Israel. |
Major Shareholders Voting Rights
The
voting rights of our major shareholders do not differ from the voting rights of other holders of our ordinary shares.
Record Holders
Based
on a review of the information provided to us by our transfer agent, as of April 19, 2023, there were 27 holders of record of our ordinary
shares, of which 23 record holders holding approximately 91.29% of our ordinary shares had registered addresses in the United States.
These numbers are not representative of the number of beneficial holders of our shares nor is it representative of where such beneficial
holders reside since many of these ordinary shares were held of record by brokers or other nominees, including CEDE & Co., the nominee
for the Depositary Trust Company (the central depositary for the U.S. brokerage community), which held approximately 91.27% of our outstanding
ordinary shares as of such date.
B. |
Related Party Transactions. |
None
C. |
Interests of Experts and Counsel. |
Not
applicable.
ITEM 8.
Financial Information
A. |
Consolidated Statements and Other Financial Information. |
Consolidated Financial Statements
See
the consolidated financial statements included under Item 18, “Financial Statements.”
Legal Proceedings
We
are subject to legal proceedings arising in the normal course of business. Based on the advice of our legal counsel, management believes
that these proceedings will not have a material adverse effect on our financial position or results of operations.
In
February 2019, Magal Mexico (our former subsidiary whose shares were sold as part of the Integrated Solutions Division sale) initiated
a dispute procedure with the Mexican tax authorities requesting the recognition of deduction of certain expenses as claimed by the former
Mexican subsidiary in its annual tax filings. In July 2019, the tax authorities denied the former Mexican subsidiary position. On September 11,
2019, Magal Mexico filed a nullity claim (administrative trial) against the resolution of the Mexican Internal Revenue Service (Servicio
de Administración Tributaria) that had requested the former subsidiary to correct its tax situation on virtue that certain invoices
did not produce any legal effect. The claim was admitted and resolved in favor of the former subsidiary, on August 5, 2020. This resolution
was then challenged by the tax authority, through a motion of review before the Collegiate Courts of Circuit; which resolved the appeal
by the tax authority unfavorably to the former Mexican subsidiary, on June 4, 2021. The Collegiate Court had confirmed the legality of
the tax resolution and had directed the lower court to issue a similar resolution which was issued on July 2, 2021, whereby the lower
court had ruled in favor of the Tax Authority.
On
September 21, 2021, the former Mexican subsidiary appealed the resolution by the lower court before the Collegiate Courts of Circuit,
in October 2021, the Collegiate Court admitted the appeal, however, on March 14, 2022, the Court notified the resolution whereby it ruled
in favor of the Tax Authority, deciding to confirm the challenged resolution. On March 25, 2022, the former Mexican subsidiary appealed
the Collegiate Court's decision before the Mexican Supreme Court of Justice. On May 17, 2022, the Mexican Court rejected the former Mexican
subsidiary's annulment claim regarding the Mexican Tax authority’s decision not to allow the deduction of expenses and credit of
VAT in respect of the engagement of Cuceju by the former Mexican subsidiary.
According
to the Purchase Agreement of the Integrated Solutions division dated February 7, 2021, we were financially liable for the outcome of this
dispute and so had to indemnify Aeronautics Ltd. according to the final tax resolution in this matter. Therefore, on July 19, 2022, Aeronautics
Ltd. and Magal Security Systems Ltd. (formerly Onlishel Ltd.) (collectively for this section the "Buyer") and us, agreed that we, reimburse
the Buyer in the amount of $4.3 million (approximately 86,855 thousands Mexican Peso, in accordance with the then USD-Mexican Peso exchange
rate) (the "Tax Payment Amount"), as set forth in the closing protocol dated June 30, 2021 to the Purchase Agreement. The Buyer committed
to pay the Tax Payment Amount to the relevant Mexican tax authorities.
Dividend Distribution Policy
While
we have historically retained our earnings to finance operations and expand our business, on December 7, 2020, we announced a cash distribution
in the amount of US$1.079 per share (approximately US$ 25 million in the aggregate) which was paid on December 28, 2020, and, following
the completion of the sale of Integration Solutions Division and court approval, we announced on August 16, 2021 a cash distribution in
the amount of $1.725 per share (approximately $40 million in the aggregate), which was paid on September 22, 2021. Future dividend distributions
are subject to the discretion of our board of directors and approval of our shareholders and will depend on a number of factors, including
our operating results, future capital resources available for distribution, capital requirements, financial condition, the tax implications
of dividend distributions on our income, future prospects and any other factors our board of directors may deem relevant.
The
distribution of dividends also may be limited by Israeli law, which permits the distribution of dividends only out of profits (as defined
by the Israeli Companies Law) or otherwise upon the permission of the court, and only if the Board of Directors determines that such distribution
will not jeopardize the ability of the company to repay its debts on the due date thereof. “Profits’’ are defined in
the Israeli Companies Law as the balance of surpluses, or the surpluses accumulated over the past two years, whichever is the greater,
in accordance with the latest adjusted financial statements, audited or reviewed, prepared by the company, provided that the date in respect
of which the statements were prepared is no earlier than six months prior to the date of distribution. ‘‘Surplus’’
means sums included in a company’s shareholders’ equity originating from the net profit of the company, as determined according
to generally accepted accounting principles, and sums other than share capital or premiums that are included in shareholders’ equity
under generally accepted accounting principles and that the Minister of Justice has prescribed to be considered surplus.
Since
the date of the annual consolidated financial statements included in this annual report, no significant changes have occurred.
ITEM 9.
The Offer and Listing
A. |
Offer and Listing Details. |
Our
ordinary shares are traded on the NASDAQ Global Market. Our ticker symbol is “SNT.”
Not
applicable.
Our
ordinary shares have traded on the NASDAQ Global Market since our initial public offering in 1993. Since September 30, 2021 our ordinary
shares trade under the symbol “SNT” (previously under the symbol “MAGS”).
Not
applicable.
Not
applicable.
F. |
Expenses of the Issue. |
Not
applicable.
ITEM 10.
Additional Information
Not
applicable.
B. |
Memorandum and Articles of Association. |
Purposes and Objects of the Company
We
are a public company registered with the Israeli Companies Registrar and have been assigned company number 52‑003892‑8. Under
our memorandum of association, we were established for the purposes of acquiring a plant from Israel Aircraft Industries known as the
Magal Plant, which was engaged in the development, manufacture, sale and support of alarm devices and dealing in the development, manufacturing
and support of security alarm devices and other similar products. In addition, the purpose of our Company is to be eligible to perform
and act in connection with any right or obligation of whatever kind or nature permissible under Israeli law.
Board of Directors
The
strategic management of our business (as distinguished from the daily management of our business affairs) is vested in our board of directors,
which may exercise all such powers and do all such acts as our company is authorized to exercise and do, and which are not required to
be exercised by a resolution of the general meeting of our shareholders. The board of directors may, subject to the provisions of the
Israeli Companies Law, delegate some of its powers to committees, each consisting of one or more directors, provided that at least one
member of such committee is an external director.
According
to the Israeli Companies Law, we may stipulate in our articles of association that the general meeting of shareholders is authorized to
assume the responsibilities of the board of directors. In the event the board of directors is unable to act or exercise its powers, the
general meeting of shareholders is authorized to exercise the powers of the board of directors, even if the articles of association do
not stipulate so. Our board of directors has the power to assume the responsibilities of our chief executive officer if he is unable to
act or exercise his powers or if he fails to fulfill the instructions of the board of directors with respect to a specific matter.
Our
articles of association do not impose any mandatory retirement or age limit requirements on our directors and our directors are not required
to own shares in our company in order to qualify to serve as directors.
The
authority of our directors to enter into borrowing arrangements on our behalf is not limited, except in the same manner as any other transaction
by us.
For
a discussion of Israeli law concerning a director’s fiduciary duties and the approval of transactions with office holders, see Item
6.C. “Directors, Senior Management and Employees – Board Practices – Approval of Related Party Transactions under Israeli
Law.”
General Meetings of Shareholders
Under
the Israeli Companies Law, a company must convene an annual meeting of shareholders at least once every calendar year and within 15 months
of the last annual meeting. Depending on the matter to be voted upon, notice of at least 21 days or 35 days prior to the date of the meeting
is required. Our board of directors may, in its discretion, convene additional meetings as “special general meetings.” In
addition, the board must convene a special general meeting upon the demand of two of the directors, 25% of the nominated directors, one
or more shareholders having at least 5% of the outstanding share capital and at least 1% of the voting power in the company, or one or
more shareholders having at least 5% of the voting power in the company.
A
shareholder present, in person or by proxy, at the commencement of a general meeting of shareholders may not seek the cancellation of
any proceedings or resolutions adopted at such general meeting of shareholders on account of any defect in the notice of such meeting
relating to the time or the place thereof. Shareholders who are registered in our register of shareholders at the record date may vote
at the general meeting of shareholders. The record date is set in the resolution to convene the general meeting of shareholders, provided,
however, that such record date must be between 14 to 21 days or, in the event of a vote by ballots, between 28 to 40 days prior the date
the general meeting of shareholders is held.
The
quorum required for a general meeting of shareholders consists of at least two record shareholders, present in person or by proxy, who
hold, in the aggregate, at least one third of the voting power of our outstanding shares. A general meeting of shareholders will be adjourned
for lack of a quorum after half an hour from the time appointed for such meeting to the same day in the following week at the same time
and place or any other time and place as the board of directors designates in a notice to the shareholders. At such reconvened meeting,
if a quorum is not present within half an hour from the time appointed for such meeting, two or more shareholders, present in person or
by proxy, will constitute a quorum. The only business that may be considered at an adjourned general meeting of shareholders is the business
that might have been lawfully considered at the general meeting of shareholders originally convened and the only resolutions that may
be adopted are the resolutions that could have been adopted at the general meeting of shareholders originally convened.
Please
refer to Exhibit 2.5 for Items 10.B.3, B.4, B.6, B.7, B.8, B.9 and B.10.
On
June 30, 2021, we completed the sale of our Integration Solution Division to Aeronautics Ltd., a subsidiary of RAFAEL Advanced Defense
Systems Ltd., in a share and asset purchase agreement for total consideration of $35 million in cash, on a cash-free, debt-free basis.
As part of the acquisition, Aeronautics acquired our facility in Yehud, Israel.
Israeli
law and regulations do not impose any material foreign exchange restrictions on non‑Israeli holders of our ordinary shares.
The
following is a discussion of Israeli and United States tax consequences material to us and to our shareholders. To the extent that the
discussion is based on new tax legislation which has not been subject to judicial or administrative interpretation, the views expressed
in the discussion might not be accepted by the tax authorities in question. The discussion is not intended, and should not be construed,
as legal or professional tax advice and does not exhaust all possible tax considerations.
Holders of our ordinary
shares should consult their own tax advisors as to the United States, Israeli or other tax consequences of the purchase, ownership and
disposition of ordinary shares, including, in particular, the effect of any foreign, state or local taxes.
Israeli Tax Considerations
The
following is a summary of the material Israeli tax laws applicable to us, and some Israeli Government programs benefiting us. This section
also contains a discussion of material Israeli tax consequences concerning the ownership of and disposition of our ordinary shares. This
summary does not discuss all the acts of Israeli tax law that may be relevant to a particular investor in light of his or her personal
investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of this kind of investor
include residents of Israel or traders in securities who are subject to special tax regimes not covered in this discussion. Since some
parts of this discussion are based on new tax legislation that has not yet been subject to judicial or administrative interpretation,
we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion.
The discussion below should not be construed
as legal or professional tax advice and does not cover all possible tax considerations. Potential investors are urged to consult their
own tax advisors as to the Israeli or other tax consequences of the purchase, ownership and disposition of our ordinary shares, including
in particular, the effect of any foreign, state or local taxes.
General Corporate Tax Structure
Generally, Israeli companies
are subject to corporate tax on their taxable income. Since January 2018, the corporate tax rate is 23%. In addition, Israeli companies
are currently subject to regular corporate tax rate on their capital gains.
Israeli Transfer Pricing Regulations
On
November 29, 2006, Income Tax Regulations (Determination of Market Terms), 2006, promulgated under Section 85A of the Israeli Tax Ordinance,
came into effect, or the TP Regs. Section 85A of the Tax Ordinance and the TP Regs generally require that all cross-border transactions
carried out between related parties be conducted on an arm’s length principle basis and will be taxed accordingly. The TP Regs are
not expected to have a material effect on us.
Until
the sale of the Integrated Solution Division on June 30, 2021, we believed that we qualified as a Preferred Enterprise, under Law for
the Encouragement of Capital Investments, 1959 ("the Law") and accordingly were eligible for a reduced corporate tax rate of 16% on our
preferred income, as defined in the Law.
In
addition, any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings as above were subject
to tax at a rate of 20%.
Following
the sale of the Integrated Solution Division, our income is not eligible for Preferred Enterprise benefits and is taxed at the regular
corporate tax rate for Israeli companies at 23%.
Taxation under Inflationary Conditions
In
February 2008, the “Knesset” (Israeli parliament) passed an amendment to the Income Tax (Inflationary Adjustments) Law, 1985,
which limits the scope of the law starting 2008 and thereafter. Since 2008, the results for tax purposes are measured in nominal values,
excluding certain adjustments for changes in the Israeli CPI carried out in the period up to December 31, 2007. Adjustments relating to
capital gains such as for sale of property (betterment) and securities continue to apply until disposal. Since 2008, the amendment to
the law includes, among others, the cancellation of the inflationary additions and deductions and the additional deduction for depreciation
(in respect of depreciable assets purchased after the 2007 tax year).
Capital Gains Tax on Sales of Our Ordinary
Shares by Foreign Holders
Israeli
law generally imposes a capital gains tax on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes,
and on the sale of assets located in Israel, including shares in Israeli companies, by non-residents of Israel, unless a specific exemption
is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The law distinguishes
between real gain and inflationary surplus. The inflationary surplus is a portion of the total capital gain which is equivalent to the
increase of the relevant asset’s purchase price which is attributable to the increase in the CPI or, in certain circumstances, a
foreign currency exchange rate, between the date of purchase and the date of sale. The real gain is the excess of the total capital gain
over the inflationary surplus.
Generally,
as of January 1, 2012, the tax rate applicable to capital gains derived from the sale of shares, whether listed on a stock market or not,
is 25% for Israeli individuals, unless such shareholder claims a deduction for financing expenses in connection with such shares, in which
case the gain will generally be taxed at a rate of 30%. Additionally, if such shareholder is considered a “significant shareholder”
at the time of sale or at any time during the 12-month period preceding such sale, i.e., such shareholder holds directly or indirectly,
including with others, at least 10% of any means of control in the company, the tax rate shall be 30% (in case of Israeli individual shareholders
who acquired shares before January 1, 2012 the rates applicable to the holding period between January 1, 2003 and December 31, 2012 should
be 20% and 25% instead of the abovementioned 25% and 30% respectively. In case of individual shareholders who acquired shares before January
1, 2003, the rates applicable to the holding period until such date shall be based on tax brackets and rates applicable to regular income.
Real capital gain in such cases shall be calculated based on linearity throughout the entire holding period). However, the foregoing tax
rates do not apply to: (i) dealers in securities; and (ii) shareholders who acquired their shares prior to an initial public offering
(that may be subject to a different tax arrangement). Israeli companies are subject to the Corporate Tax rate on capital gains derived
from the sale of listed shares. A surtax of 3% applies on top of the above rates in case of individuals whose taxable income (including
inter-alia income from real capital gain) in the relevant year exceeds a threshold of NIS 647,640 (for 2021 – indexed annually).
The
tax basis of our ordinary shares acquired prior to January 1, 2003 will generally be determined in accordance with the average closing
share price in the three trading days preceding January 1, 2003.
However,
a request may be made to the tax authorities to consider the actual adjusted cost of the shares as the tax basis if it is higher than
such average price.
Non-Israeli
residents are exempt from Israeli capital gains tax on any gains derived from the sale of shares of Israeli companies publicly traded
on a recognized stock exchange or regulated market outside of Israel, provided however that certain conditions are met including, but
not limited to that such capital gains are not derived from a permanent establishment in Israel and such shareholders did not acquire
their shares prior to an initial public offering. However, non-Israeli corporations will not be entitled to such exemption if Israeli
residents (i) have a controlling interest (through any means of control) of more than 25% in such non-Israeli corporation, or (ii) are
the beneficiaries or are entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.
In
some instances, where our shareholders may be liable to Israeli tax on the sale of their ordinary shares, the payment of the consideration
may be subject to the withholding of Israeli tax at the source (generally, withholding tax under Israeli law is not self-assessed by the
payer and reduced or no withholding tax (where relevant) requires pre-approval from the ITA).
Pursuant
to the Convention Between the government of the United States of America and the government of Israel with Respect to Taxes on Income,
as amended, or the U.S.-Israel Tax Treaty, the sale, exchange or disposition of ordinary shares by a person who (i) holds the ordinary
shares as a capital asset, (ii) qualifies as a resident of the United States within the meaning of the U.S.-Israel Tax Treaty, or a Treaty
U.S. Resident, and (iii) is entitled to claim the benefits afforded to such person by the U.S.-Israel Tax Treaty, generally, will not
be subject to the Israeli capital gains tax. Such exemption will not apply if (i) such Treaty U.S. Resident holds, directly or indirectly,
shares representing 10% or more of our voting power during any part of the 12-month period preceding such sale, exchange or disposition,
subject to certain conditions, or (ii) the capital gains from such sale, exchange or disposition can be allocated to a permanent establishment
in Israel. In such case, the sale, exchange or disposition of ordinary shares would be subject to Israeli tax, to the extent applicable;
however, under the U.S.-Israel Tax Treaty, such Treaty U.S. Resident would be permitted to claim a credit for such taxes against the U.S.
federal income tax imposed with respect to such sale, exchange or disposition, subject to the limitations in U.S. laws applicable to foreign
tax credits. The U.S.-Israel Tax Treaty does not relate to U.S. state or local taxes.
Taxation of Dividends paid to Non-Resident
Holders of Shares
Non-residents
of Israel are subject to Israeli income tax on income accrued or derived from sources in Israel. Such sources of income include passive
income such as dividends. On distributions of dividends other than bonus shares or stock dividends, income tax is applicable at the rate
of 25%, or 30% for a shareholder that is considered a “significant shareholder” at the time of receipt of the dividend or
at any time during the 12-month period preceding such, unless a different rate is provided in a treaty between Israel and the shareholder’s
country of residence. However, under the Investments Law, dividends generated by an Approved Enterprise (or Benefited Enterprise) are
taxed at the rate of 15%. A surtax of 3% applies on top of the above rates in case of individuals whose taxable income (including inter-alia
income from dividend) in the relevant year exceeds a threshold of NIS 663,240 (for 2022 – indexed annually).
Under
the U.S.-Israel Tax Treaty, the maximum tax on dividends paid to a holder of ordinary shares who is a Treaty U.S. Resident is 25%. However,
if the income out of which the dividend is paid is not generated by an Approved Enterprise (or Benefited Enterprise), and not more than
25% of our gross income consists of interest or dividends, dividends paid to a U.S. corporation holding at least 10% of our issued voting
power during the part of the tax year which precedes the date of payment of the dividend and during the whole of its prior tax year, are
generally taxed at a rate of 12.5%. Dividends generated by an Approved Enterprise (or Benefited Enterprise) are taxed at the rate of 15%
under the U.S.-Israel Tax Treaty. With respect to the December 2020 and 2021 cash distributions the Company requested the ITA for a ruling
determining whether the said distribution should be treated as a capital reduction or dividend. Note that treaty rates are not automatically
applied under Israeli law and require preapproval from the ITA (by way of a withholding tax reduction certificate) which should be actively
sought by the payee.
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
The
following is a description of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our ordinary
shares. This description addresses only the U.S. federal income tax considerations that are relevant to U.S. Holders (as defined below)
who hold our ordinary shares as capital assets. This summary is based on the U.S. Internal Revenue Code of 1986, as amended, or the Code,
Treasury regulations promulgated thereunder, judicial and administrative interpretations thereof, and the U.S.-Israel Tax Treaty, or the
Treaty, all as in effect on the date hereof and all of which are subject to change either prospectively or retroactively.
There
can be no assurance that the U.S. Internal Revenue Service, or the IRS, will not take a different position concerning the tax consequences
of the acquisition, ownership and disposition of our ordinary shares or that such a position would not be sustained. This description
does not address all tax considerations that may be relevant with respect to an investment in our ordinary shares. In addition, this description
does not account for the specific circumstances of any particular investor, such as:
|
• |
financial institutions; |
|
• |
certain insurance companies; |
|
• |
investors liable for alternative minimum tax; |
|
• |
regulated investment companies, real estate investment trusts, or grantor trusts; |
|
• |
dealers or traders in securities, commodities or currencies; |
|
• |
tax-exempt organizations; |
|
• |
non-resident aliens of the United States or taxpayers whose functional currency is not the U.S. dollar; |
|
• |
persons who hold the ordinary shares through partnerships or other pass-through entities; |
|
• |
persons who acquire their ordinary shares through the exercise or cancellation of employee stock options or otherwise as compensation
for services; |
|
• |
persons (or their direct, indirect or constructive owners) that actually or constructively own 10% or more of our shares by vote
or value; or |
|
• |
investors holding ordinary shares as part of a straddle, appreciated financial position, a hedging transaction or conversion transaction.
|
If
a partnership or an entity treated as a partnership for U.S. federal income tax purposes owns our ordinary shares, the U.S. federal income
tax treatment of a partner in such a partnership will generally depend upon the status of the partner and the activities of the partnership.
A partnership that owns our ordinary shares and the partners in such partnership should consult their tax advisors about the U.S. federal
income tax consequences of holding and disposing of ordinary shares.
This
summary does not address the effect of any U.S. federal taxation (such as estate and gift tax) other than U.S. federal income taxation.
In addition, this summary does not include any discussion of state, local or non-U.S. taxation. You are urged to consult your tax advisors
regarding the non-U.S. and U.S. federal, state and local tax consequences of an investment in ordinary shares.
For
purposes of this summary, as used herein, the term “U.S. Holder” means a person that is eligible for the benefits of the Treaty
and is a beneficial owner of an ordinary share who is, for U.S. federal income tax purposes:
|
• |
an individual who is a citizen or, for U.S. federal income tax purposes, a resident of the United States; |
|
• |
a corporation or other entity taxable as a corporation created or organized in or under the laws of the United States or any political
subdivision thereof; |
|
• |
an estate the income of which is subject to U.S. federal income taxation regardless of its source; or |
|
• |
a trust if such trust has validly elected to be treated as a U.S. person for U.S. federal income tax purposes or if (1) a court within
the United States is able to exercise primary supervision over its administration and (2) one or more U.S. persons have the authority
to control all of the substantial decisions of such trust. |
Unless
otherwise indicated, this discussion assumes that the Company is not, and will not become, a “passive foreign investment company,”
or a PFIC, for U.S. federal income tax purposes. See“—Passive
Foreign Investment Companies” below.
Taxation of Distributions
Subject
to the discussion below under the heading “—Passive
Foreign Investment Companies,” the gross amount of any distributions received with respect to our ordinary shares, including
the amount of any Israeli taxes withheld therefrom, will constitute dividends for U.S. federal income tax purposes to the extent of our
current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. Because we do not expect to maintain
calculations of our earnings and profits under U.S. federal income tax principles, it is expected that the entire amount of any distribution
will generally be reported as dividend income to you. Dividends are included in gross income as ordinary income. Distributions in excess
of our current and accumulated earnings and profits would be treated as a non-taxable return of capital to the extent of your tax basis
in our ordinary shares and any amount in excess of your tax basis will be treated as gain from the sale of ordinary shares. See “—Disposition
of Ordinary Shares” below for a discussion of the taxation of capital gains. Our dividends would not qualify for the dividends-received
deduction generally available to corporations under section 243 of the Code.
Dividends
that we pay in NIS, including the amount of any Israeli taxes withheld therefrom, will be included in your income in a U.S. dollar amount
calculated by reference to the exchange rate in effect on the day such dividends are received, regardless of whether the payment is in
fact converted into U.S. dollars. A U.S. Holder who receives payment in NIS and converts NIS into U.S. dollars at an exchange rate other
than the rate in effect on such day may have a foreign currency exchange gain or loss that would be treated as U.S.-source ordinary income
or loss. U.S. Holders should consult their own tax advisors concerning the U.S. tax consequences of acquiring, holding and disposing of
NIS.
Subject
to complex limitations, some of which vary depending upon the U.S. Holder’s circumstances, any Israeli withholding tax imposed on
dividends paid with respect to our ordinary shares, at a rate not exceeding the applicable rate provided by the Treaty, will be a foreign
income tax eligible for credit against a U.S. Holder’s U.S. federal income tax liability (or, alternatively, for deduction against
income in determining such tax liability). Israeli taxes withheld in excess of the applicable rate allowed by the Treaty (if any) will
not be eligible for credit against a U.S. Holder’s federal income tax liability. The limitation on foreign income taxes eligible
for credit is calculated separately with respect to specific classes of income. Dividends generally will be treated as foreign-source
passive category income or, in the case of certain
U.S. Holders, general
category income for U.S. foreign tax credit purposes. Further, there are special rules for computing the foreign tax credit limitation
of a taxpayer who receives dividends subject to a reduced tax rate (see discussion below). A U.S. Holder may be denied a foreign tax credit
with respect to Israeli income tax withheld from dividends received on our ordinary shares if such U.S. Holder fails to satisfy certain
minimum holding period requirements or to the extent such U.S. Holder’s position in ordinary shares is hedged. An election to deduct
foreign taxes instead of claiming foreign tax credit applies to all foreign taxes paid or accrued in the taxable year. The rules relating
to the determination of the foreign tax credit are complex, and you should consult with your own tax advisors to determine whether and
to what extent you would be entitled to this credit.
Subject
to certain limitations (including the PFIC rules discussed below), “qualified dividend income” received by a non-corporate
U.S. Holder will be subject to tax at the lower long-term capital gain rates (currently a maximum of 20%). Distributions taxable as dividends
paid on our ordinary shares should qualify for a reduced rate provided that either: (i) we are entitled to benefits under the Treaty,
or (ii) our ordinary shares are readily tradable on an established securities market in the United States and certain other requirements
are met. We believe that we are entitled to benefits under the Treaty and that our ordinary shares currently are readily tradable on an
established securities market in the United States (see discussion below). However, no assurance can be given that our ordinary shares
will remain readily tradable. The rate reduction does not apply unless certain holding period requirements are satisfied, nor does it
apply to dividends received from a PFIC (see discussion below), in respect of certain risk-reduction transactions, or in certain other
situations. The legislation enacting the reduced tax rate on qualified dividend income contains special rules for computing the foreign
tax credit limitation of a taxpayer who receives dividends subject to the reduced tax rate. U.S. Holders of our ordinary shares should
consult their own tax advisors regarding the effect of these rules in their particular circumstances.
Sale or Disposition of
Ordinary Shares
Subject
to the discussion of PFIC rules below, if you sell or otherwise dispose of our ordinary shares, you will generally recognize gain or loss
for U.S. federal income tax purposes in an amount equal to the difference between the amount realized on the sale or other disposition
and your adjusted tax basis in our ordinary shares, in each case determined in U.S. dollars. Such gain or loss will generally be capital
gain or loss and will be long-term capital gain or loss if you have held the ordinary shares for more than one year at the time of the
sale or other disposition. Long-term capital gain realized by a non-corporate U.S. Holder is generally eligible for a preferential tax
rate (currently a maximum of 20%). In general, any gain that you recognize on the sale or other disposition of ordinary shares will be
U.S.-source for purposes of the foreign tax credit limitation; losses will generally be allocated against U.S. source income. Deduction
of capital losses is subject to certain limitations under the Code.
In
the case of a cash basis U.S. Holder who receives NIS in connection with the sale or disposition of our ordinary shares, the amount realized
will be based on the U.S. dollar value of the NIS received with respect to the ordinary shares as determined on the settlement date of
such exchange. A cash basis U.S. Holder who receives payment in NIS and converts NIS into U.S. dollars at a conversion rate other than
the rate in effect on the settlement date may have a foreign currency exchange gain or loss, which would be treated as ordinary income
or loss.
An
accrual basis U.S. Holder may elect the same treatment required of cash basis taxpayers with respect to a sale or disposition of our ordinary
shares that are traded on an established securities market, provided that the election is applied consistently from year to year. Such
election may not be changed without the consent of the IRS. In the event that an accrual basis U.S. Holder does not elect to be treated
as a cash basis taxpayer (pursuant to the Treasury regulations applicable to foreign currency transactions), such U.S. Holder may have
a foreign currency gain or loss for U.S. federal income tax purposes because of differences between the U.S. dollar values of the currency
received prevailing on the trade date and the settlement date. Any such currency gain or loss would be treated as U.S.- source ordinary
income or loss and would be in addition to the gain or loss, if any, recognized by such U.S. Holder on the sale or disposition of such
ordinary shares.
Passive Foreign Investment
Companies
Based
on the composition of our income, assets (including the value of our goodwill, going-concern value or any other unbooked intangibles,
which may be determined based on the price of the ordinary shares), and operations, we believe we will not be classified as a “passive
foreign investment company”, or PFIC, for the 2022 taxable year. However, because PFIC status is based on our income, assets and
activities for the entire taxable year, it is not possible to determine whether we will be characterized as a PFIC for our current taxable
year or future taxable years until after the close of the applicable taxable year. Moreover, we must determine our PFIC status annually
based on tests that are factual in nature, and our status in the current year and future years will depend on our income, assets and activities
in each of those years and, as a result, cannot be predicted with certainty as of the date hereof. If we were a PFIC for any taxable year
during which a U.S. Holder owned Ordinary Shares, certain adverse consequences could apply to the U.S. Holder. Specifically, unless a
U.S. Holder makes one of the elections mentioned below, gain recognized by the U.S. Holder on a sale or other disposition of Ordinary
Shares would be allocated ratably over the U.S. Holder’s holding period for the Ordinary Shares. The amounts allocated to the taxable
year of the sale or other disposition and to any year before we became a PFIC would be taxed as ordinary income. The amount allocated
to each other taxable year would be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for
that taxable year, and an interest charge would be imposed on the resulting tax liability. Further, any distribution in excess of 125%
of the average of the annual distributions received by the U.S. Holder on our Ordinary Shares during the preceding three years or the
U.S. Holder’s holding period, whichever is shorter, would be subject to taxation as described immediately above. In addition, if
we were a PFIC for a taxable year in which we pay a dividend or the immediately preceding taxable year, the preferential dividend rates
discussed above with respect to dividends paid to certain non-corporate U.S. Holders would not apply. If we were a PFIC for any taxable
year in which a U.S. Holder owned our shares, the U.S. Holder would generally be required to file annual returns with the IRS on IRS Form
8621.
If
we are treated as a PFIC with respect to you for any taxable year, you will be deemed to own shares in any entities in which we own equity
that are also PFICs (“lower tier PFICs”), and you may be subject to the tax consequences described above with respect to the
shares of such lower tier PFIC you would be deemed to own.
|
i. |
Mark-to-market elections |
If
we are a PFIC for any taxable year during which you hold ordinary shares, then instead of being subject to the tax and interest charge
rules discussed above, you may make an election to include gain on the ordinary shares as ordinary income under a mark-to-market method,
provided that such ordinary shares are “marketable.” The ordinary shares will be marketable if they are “regularly traded”
on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations, such as the New York Stock Exchange (or on
a foreign stock exchange that meets certain conditions). For these purposes, the ordinary shares will be considered regularly traded during
any calendar year during which they are traded, other than in de minimis quantities, on at least 15 days during each calendar quarter.
Any trades that have as their principal purpose meeting this requirement will be disregarded. However, because a mark-to-market election
cannot be made for any lower tier PFICs that we may own, you will generally continue to be subject to the PFIC rules discussed above with
respect to your indirect interest in any investments we own that are treated as an equity interest in a PFIC for U.S. federal income tax
purposes. As a result, it is possible that any mark-to-market election with respect to the ordinary shares will be of limited benefit.
If
you make an effective mark-to-market election, in each year that we are a PFIC, you will include in ordinary income the excess of the
fair market value of your ordinary shares at the end of the year over your adjusted tax basis in the ordinary shares. You will be entitled
to deduct as an ordinary loss in each such year the excess of your adjusted tax basis in the ordinary shares over their fair market value
at the end of the year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election.
If you make an effective mark-to-market election, in each year that we are a PFIC, any gain that you recognize upon the sale or other
disposition of your ordinary shares will be treated as ordinary income and any loss will be treated as ordinary loss, but only to the
extent of the net amount of previously included income as a result of the mark-to-market election.
Your
adjusted tax basis in the ordinary shares will be increased by the amount of any income inclusion and decreased by the amount of any deductions
under the mark-to-market rules discussed above. If you make an effective mark-to-market election, it will be effective for the taxable
year for which the election is made and all subsequent taxable years unless the ordinary shares are no longer regularly traded on a qualified
exchange or the IRS consents to the revocation of the election. You should consult your tax advisor about the availability of the mark-to-market
election, and whether making the election would be advisable in your particular circumstances.
|
ii. |
Qualified electing fund elections |
In
certain circumstances, a U.S. equity holder in a PFIC may avoid the adverse tax and interest charge regime described above by making a
“qualified electing fund” election to include in income its share of the corporation’s income on a current basis. However,
you may make a qualified electing fund election with respect to the ordinary shares only if we agree to furnish you annually with a PFIC
annual information statement as specified in the applicable U.S. Treasury regulations. We do not intend to provide the information necessary
for you to make a qualified electing fund election if we are classified as a PFIC. Therefore, you should assume that you will not receive
such information from us and would therefore be unable to make a qualified electing fund election with respect to any of our ordinary
shares were we to be or become a PFIC.
Additional Tax on Investment
Income
In
addition to the income taxes described above, U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds
will be subject to a 3.8% Medicare contribution tax on net investment income, which includes dividends and capital gains from the sale
or exchange of our Ordinary shares.
Backup Withholding and
Information Reporting
Payments
in respect of our ordinary shares may be subject to information reporting to the IRS and to U.S. backup withholding tax at the rate (currently)
of 24%. Backup withholding will not apply, however, if you (i) are a corporation, or fall within certain exempt categories, and demonstrate
the fact when so required, or (ii) furnish a correct taxpayer identification number and make any other required certification.
Backup
withholding is not an additional tax. Amounts withheld under the backup withholding rules may be credited against a U.S. Holder’s
U.S. tax liability. A U.S. Holder may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the
appropriate claim for refund with the IRS.
U.S.
citizens and individuals taxable as resident aliens of the United States that own “specified foreign financial assets” with
an aggregate value in a taxable year in excess of certain thresholds (as determined under rules in Treasury regulations) and that are
required to file a U.S. federal income tax return generally will be required to file an information report with respect to those assets
with their tax returns. IRS Form 8938 has been issued for that purpose. “Specified foreign financial assets” include any financial
accounts maintained by foreign financial institutions, foreign stocks held directly, and interests in foreign estates, foreign pension
plans or foreign deferred compensation plans. Under those rules, our ordinary shares, whether owned directly or through a financial institution,
estate or pension or deferred compensation plan, would be “specified foreign financial assets.” Under Treasury regulations,
the reporting obligation applies to certain U.S. entities that hold, directly or indirectly, specified foreign financial assets. Penalties
can apply if there is a failure to satisfy this reporting obligation. A U.S. Holder is urged to consult the U.S. Holder’s tax advisor
regarding the reporting obligation.
Any
U.S. Holder who acquires more than $100,000 of our ordinary shares or holds 10% or more in vote or value of our ordinary shares may be
subject to certain additional U.S. information reporting requirements.
The above description is not intended to constitute
a complete analysis of all tax consequences relating to acquisition, ownership and disposition of our ordinary shares. You should consult
your tax advisor concerning the tax consequences of your particular situation.
F. |
Dividends and Paying Agents. |
Not
applicable.
G. |
Statements by Experts. |
Not
applicable.
We
are subject to certain of the reporting requirements of the Securities and Exchange Act of 1934, as amended, or the Exchange Act, as applicable
to “foreign private issuers” as defined in Rule 3b-4 under the Exchange Act. As a foreign private issuer, we are exempt from
certain provisions of the Exchange Act. Accordingly, our proxy solicitations are not subject to the disclosure and procedural requirements
of Regulation 14A under the Exchange Act, and transactions in our equity securities by our officers and directors are exempt from reporting
and the “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required
to file quarterly reports including financial statements. We file with the SEC an annual report on Form 20-F containing financial statements
audited by an independent accounting firm. We also submit to the SEC reports on Form 6-K containing, among other things, press releases
and unaudited financial information. We post our annual report on Form 20-F on our website (www.senstartechnologies.com)
promptly following the filing of our annual report with the SEC. The information on our website is not incorporated by reference into
this annual report.
The
SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the
SEC. The address of that website is www.sec.gov.
We make our reports available on our internet website, free of charge, as soon as reasonably practicable after such material is electronically
filed with the SEC. The documents concerning our company that are referred to in this annual report may also be inspected at our executive
offices in Israel.
I. |
Subsidiary Information. |
Not
applicable.
J. |
Annual Report to Security Holders. |
Not
applicable.
ITEM 11.
Quantitative and Qualitative Disclosures about Market Risk
We
are exposed to a variety of risks, including changes in interest rates and foreign currency fluctuations.
Foreign Currency Exchange Risk
We
sell most of our products in North America, Europe, Latin America and Israel. Our revenues are primarily denominated in U.S. dollars,
Canadian dollars, Euros and NIS, while a portion of our expenses, primarily labor expenses, is incurred in NIS and Canadian Dollars. Additionally,
certain assets, especially trade receivables, as well as part of our liabilities are denominated in NIS and CAD. As a result, fluctuations
in rates of exchange between the U.S. dollar and non-U.S. dollar currencies may affect our operating results and financial condition.
The dollar cost of our operations in Israel may be adversely affected by the appreciation of the NIS against the U.S. dollar. The U.S.
dollar cost of our operations in Canada may be adversely affected by the appreciation of the Canadian dollars against the U.S. dollar.
The U.S. dollar cost of our operations in Mexico may be adversely affected by the appreciation of the Mexican peso against the U.S. dollar.
In addition, the value of our non-U.S. dollar revenues could be adversely affected by the depreciation of the U.S. dollar against such
currencies.
The
U.S. dollar cost of our operations in Canada is influenced by the exchange rate between the U.S. dollar and the CAD. In 2022 the CAD depreciated
against the U.S. dollar by 6.4%. In 2021 and 2020 the CAD appreciated against the U.S. dollar by 0.1% and 2.1%, respectively.
In
2022, foreign currency fluctuations had a positive impact on our results of operations as we recorded foreign exchange gain, net of $0.4
million. In 2021 and 2020, foreign currency fluctuations had a negative impact on our results of operations as we recorded foreign exchange
loss, net of $1 million and $1 million, respectively.
We
cannot assure you that in the future our results of operations may not be materially affected by currency fluctuations.
ITEM 12. Description
of Securities Other Than Equity Securities
Not
applicable.
PART II
ITEM 13. Defaults,
Dividend Arrearages and Delinquencies
Not
applicable.
ITEM 14. Material
Modifications to the Rights of Security Holders and Use of Proceeds
Not
applicable.
ITEM 15.
Controls and Procedures
Disclosure Controls and Procedures
We
maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in its Exchange Act
reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that
such information is accumulated and communicated to our chief executive officer and chief financial officer to allow timely decisions
regarding required disclosure. Our management, including our chief executive officer and chief financial officer, conducted an evaluation
of our disclosure controls and procedures, as defined under Exchange Act Rule 13a-15(e), as of the end of the period covered by this Annual
Report on Form 20-F. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure
controls and procedures were effective.
Management’s Report on Internal Control
over Financial Reporting
Our
management, including our chief executive officer and chief financial officer, is responsible for establishing and maintaining adequate
internal control over financial reporting, as defined under Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial
reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with accounting principles generally accepted in the United States. Internal
control over financial reporting includes those policies and procedures that:
(i) pertain
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets,
(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with appropriate
authorizations; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition
of our assets that could have a material effect on the financial statements.
Our
management assessed the effectiveness of our internal control over financial reporting as of December 31, 2022. In conducting its assessment
of internal control over financial reporting, management based its evaluation on the framework in “Internal Control – Integrated
Framework” (2013) issued by the Committee of Sponsoring Organizations, or the COSO, of the Treadway Commission. Based on that assessment,
our management has concluded that our internal control over financial reporting was effective as of December 31,2022.
Changes in Internal Control over Financial
Reporting
During
the period covered by this Annual Report on Form 20-F, no changes in our internal control over financial reporting have occurred that
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
ITEM 16. [Reserved]
ITEM 16A.
Audit Committee Financial Expert
Our
board of directors has determined that Ms. Limor Steklov, an external and independent director, meets the definition of an audit committee
financial expert, as defined by rules of the SEC. For a brief description of Ms. Steklov’s relevant experience, see Item 6.A. “Directors,
Senior Management and Employees – Directors and Senior Management.”
ITEM 16B. Code
of Ethics
Our
amended and restated code of ethics, which was initially adopted in April 2010 and thereafter amended in 2017 and is reviewed periodically
by the Board, applies to our chief executive officer and all senior financial officers of our company, including our chief financial officer,
chief accounting officer or controller, and persons performing similar functions. The amended and restated code of ethics reflects our
growing emphasis on international operations and better addresses issues related with such activities by providing clear instructions
in connection with commercial international activities. The code of ethics is publicly available on our website at www.senstartechnologies.com.
Written copies are available upon request. If we make any substantive amendment to the code of ethics or grant any waivers, including
any implicit waiver, from a provision of the code of ethics, we will disclose the nature of such amendment or waiver on our website.
ITEM 16C.
Principal Accountant Fees and Services
Independent Public Accountant Fees and Services
The
following table sets forth, for each of the years indicated, the fees billed by our principal independent registered public accounting
firm, Kost Forer Gabbay & Kasierer, a member of Ernst & Young global. All of such fees were pre-approved by our Audit Committee.
|
|
|
|
|
|
|
|
|
|
|
Audit (1) |
|
|
232,000 |
|
|
|
270,000 |
|
Tax (2) |
|
|
56,000 |
|
|
|
43,000 |
|
Other (3) |
|
|
|
|
|
|
|
|
Total |
|
|
292,000 |
|
|
|
317,000 |
|
|
(1) |
Audit fees are for audit services for each of the years shown in the table, including fees associated with the annual audit (including
audit of our internal control over financial reporting), consultations on various accounting issues and audit services provided in connection
with other statutory or regulatory filings. |
|
(2) |
Tax fees are for professional services rendered by our auditors for tax compliance, tax planning and tax advice on actual or contemplated
transactions, tax consulting associated to international taxation, tax assessment deliberation, transfer pricing and withholding tax assessments.
|
|
(3) |
Other fees primarily relate to out of pocket reimbursement of expenses and primarily traveling expenses of our auditors. These fees
also relate to fees associated with the conflict Minerals work plan, due diligence, and the Risk Assessment Service. |
Pre-Approval Policies and Procedures
Our
audit committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by our independent public
accounting firm, Kost Forer Gabbay & Kasierer and their affiliates. Pre-approval of an audit or non-audit service may be given as
a general pre-approval, as part of the audit committee’s approval of the scope of the engagement of our independent auditor, or
on an individual basis. Any proposed services exceeding general pre-approved levels also require specific pre-approval by our audit committee.
The policy prohibits retention of the independent public accountants to perform the prohibited non-audit functions defined in Section
201 of the Sarbanes-Oxley Act or the rules of the SEC, and also requires the audit committee to consider whether proposed services are
compatible with the independence of the public accountants.
ITEM 16D.
Exemptions from the Listing Standards for Audit Committees
Not
applicable.
ITEM 16E. Purchase
of Equity Securities by the Issuer and Affiliated Purchasers
We
did not purchase any ordinary shares of our company nor did an affiliated purchaser purchase any shares of our company on our behalf during
2022.
ITEM 16F. Changes
in Registrant’s Certifying Accountant
None.
Under
NASDAQ Stock Market Rule 5615(a)(3), foreign private issuers, such as our company, are permitted to follow certain home country corporate
governance practices instead of certain provisions of NASDAQ Stock Market Rules. A foreign private issuer that elects to follow a home
country practice instead of any of such NASDAQ requirements must submit to NASDAQ in advance a written statement from an independent counsel
in such issuer’s home country certifying that the issuer’s practices are not prohibited by the home country’s laws.
We currently follow Israeli law and practice
in respect of the following requirements:
|
• |
the requirement regarding the process of nominating directors. Instead, we follow Israeli law and practice in accordance with which
our directors are recommended by our board of directors for election by our shareholders. See Item 6.C. “Directors, Senior Management
and Employees – Board Practices – Election of Directors.” |
|
• |
the requirement regarding the compensation of our chief executive officer and all other executive officers. Instead, we follow Israeli
law and practice in accordance with which our board of directors must approve all compensation arrangements for our chief executive officer
and all compensation arrangements for officers are subject to the chief executive officer’s approval. See Item 6.C. “Directors,
Senior Management and Employees – Compensation.” |
|
• |
the requirement that our independent directors have regularly scheduled meetings at which only independent directors are present.
Under Israeli law, independent directors are not required to hold executive sessions. |
|
• |
the requirement that we maintain a majority of independent directors, as defined under NASDAQ Stock Market Rules. Under Israeli law
and practice we are required to appoint at least two external directors, within the meaning of the Israeli Companies Law, to our board
of directors. |
ITEM 16H. MINE
SAFETY DISCLOSURE
Not applicable.
ITEM 16I. Disclosure
Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
ITEM 16J. Insider
Trading Policies .
Not applicable.
PART III
ITEM 17. Financial
Statements
We have elected to furnish financial statements
and related information specified in Item 18.
ITEM 18. Financial
Statements
The financial statements required by this
item are found at the end of this annual report, beginning on page F-1.
ITEM 19.
Exhibits
|
1.1 |
Memorandum of Association of the Registrant (1) |
|
101.INS |
Inline XBRL Instance Document.* |
|
101.SCH |
Inline XBRL Taxonomy Extension Schema Document.* |
|
101.PRE |
Inline XBRL Taxonomy Presentation Linkbase Document.* |
|
101.CAL |
Inline XBRL Taxonomy Calculation Linkbase Document.* |
|
101.LAB |
Inline XBRL Taxonomy Label Linkbase Document.* |
|
101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document.* |
|
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)* |
|
* |
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or
prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for the purposes of Section
18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections. |
|
(1) |
Filed as an exhibit to our Registration Statement on Form F-1 (File No. 33‑57438), filed with the Securities and Exchange Commission
on January 26, 1993, as amended, and incorporated herein by reference. |
|
(2) |
Filed as an exhibit to our Registration Statement on Form F-1 (No. 33‑57438), filed with the Securities and Exchange Commission
on January 26, 1993, as amended, and incorporated herein by reference, as amended by an amendment filed as an exhibit to our Registration
Statement on Form S-8 (File No. 333-6246), filed with the Commission on January 7, 1997 and incorporated herein by reference, as further
amended by an amendment filed as an exhibit to our Annual Report on Form 20-F for the fiscal year ended December 31, 2000, filed with
the Securities and Exchange Commission on June 29, 2001 and incorporated herein by reference, as further amended by the company’s
shareholders on July 17, 2002, as described under Form 6-K furnished to the SEC on June 19, 2002, as further amended by the company’s
shareholders on August 20, 2008, as described under Form 6-K furnished to the SEC on July 17, 2008, and as further amended by the company’s
shareholders on August 31, 2011, as described under Form 6-K furnished to the SEC on July 27, 2011. |
|
(3) |
Filed as Exhibit 2.1 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2019, and incorporated
herein by reference. |
|
(4) |
Filed as Exhibit 2.3 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2010, and incorporated
herein by reference. |
|
(5) |
Filed as Exhibit 2.4 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2013, and incorporated
herein by reference. |
|
(6) |
Filed as Exhibit 2.5 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2019, and incorporated
herein by reference. |
|
(7) |
Filed as Exhibit A to Exhibit 99.1 to the Registrant’s Proxy Statement on Form 6-K furnished to the Securities and Exchange
Commission on July 15, 2019 and incorporated herein by reference. |
|
(8) |
Filed as Exhibit A to Exhibit 99.1 to the Registrant’s Proxy Statement on Form 6-K furnished to the Securities and Exchange
Commission on July 16, 2021 and incorporated herein by reference. |
|
(9) |
Filed as Exhibit 99.2 to the Registrant’s Report on Form 6-K furnished to the Securities and Exchange Commission on February
8, 2021 and incorporated herein by reference. |
|
(10) |
Filed as Exhibit 8.1 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2021, and incorporated
herein by reference. |
SENSTAR TECHNOLOGIES LTD. (FORMERLY: MAGAL SECURITY SYSTEMS LTD.)
AND ITS SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2022
IN U.S. DOLLARS
INDEX
|
|
|
|
|
F-2 – F-3
|
|
|
|
F-4 – F-5
|
|
|
|
F-6
|
|
|
|
F-7
|
|
|
|
F-8 – F-9
|
|
|
|
F-10 – F-12
|
|
|
|
F-13 – F-47
|
|
|
|
Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A,
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
SENSTAR TECHNOLOGIES LTD.
(Formerly: Magal Security Systems Ltd.)
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Senstar Technologies Ltd. (formerly: Magal Security Systems Ltd.) and its Subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
|
Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A,
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Title
|
|
Goodwill impairment assessment
|
|
|
|
Description of the Matter
|
|
At December 31, 2022, the Company had $10.9 million of goodwill on its consolidated balance sheet. As discussed in Note 2 to the consolidated financial statements, the Company's evaluation of goodwill for impairment involves the comparison of the Company's reporting unit estimated fair value to its carrying amount annually in the fourth quarter of each year or more frequently if a change in circumstances or the occurrence of events indicates that potential impairment exists. During the fourth quarter of 2022, the Company estimated the fair value of its reporting unit using discounted cash flow calculation and performed a quantitative goodwill impairment test.
Auditing the Company's estimated fair value involved a high degree of auditor judgement due to the effort to evaluate management's assumptions and estimates that are subject to risk and uncertainty related to future growth rates, margin projections, and the discount rate.
|
How We
Addressed the Matter in Our Audit
|
|
Our audit procedures included, among others, evaluating management's ability to accurately forecast future sales growth by comparing actual results to management's historical forecasts, evaluating the reasonableness of management's sales and operating profit forecasts by comparing the forecasts to (1) historical sales and operating profit and (2) internal communications to management and the Board of Directors, and evaluating with the assistance of our fair value specialists, the discount rate, including testing the underlying source information and the mathematical accuracy of the calculation, and by developing a range of independent estimates and comparing those to the discount rate selected by management. Additionally, we performed sensitivity analyses of the significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from reasonably expected changes in the significant assumptions.
|
We have served as the Company's auditor since 1984.
Tel-Aviv, Israel
April 20, 2023
|
|
/s/ Kost Forer Gabbay & Kasierer
KOST FORER GABBAY & KASIERER
|
|
A Member of Ernst & Young Global
|